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Zusammenfassung
Die Wechselwirkung von Membranen mit kleinsten Masseteilchen ist ein zentrales Element
in der Pharmakotherapie wie auch in der Interaktion von Viren und Nanopartikeln mit
Zellen. Sie ist gekennzeichnet durch topologische Übergänge wie zum Beispiel die En-
dozytose, den Austritt aus dem Endosom sowie den Eintritt in den Zellkern. Bisherige
Rechenmethoden eigneten sich allerdings nicht für eine umfassende Beschreibung solcher
topologischen Reaktionen. Die vorliegende Arbeit beschreibt und vergleicht die Anwendung
mathematischer und regelbasierter Modellierungsmethoden (Pi-Kalkül) auf Daten über die
Aufnahme und Verteilung von Nanopartikeln, um das Verhalten nanopartikelförmiger Sys-
teme und der zugehörigen zellulären Einsatzorte zu verstehen. Zudem wurde eine formale
Modellierungssprache zur Beschreibung topologischer Übergänge entwickelt. Die von uns
aufgestellten Modelle wurden mit Hilfe von Experimenten an Modellmembransystemen auf
ihre Gültigkeit hin überprüft.
Im zweiten Kapitel wird ein erstes Beispiel für ein nicht-virales Gentransfersystem
vorgestellt, in dem der intrazelluläre Transport von Teilchen zu einer direkt messbaren
exogenen Genexpression führt. Hierzu wurde in Zusammenarbeit mit J.-T. Kuhr aus der
Arbeitsgruppe von Prof. Dr. Erwin Frey ein Hybridmodell aus Differentialgleichungen
und einem stochastischen Modell geschaffen. Dieses Modell wurde dazu verwendet, die Ur-
sache für Schwankungen von Genexpressionsparametern wie der maximalen Anzahl grün
fluoreszierender Proteine (GFP) pro Zelle, der Expressionsrate und des Zeitpunkts des
Expressionsbeginns zu verstehen. Es erfasst nicht nur die Verteilung der Daten, sondern
kann auch dazu verwendet werden, die Anzahl der tatsächlich transkribierten Plasmide
abzuschätzen. Hierbei zeigt sich, dass diese Zahl deutlich kleiner ist als die Anzahl der
ursprünglich durch die Zelle aufgenommenen Plasmide. Der größte Verlust an Vektoren
vor dem Eintritt in den Zellkern kann dabei der unzureichenden Freisetzung aus den En-
dosomen zugeschrieben werden.
Die Vielfalt an kombinatorischen Möglichkeiten, die sich bei einer schrittweisen Beschrei-
bung von Partikelaggregation bis zur Interaktion der Aggregate mit den verschiedenen
Zellkompartimenten ergibt, limitiert die Anwendbarkeit von Differentialgleichungen. Aus
diesem Grund wurde ein regelbasiertes Modelle entwickelt, das die Komplexität des Prob-
lems auf die Anzahl der einzelnen Reaktionsmuster reduziert. Im dritten Kapitel wird
aufgezeigt, inwiefern sich das stochastische Pi-Kalkül, welches eine formale und regel-
basierte Sprache zur Modellierung von nebenläufigen, kommunizierenden Systemen ist, zur
Modellierung biologischer Systeme eignet. Die Semantik des Pi-Kalküls bietet zwar einen
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rudimentären Lösungsansatz für die Darstellung von Zellkompartimenten, jedoch keine op-
timale Beschreibung von komplexen Systemen mit tief verschachtelten Reaktionsräumen.
Aus diesem Grund führen wir zusätzlich einen Formalismus, den sogenannten “projective
brane calculus based on activate, bud and mate as primitive actions (PABM)”, ein. Dieser
Formalismus berücksichtigt bestimmte Regeln bei membrantopologischen Umformungen
sowie die Heterogenität (“patchiness”) der Membran.
Im vierten Kapitel verwenden wir diese Pi-Kalkül Modelle, um die intrazelluläre Ver-
teilung von Goldnanopartikeln zu beschreiben. Die Lokalisierung solcher Nanopartikel in
Zellkompartimenten kann mit Hilfe von Transmissionselektronenmikroskopie (TEM) gut
visualisiert werden. Des Weiteren sind aufgrund von ausführlichen Charakterisierungsstu-
dien über Goldnanopartikel kinetische Daten zu deren Aggregation, Aufnahme, endoso-
malem Austritt sowie Eintritt in den Zellkern entweder bereits vorhanden oder aber le-
icht abzuschätzen. Unsere Ergebnisse und Voraussagen demonstrieren, dass sich das hier
verwendete Kalkül für die Modellierung relativ einfacher Probleme aus dem Bereich der
Interaktion von Zellen mit Partikeln eignet. Im Gegensatz dazu wäre die Modellierung
solcher Wechselwirkungen mit Hilfe von Differentialgleichungen bereits relativ komplex.
Im Anschluss hieran wurde ein Experiment modelliert und durchgeführt, in dem der
topologische Übergang des Austritts aus dem Endosom kontrolliert werden kann. Die
dazugehörigen Ergebnisse sind im fünften Kapitel zusammengefasst: In Zusammenarbeit
mit A. Schmidt aus der Gruppe von Prof. Dr. Thomas Bein wurden lipidbeschichtete,
kolloidal-, mesoporöse Nanopartikel, welche mit Protoporphyrin (PPIX) sowie Atto633-
QSY21 konjugiert sind, verwendet, um zeitliche Verteilungen einzelner Austrittsereignisse
aus Endosomen zu generieren. Die kontrollierte, lichtinduzierte Auflösung von Endosomen
über die Aktivierung von PPIX lieferte überraschenderweise unterschiedliche Profile der
Lysis in Fibroblasten und Karzinomzellen. Außerdem variierten die Verteilungen der Auf-
nahmeraten dieser Nanopartikel. Um den Einfluss jener Faktoren auf Seiten der Zellen wie
auch der Nanopartikel, welche die PPIX-induzierte Lysis beeinflussen, abschätzen zu kön-
nen, wurde das Goldnanopartikelmodell erweitert. Details wie der unterschiedliche PPIX-
Inhalt pro Nanopartikel, die Anzahl von Nanopartikeln je Endosom sowie die Nanopar-
tikelaggregation wurden nun zusätzlich berücksichtigt. Unsere Ergebnisse zeigen, dass die
zellabhängigen Verteilungen des Austritts aus Endosomen hauptsächlich durch die mini-
male Nettoanzahl von PPIX, die für die Auflösung eines Endosoms erforderlich ist, bes-
timmt werden. Dies steht im Einklang mit unseren Daten sowie Voraussagen aus einem
weiteren theoretischen Modell über die AbhŁngigkeit des Zeitpunkts des endosomalen Aus-
tritts von der Größe des Endosoms.
In Kapitel 6 wird schlieğlich ein biologisches Membransystem modelliert, das die meis-
ten Eigenschaften eines idealen Gentransfersystems besitzt: das Virus. Insbesondere mod-
ellierten wir die Dynamik des Beginns des Influenza Hämagglutinin(HA)-vermittelten en-
dosomalen Austritts. In diesem Fall ist der Auslöser des topologischen Übergangs keine
einfache Rate wie im Fall der lichtinduzierten Lysis, sondern die präzise Aggregation und
Konformationsänderung von Membranproteinen. Wir verwenden hier ein PABM Modell,
welches mit dem Modellchecker PRISM simuliert wird und die Unterschritte beim Aufbau
der HA-Fusionspore beschreibt. Die besten Ergebnisse erhält man mit mindestens sechs
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HA Trimeren pro Fusionspore, von denen drei eine Konformationsänderung durchlaufen
müssen, um fusionsfördernd zu werden.
Zusammenfassend lässt sich sagen, dass die vorliegende Arbeit zeigt, wie man unter Ver-
wendung regelbasierter Formalismen Modelle erstellen kann, die topologische Übergänge
explizit beinhalten. Die mit solchen Modellen generierten Daten sowie die Voraussagen,
welche durch sie getroffen werden können, sind von großem Wert für die Verbesserung
künstlicher Gentransfersysteme.
xiv Summary
Summary
The interaction of membrane systems with particulate material, a recurring theme in drug
delivery, and in virus- and nanoparticle (NP)-cell interaction, is characterized by topological
transitions such as endocytosis, endosomal escape, and nuclear entry. However, current
computational methods do not provide a way for handling topological reactions. In this
work, we describe and compare the application of mathematical and rule-based, pi calculus
models to uptake and delivery data in order to understand the behavior of nanoparticulate
material with their corresponding cellular targets. We also developed a formal modeling
language for specifically handling topological transformations. We subsequently designed
and performed experiments on model membrane systems in order to test the validity of
the created models.
In Chapter 2, we show a first example of artificial gene delivery, where the intracellular
transfer of particulate material has a directly measurable outcome in the form of extroge-
nous gene expression. We created hybrid ordinary differential equation (ODE)/two-step
stochastic model, in collaboration with J.-T. Kuhr the group of Prof. Dr. Erwin Frey,
to understand the source of variation in the distributions of gene expression parameters,
such as the maximum GFP per cell, expression rate and expression onset time. The model
not only captures the data distributions, but can also be used to estimate the number of
transcribed plasmids, which was found to be significantly less than the number of plasmids
originally delivered to the cell. Of the processes upstream of nuclear entry, majority of the
vector loss has been attributed to poor endosomal escape.
The application of ODEs, however, is limited by describing these upstream events,
where a step-by-step description of how particles agglomerate and how these interact with
the species in different cell compartments leads to combinatorial explosion. For this rea-
son, we created rule-based models, which reduce complexity to the number of distinct
reaction patterns. In Chapter 3, we show how stochastic pi calculus, a rule-based formal
language for modeling concurrent mobile, communicating systems, can be used for mod-
eling biological systems. Pi calculus semantics, while providing a rudimentary solution
for representing compartments, is still not the best suited for manipulating complex sys-
tems with deeply-nested compartments. For this reason, we also introduced a formalism,
a projective brane calculus based on activate, bud and mate as primitive actions (PABM),
that has specific rules for handling membrane topological transformations, and that takes
membrane patchiness into account.
In Chapter 4, we applied this pi calculus approach to model the intracellular distri-
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bution of gold NPs. We chose gold NPs because these can be imaged using transmission
electron microscopy (TEM) to obtain localization data across cellular compartments. Ad-
ditionally, kinetic data for aggregation, uptake, endosomal escape, and nuclear entry are
either available or easily estimated for gold NPs, owing to its extensive characterization.
Data fits and predictions of NP intracellular distribution at time points used in indepen-
dent gold NP studies demonstrate the adequacy of the calculus for modeling relatively
simple problems of cell-particulate material interactions, which would have otherwise been
already fairly difficult to model with ODEs.
We then created, and subsequently modeled, an experimental system where a topo-
logical transition, endosomal escape, is triggered on demand, results of which are sum-
marized in Chapter 5. Time distributions of individual endosomal escape events were
generated using a protoporphyrin (PPIX)- and Atto633-QSY21-conjugated, lipid-coated
colloidal mesoporous silica (CMS) NP system, in a joint project with A. Schmidt from the
group of Prof. Dr. Thomas Bein. Controlled, light-induced endosomal lysis through PPIX
activation surprisingly yielded different lysis profiles in fibroblast and carcinoma cells, and
also exhibited varying uptake profiles. In order to estimate the contributions of cell- and
NP-related factors that affect PPIX-induced lysis, we extended the previous gold NP model
to include details such as varying PPIX load per NP, NP load per endosome, and NP ag-
gregation. Our results indicate that these cell-dependent endosomal escape profiles are
primarily influenced by the minimum net number of PPIX required to lyse an endosome.
This is consistent with our data, as well as predictions from an independent, theoretical
model of escape time dependence on endosome size variance.
In Chapter 6, we finally model a biological membrane system that exhibits most of
the characteristics the ideal gene delivery system: the virus. In particular, we model the
early fusion dynamics of influenza hemagglutinin (HA)-mediated endosomal escape. In this
case, the trigger of topological change is no longer governed by a simple rate, as the case
was in light-induced rupture, but by the concerted aggregation and conformational change
of membrane proteins. Here, we use a PABM model, simulated using the model checker
PRISM, to create a model that includes individual steps of HA pore unit assembly. The
best fit obtained was for a minimum of six HA trimers that form the fusion pore, of which
three need to undergo a conformational change to become fusogenic. Collectively, this work
shows how models that incorporate topological transitions explicitly can be created using
rule-based formalisms; the type of data that can be obtained from such models; and the
value of the predictions in terms of how these could be used in improving vector design.
Chapter 1
Introduction
1.1 Motivation
The ability to predict and control uptake and intracellular interactions of nanoparticulate
material, which include artificial delivery vectors, nanoparticles (NPs), and viruses them-
selves, is a central theme in gene and drug delivery. To some extent, control is imbued
by adding targeting sequences to artificial vectors and NPs, including cell- and organelle-
specific ligands. The numerous steps and interactants in delivery, however, could easily
result in unexpected vector behavior [1, 2]. Key to understanding these processes is the
creation of quantitative, mechanistic models and experimental model systems, that allow
us to dissect and interpolate between the steps in these processes, explain why certain
behaviors arise, and eventually use these information in vector design. In this thesis, we
focus on the construction of such models and model systems, as well as on the development
of a modeling language that is specifically appropriate for detailing effects of topological
transformations in the cell.
1.2 State-of-the art
Vector design currently entails an extensive evaluation of physico-chemical properties, as
well as biological barriers that may affect vector performance [3]. Computer-aided vector
design has been mostly used for predicting the so-called ADME parameters (adsorption,
distribution, metabolism and excretion). On the design side, the quantitative structure-
activity relationship (QSAR) approach, a multivariate regression model that attempts to
link the molecular structure of compounds to its biological activity, is currently being
adapted to NP activity and toxicity assessment. In particular, a focus is given on evalu-
ating which existing data are appropriate for “nano-QSARs”, and which physico-chemical
properties, or descriptors, have to be specifically obtained for NPs [4]. Previously used
in applications ranging from drug discovery to chemical risk management, it is currently
being adapted to identify key physical parameters of an NP, including surface parameters,
geometry, size and composition, that can be used as predictors of its performance and
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cytotoxicity [5]. Currently, nano-QSAR studies account for most of the modeling done
in NP-related research. It has been used to predict the uptake [6] and toxicity [5, 7] of
different types of metal oxide particles based on twelve structural descriptors, including
area and volume parameters [6, 5], as well as detachment enthalpies of metal and gaseous
cations from the NP [5]; QSARs have also been adapted to specifically predict the be-
havior of compounds with the lipid bilayer, and has been used in identifying factors that
may influence carbon nanotube toxicity [8]. However, it is speculated that there will be
no generalized, one-nano-QSAR-fits-all solution due to the extremely high variability of
molecular structure, which presumably also translates to a similarly wide variety of action
mechanisms; instead, it is surmised that different QSARs will be applied to different classes
of NPs [4].
Statistical analysis has also been used to characterize the delivery of both protein-
targeted and unmodified NPs; the uptake events in both cases were characterized by a
broadly-spread Poisson distribution whose variance is greater than its mean. Such a dis-
tribution is consistent with heterogenous adsorption and internalization, i.e. uptake events
are random [9]. The fates of NPs following cell division were also demonstrated to be
both random and asymmetric; the asymmetry might be due to endosome association with
microtubules [10, 9], in turn thought to arise from an evolved, protective mechanism of
asymmetric partitioning of damaged proteins [11, 12, 9]. The implications of the study on
dosing and delivery are very important: given that number of NPs per endosome is ran-
dom, and that intrinsic cell-to-cell variability provides an additional layer of randomness
to the delivery process, maximizing the number of dose units per cell is crucial – in this
case, defined by the endosome; with the number of endosomes, which effectively limits the
number of delivery trials, at around 102 per cell, the minimum dose variation that can be
achieved is approximately 10%. Direct cytosolic delivery, however, has been reported to
result in the internalization of up to 106 molecules, resulting in a variation of around 0.1%
[13, 9]. Consequently, the latter mode of delivery is more desirable, if precise dosing is
required [9].
Statistical models by themselves, however, do not the explain the mechanism behind a
predicted outcome. This is where mechanical models, frequently in the form of ordinary
differential equation (ODE) models, have been used. For instance, a combination of QSAR
and molecular dynamics simulation was used for elucidating the most likely structural and
dynamic contributors to carbon nanotube cellular toxicity [8]. Several ODE and thermo-
dynamic models have also been constructed to understand how NP design, particularly,
NP size and ligand density, affect cellular uptake [14, 15, 16], which have predicted optimal
size and ligand density ranges for NPs. There have also been ODE models that detail viral
[17] or delivery vector [18, 19] intracellular movement and interaction with cellular com-
ponents, which have led to the identification of critical components or steps governing the
delivery process. The fact that a number of biological events are driven by molecules with
low copy numbers, stochastic representations have also been used to supplement contin-
uum approaches [20]. Among the recent stochastic models relevant to our work describes
protease-dependent endosomal escape of nonenveloped viruses, where the escape probabil-
ity was shown to be dependent on the net number of proteases in the endosome and the
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endosome size [21].
It is conceded, however, that more realistic and better-integrated approaches that could
bridge the different scales of the problem – from atom to organism, are needed [22, 23].
The complexity of biological networks, however, is itself hampering the development of
models that capture this “whole picture”. While ODE models have become a standard
for monitoring fluxes of biological and biochemical systems, these suffer severely from
problems of scale [20]. This is where the advantages of rule-based modeling, which uses
reaction patterns, rather than individual reaction definitions, become evident. Rule based
models prevent the combinatorial explosion that would otherwise occur with ODEs, and
allow models to be written practically module by module. The latter provides a degree of
extensibility, permitting the model to be scaled to higher or lower levels of organization [24].
In this thesis, we describe experimental and modeling solutions for evaluating one of the
most problematic steps in targeted gene and drug delivery, endosomal escape. Through the
methods presented here, we provide the characterization of a reporter system for detecting
single-endosome escape events, which, together with a rule-based model, give insights into
the immense influence of cell type-specific uptake on endosomal escape.
1.3 Overview of the thesis
In this thesis, we focus on the interplay between experiment and modeling for understand-
ing uptake and intracellular movement of different NP-sized material, including synthetic
gene delivery vectors, mesoporous NPs that can be used as drug carriers, and viruses. In
Chapter 2, we introduce the recurring theme of this work, which is understanding the in-
fluence of vector uptake and intracellular distribution on individual cell behavior. In the
first work, we study synthetic gene delivery; here, we use a mathematical model to show
that the high variability of individual cell expression signatures arises from the stochas-
ticity of vector translocation and activation in the nucleus. We also show how the model
can predict important vector performance markers, such as percentage of transfection and
the number of efficient plasmids per vector complex. We then discuss scalability limita-
tions of the model when processes upstream of nuclear entry are included, such as vector
complexation and movement across cellular compartments. In Chapter 3, we present the-
oretical frameworks, namely pi calculus and the compartment-based PABM calculus, for
addressing these problems. We then demonstrate the potential of these frameworks in
Chapter 4 by modeling the intracellular distribution of gold nanoparticles (NPs) based on
some transmission electron microscopy (TEM) data and parameters derived from detailed
studies of gold NP behavior. We also extended the experimental setup to include real-time
analysis of individual, light-induced endosomal escape using a nanoparticle (NP)-based
detector/delivery system. The experiments and model extensions required to analyze the
distribution results that we obtained are detailed in Chapter 5. Finally, in Chapter 6, we
present a mechanistic model, formulated in PABM and simulated in the model checker
PRISM, that shows how a minimum number of influenza hemagglutinin (HA) can form
a fusion pore that facilitates endosomal escape. Although it is currently not possible to
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engineer NP carriers that have preassembled pore-forming units, or a fixed numbers of
attached molecules, such information may eventually be used to improved non-viral vector
performance [25, 26].
Chapter 2
Modeling non-viral gene transfer using
a hybrid stochastic model
The development of safe and efficient transgene and drug delivery methods has been the
focus of extensive research efforts for more than 30 years [27, 28, 29]. Most of the vectors
are modified viruses, which have the inherent ability to transfer genetic material to cells;
however, safety issues and manufacturing issues have shifted the focus on non-viral vector
development [27]. However, the most-used synthetic protocol, lipofection has only been
used in 6.4 % of the Phase III vector clinical trials [30, 31]. This is because of the relative
inefficiency of the non-viral vector compared to its viral counterparts [27]. At the systemic
level, this is due extensive interaction of the vectors with serum proteins, which results
in rapid clearance [32]; at the cellular level, this can be due to its inefficient endosomal
escape, cytosolic degradation or trapping, and suboptimal transport and nuclear entry [33].
Even if the vector enters the nucleus, the transgene is not necessarily stably integrated into
the host genome [29]. Nonetheless, non-viral vectors still present several advantages over
viral counterparts, which make further research in the field relevant. For instance, non-
viral vectors are associated with less safety, toxicity and immune response-related issues
[34]. Additionally, it can carry larger transgenes than 8.0 kb limit of most viral vectors [35].
Currently, a lot of effort is in hybrid vector design. These hybrids ideally contain functional
elements from viruses to improve targeting, escape and gene integration efficiency without
inducing adverse effects [34]. Nonetheless, the success of any hybrid vector design depends
on how well the molecular mechanisms governing its delivery is understood.
It is consequently of interest to come up with a way to systematically evaluate and
improve the performance of existing vectors and to predict the behavior of new ones. For
this, we need to understand the intracellular processes in which both viral and nonviral gene
expression systems are involved, to identify events that control transgene expression, and
to identify particular strengths and weaknesses of different vectors that have been tested
so far [36]. A number of mathematical and computational models have been constructed in
attempts to address this need [36]. In a first approach, we evaluate the performance of two
synthetic, DNA-condensing delivery systems, polyethyleneimine (PEI) and lipofectamine,
using a simple hybrid mathematical model to describe gene expression characteristics in
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individual lung epithelial cells.
2.1 Single cell expression data-derived distributions of
exogenous gene expression characteristics
Until early 2000, most experiments investigating gene expression were based on population
averages. While such data could be used as indicators for transgene expression efficiency,
these naturally do not give insight into the expression behavior of single cells. With
the development of semi-automated fluorescence microscopy methods, single-cell image
tracking and analysis algorithms, and the and a wider range of fluorophores, single-cell
time course studies have become feasible, high-throughput sources of data.
A question that we wished to answer using this approach was how steps in artificial
gene delivery influence the population expression characteristics and vice versa. In this
study, we analyzed exogenous gene expression from two synthetic delivery vectors, PEI, a
cationic polymer; and lipofectamine, a lipid-based system delivery system that condense
plasmid DNA into nanoparticle-sized complexes. The two vectors were tested on the lung
epithelial cell line, BEAS2B, in both unsynchronized and synchronized setups with plasmids
encoding enhanced green fluorescence protein (EGFP) as the load. Each experiment was
performed for 30 hours, with a 10-minute sampling interval over 25 view fields. From
these images, the change in integrated density over time were extracted for single cells;
the integrated density measurements calibrated against EGFP-coated beads to yield the
approximate number of EGFP molecules per cell. Typical time-course results for PEI and
lipofectamine demonstrate response heterogeneity in terms of exogenous gene expression
levels and expression onset (Figure 2.1).
To generate distributions of the maximum expression level Imax, the time to half-
maximum expression (t1/2), and the characteristic rise time (trise), we used the following
phenomenological fit function to fit individual time traces:
I(t) =
Imax
2
[
1 + tanh
(
t− t1/2
trise
)]
(2.1)
The expression onset time, (t0), was subsequently approximated as t1/2− trise. We sur-
mised that the Imax distribution, which reflects steady-state exogenous protein expression,
will also be indicative of the number of successfully incorporated plasmids. Distributions
of these values are shown in Figure 2.2. Note that lipofectamine has an earlier expression
peak at eight hours, compared to the 16 hours required by PEI in non-synchronized cul-
tures; this difference disappears with synchronization, indicating that delivery is cell cycle
dependent. Synchronization also results in twofold higher Imax values for both vectors.
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Figure 2.1: Single-cell time traces of exogenous EGFP expression using PEI and lipofec-
tamine (inset). The population average (red) is shown in comparison. Note the loss of
information on the expression variability, as well as the sigmoidal shape of the expression
curves. Figure from Paper A [18].
2.2 Use of a hybrid deterministic/stochastic model to
describe delivery processes
To analyze the expression steady states shown in Figure 2.2, we constructed a hybrid
stochastic/deterministic model of nuclear delivery and gene expression. First, we attempt
to model the EGFP expression steady state; for this, we used a series of differential equa-
tions to describe the expression of EGFP from a single, activated plasmid that considers
synthesis (sa, sp) and degradation (δR, δU , δG) rates for RNA, unfolded and folded GFP, as
well as a maturation rate for folded GFP (km), from which the following analytical steady
state relation can be derived:
Imax = G(t→∞) = kmspsA
δGδR(kM + δG)
X (2.2)
which can be alternatively expressed as follows:
[GFP ] = kexp[plasmids] (2.3)
Here, kexp corresponds to the number of proteins expressed in the steady state per plas-
mid, denoted the expression factor. Interestingy, kexp is approximately 4 x 106 molecules/plasmid,
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which leaves [plasmids] to have a value of 1. This result implies that expression level vari-
ance originates from a small number of delivered plasmids. We subsequently model delivery
as a two-step stochastic process, where the nuclear translocation step, occurs with a prob-
ability µ and the plasmid activation step occurs with probability q. The activation step
refers to the actual unpacking of the plasmid from a vector and its subsequent expres-
sion. We assumed that nuclear delivery occurs rarely, and that the events are statistically
independent:
P (C) =
µC
C!
e−µ (2.4)
Supposing that there are X activated plasmids, then n ≥ X plasmids must have first
entered the nucleus, with each of the n plasmids having a probability q of being acti-
vated. The probability P (X) of finding X activated plasmids is thus given by a binomial
distribution:
P (X|n) =
(
n
X
)
qx(1− q)n−X (2.5)
The distribution of expressed plasmids, directly related to the number of expressed
GFPs, can then be related to equation 2.3 with a well defined mean:
〈[plasmids]〉 = µmq (2.6)
The transfection ratio (TR) is then related to this mean, and depends on the average
number of complexes delivered, as well as q¯, the effective probability that from any complex,
at least one plasmid is transcribed:
TR(µ,m, q) = 1− exp {−uq¯} (2.7)
For our data, TR is approximately 20 % (Figure 2.3), while the average number of
activated plasmids is three, confirming previous reports and estimates on the extremely
low amount of vectors that enter the nucleus [19]. The model fits data from synchronized
cells; for non-synchronized cultures, the fits are less ideal, given the occurrence of noise
occurring from cell cycle-dependence of gene expression.
2.3 Limitations of differential equation models
The results of the study highlight the effect of vector loss, and low nuclear entry and
activation probabilities. Of the processes upstream nuclear entry, poor endosomal escape
has been identified as the most likely bottleneck in the delivery process [27]. It is thus of
interest to develop a method for observing single endosomal escape events, which could be
used to directly evaluate vector loss. It would likewise be necessary to extend the model
to handle the topological change arising from endosome lysis and details pertaining to its
necessary triggers. In the next chapters, we proceed by describing rule-based modeling
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solutions (Chapter 3) and an application (Chapter 4) that demonstrates its adequacy and
suitability for modeling individual endosome lysis events (Chapter 5).
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between the expression level Imax¼ [GFP] and the number
of expressed plasmids X¼ [plasmids] is obtained:
½GFP# ¼ kexp½plasmids# (6)
Here kexp denotes an effective expression factor, corre-
sponding to the number of proteins expressed per transcribed
plasmid in the steady state. With the values given in Table I,
we find kexp$ 4% 106 molecules/plasmid, which compared
to the experimental number of molecules (1–15% 106),
results in the remarkable finding that the number of
plasmids X is of order 1. This implies that most of the
variance in expression level originates from stochastic
variations in the small number of plasmids, such that the
distribution of GFP expression is determined by the
distribution of successfully delivered plasmids, P(G)& P(X).
To further substantiate this conclusion, we designed
an experiment where the expression factor kexp is
deliberately modified through the use of destabilized
EGFP. It has a 14-fold higher degradation rate (ddesG)
due to an additional amino acid sequence (PEST), which
makes it more susceptible to proteolysis (Kain, 1999).
Figure 3e and f display the shift in the steady state
distribution of Imax, shown in a logarithmic scale. As
predicted above, the shape of the distribution function is
almost unchanged for both PEI- and Lipofectamine-
mediated transfection. In addition, the peak positions
shifted by a factor 12.5, which is close to the value 14.3
predicted from Equation (5).
Modeling Transfection Noise
Unlike in chromosomal DNA, which contains a fixed
number of genes, the transfection experiments discussed
here result in the delivery of a variable number of genes per
vector. We model gene delivery as a two-step stochastic
process as shown in Figure 4a. As we will argue in the
following, a two-step model is the simplest model that is in
accordance with the experimental data. The model consists
of (i) the nuclear translocation with probability m of
complexes containing an average of m plasmids and (ii)
intra-nuclear activation of plasmids, with probability q.
Whereas the probability q subsumes all phenomena
promoting or interfering with transcription such as DNA
methylation or complexation. We assume that the first
process, the delivery of complexes to the nucleus, is rare and
statistically independent, yielding a Poisson distribution for
the number of delivered complexes C:
PðCÞ ¼ m
C
C!
e)m (7)
characterized by its mean value m. Secondly, the indepen-
dent activation of a plasmid in the nucleus is described
by a Bernoulli process with success probability q. The
concatenation of both processes results in an expression for
P(X) which retains the characteristics of a Poissonian.
Mathematical details of its derivation can be found in the
Supplementary Data. Figure 5 shows the calculated
distribution of activated plasmids, P(X) (red bars), to the
measured experimental protein distribution, Pexp(G) (green
bars). In addition a theoretical protein distribution is shown
as black lines. Ptheo(G) is obtained from P(X) by additionally
accounting for noise in gene expression, where we have used
a relative magnitude of 0.3 for post-transfectional noise
from the literature (see Supplementary Data). Note that the
x-axis of the distributions P(G) is rescaled by the factor kexp
according to Equation (6). The agreement between
Figure 3. EGFP expression statistics for PEI- and Lipofectamine-mediated
transfection. Distributions of expression onset times ton (a and b) and maximal
expression values Imax (c and d), for PEI-mediated (red) and Lipofectamine-mediated
(dashed black) transfection depict strong variability within the cell cultures. The total
number of expressing cells was 23% out of 560 for PEI and 30% out of 502 in the case of
Lipofectamine. b and d: Thymidine kinase-synchronized cultures with 40% out of 1981
and 30% out of 1797 cells expressing EGFP for PEI and Lipofectamine, respectively. For
synchronized cells, expression onset time distributions coincide for Lipofectamine and
PEI, indicating that transfection is more likely to happen in specific phases of the cell
cycle. Distributions for Imax (given in units of EGFP molecules) cannot be explained by
post-transfectional sources of fluctuations alone. e and f: Effect of the altered
expression rates on the distribution of maximal expression levels Imax. Distributions
for d2EGFP (gray) and EGFP (red) transfected with Lipofectamine (e) or PEI (f) are
shown. d2EGFP, which has a higher degradation rate, exhibits a systematic shift of the
Imax distribution compared to EGFP, independent of the vector used. Besides this shift,
a change in the number of proteins per active plasmid, kexp, preserves the shape of the
distribution. This suggests that the shape is determined during plasmid delivery prior to
expression.
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Figure 2.2: EGFP expression statistics for PEI- (red) and lipofectamine- (black, dashed)
mediated transfection in synchronized and non-synchronized cultures for the expression
onset time, ton (a and b) and maximal EGFP values, Imax, showing strong expression
variability, even after synchronization. Note the cell cycle dependence of of transfection.
Figure from Paper A [18].
2.3 Limitations of differential equation models 11
contain both CFP- and YFP-plasmids in a single complex,
whereas post-mixed complexes contain either CFP- or YFP-
plasmids (for clarity see Fig. 6a and b). The steady-state
CFP/YFP expression was analyzed at 24 h post-transfection
for approximately 15,000 cells. We define the cotransfection
ratio, r, as the number of cells expressing both CFP and YFP
divided by the number of cells expressing either CFP or YFP.
We find that the cotransfection ratio increases from 12.9%
for post-mixed complexes to 21.9% for premixed com-
plexes. The significant difference could not be explained, if
complexes were completely dissolved in the cytosol and
delivery of plasmids was independent from the complexes.
The two-step delivery model, however, naturally explains
the discrepancy between pre-mixed and post-mixed com-
plexes. Based on our model, an analytical expression for the
cotransfection ratio can be derived (see Supplementary
Data) which predicts correctly the measured cotransfection
ratios, if the same parameters are used as determined from
the EGFP distribution function.
Discussion
We have measured the distribution of expression onset
times and steady-state expression levels derived from single
cell fluorescence time courses. Distributions of onset times
of PEI and Lipofectamine collapse on a single curve for
synchronized cell cultures, suggesting a universal cell cycle-
dependent gene delivery mechanism. Synchronized cells
exhibit a broad Poissonian distribution in expression levels
and cotransfection experiments reveal correlations in the
delivery probability for plasmids contained in one complex.
Invoking Occam’s razor, we analyzed the findings in
terms of an idealized minimalist model of gene transfection,
which describes gene delivery as a two-step stochastic
process. Yet our model proves to have considerable
predictive power by relating measurable quantities such
as the overall transfection efficiency, the cotransfection
probability and the shape of the gene expression distribution
with each other. Thus, the model allows the derivation of the
expression factor, the number of activated plasmids per
complex and the average number of delivered complexes
from the measured single cell transfection statistics. The
model also elucidates the origin of expression variance,
separating the noise due to small number fluctuations of
complexes, which is inherent to the delivery process and
extrinsic sources of noise due to cell–cell variability.
In our gene expression model, we refer to complexes as
units of coherently delivered plasmids. Those indirectly
inferred complexes are consistent with but not necessarily
identical to the complexes described in many physico-
chemical studies of PEI and lipofectamine mediated
transfection. Cationic-lipid complexes are known to form
multi-lamellar aggregates that contain a large number of
plasmids (Lasic et al., 1997; Ra¨dler et al., 1997; Zabner
et al., 1995). Following endocytotic uptake and release,
the complexes slowly dissociate in a stepwise, unwrapping
mechanism (Kamiya et al., 2002; Lin et al., 2003). PEI
complexes are torroids or rods with a typical hydrodynamic
radius of 100 nm (Boussif et al., 1995; DeRouchey et al.,
2005), which have been seen to be actively transported inside
cells (de Bruin et al., 2007) and to accumulate in the
periphery of the nucleus (Suh et al., 2003). Both scenarios
describe a situation where numerous small complexes have
equal chances of entering the nucleus during the course of
mitosis, which is consistent with our model assumptions.
Microscopy studies have argued favorably for complexes
being at least not fully dissolved at the final delivery stage
(Lin et al., 2003; Tseng et al., 1999). However, single nuclear
entry events have not been documented explicitly. The
probability of transgene expression in the nucleus again
depends on the nature of the transfection agent. Pollard et al.
(1998) reported that cationic lipids, but not PEI prevent
gene expression when complexes are directly injected in the
Figure 5. Comparison of single-cell data with the theoretical model. The the-
oretical EGFP distribution (black) is intimately connected with the underlying distribu-
tion of expressing plasmids (red). To facilitate comparison, the protein distribution has
been scaled down by the average number of proteins per active plasmid in steady
state, kexp. a and b: For synchronized cultures the measured protein distribution
(green) is fitted very well by our theoretical model (black). The fit for PEI transfection
(a) yields an average number of delivered complexes, m¼ 0.53, and an average
number of activated plasmids per complex, meff¼ 3.2. In the case of Lipofectamine
(b), we find m¼ 0.37 and meff¼ 3.2.
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Figure 2.3: A superposition of the model result (black) with the distri ution of expressed
plasmids (red) and the protein expression, scaled down by the average number of GFP
molecules per plasmid at steady state (gr en) for PEI (a) and lipofectamine (b) show a
20% transfection efficiency for both vectors. The graph also shows that the average number
of activated plasmids is three. Figure from Paper A [18].
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Chapter 3
Modeling stochastic cellular processes:
dealing with compartments and
complex networks
The gene delivery model that we have presented is able to predict the percentage of trans-
fected cells, the cotransfection ratio, the distribution of expression levels, and the number
of efficient plasmids per complex, which may be used for evaluating gene delivery vec-
tors [18]. However, if the scopes of both experiment and model are extended to include
mechanistic details of endosomal escape or cytoplasmic trafficking, then amount of detail
that has to be incorporated makes it more difficult to create the model using ODEs. For
instance, an approach for improving the cytoplasmic transport of vectors could require
a study of viral components that mediate engagement and trafficking along microtubules.
One might also need to look at signal transduction pathways that viruses activate to induce
trafficking [37, 38]. Putting all these information in a model could yield insights into the
combinations of components that one could put in a vector. Similarly, comparing models
of non-viral and hybrid vector behavior would provide information on the transport com-
ponents and mechanisms that can be exploited better [39], while simultaneously resolving
some conflicting information on artificial vector transport [40].
Apart from the complexity that inevitably arises from the inclusion of such details, the
fact that all these events occur in different cellular compartments makes the specification
or extension of existing ODE models more challenging. Such a problem is likely to be
encountered easily when constructing NP cytotoxicity models, where intracellular particle
distributions have to be modeled explicitly, alongside important details of cell signaling
pathways [41]. In order to address these needs, it is of interest to look at alternative
modeling methods, specifically rule-based modeling, and the formalisms within the emerg-
ing area of executable biology [42]. In particular, we focus on pi calculus [43]; and the
projective brane calculus with activate, bud and mate as primitive actions (PABM) [44],
a generalization and extension of brane calculus [45], which handles compartments and
membrane operations explicitly.
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3.1 Introduction to pi calculus
Pi calculus was developed by Milner and colleagues for modeling mobile, concurrent com-
municating systems [43], allowing the high-level description and logical analysis of interac-
tion, communication and synchronizations between agents known as processes. The basic
objects, operations and reduction rules of pi calculus are summarized in Table 3.1.
Object Syntax Description
Process P , Q Agents/objects that make up a system
Channel ?x, !x Named communication ports of processes;
channels are associated with rates, and may
be used to pass attributes, channels, or processes
between processes
Attributes P(att:type) Process characteristics
Operation Syntax Description
Concurrency P | Q P and Q are processes executed
concurrently
Summation !x.P+?y.Q Represents a competitive choice between mutually
exclusive interactions
Restriction (Series) (vx).P Creation of a new name in P
Replication !P Associated with processes that can always
create a new copy of P
Table 3.1: Objects and operations of pi calculus
In pi, systems are modeled using multiple processes that communicate with each other in
a pairwise, synchronized manner over named channels [43]. A computation step is denoted
as P rate−−→ P ′; the main reduction rule of pi calculus is denoted ?x(z).P |!x(y).Q rate−−→
P |Q[z/y], showing name-passing between channels. Alternately, an internal state change
may be denoted as P τ−→ P ′, where τ is a delay reaction. These features of pi calculus
permit process modification through the acquisition of new communication capabilities [46].
A stochastic extension, where non-determinism is replaced by exponentially-distributed
race conditions, was added by Priami for performance modeling of distributed systems;
the stochastic extension allows pi calculus systems to be quantitatively analysed with its
mapping to a continuous time Markov chain [47]. This particular feature has been used
extensively in quantitative models of biological systems [45].
The use of stochastic pi calculus as a foundation for biological modeling and stochastic
simulations was proposed by Regev, because of the adequacy of its coverage, semantics, and
dynamics to capture the molecular organization and dynamic behavior of these systems
[46, 24]. In particular, Regev mentions three features of pi which make it a good candi-
date for biomolecular process abstraction: 1) computability, which allows the abstraction
to simulate system behavior while providing a qualitative and quantitative reasoning be-
hind the system properties; 2) understandability, which presents an ease of correspondence
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between biological concepts and objects (Table 3.2); and 3) extensibility, which permits
the simulation to be scaled to higher levels of organization than molecules [24]. Pi calculus
has since been successfully applied in EGFR network modeling [48], early T cell signaling
[49], and more recently, in NP-cell interactions (Chapter 4).
Biochemical object Pi calculus object
Reactant (Proteins, ligands, compartments, etc.) Process
Binding site Channel
State Attribute
Table 3.2: Correspondence between biochemical and pi objects. Note that the definition
of the process is broad enough to allow it to be used as an abstraction for a compartment.
3.2 The Stochastic Pi Machine (SPIM): a pi calculus
implementation
3.2.1 Introduction to SPiM
The stochastic pi Machine (SPiM) is an implementation of a stochastic pi calculus variant
[50]. In SPiM v.0.05, each process is encoded as a computer object with a scope that
corresponds to the visibility of its associated channels; that is, a process P having a hidden
channel x excludes another process Q from seeing x. A process may evolve as a result
of an action on a channel or through a delay, which is often used to represent a change
in internal state of a process [48]. A state change is subsequently effected by changing a
parameter specification, the attribution of a new channel, or the redefinition into another
process.
In addition to the basic pi calculus implementation, SPiM allows the use of simple pro-
gramming language-type statements, including basic conditional statements and boolean
operations. This effectively extends the rule-based formalism that pi calculus provides
(Section 3.2.2). Parameters in SPiM are also not limited to channel and channel passing,
but include attributes that may assume different data types. Although not an integral
version of CCS, these attributes have been used in order to provide enough flexibility to
handle problems ranging from very straightforward handling of state changes to its ad hoc
use as coordinates in 3D space [51]. A version of SPiM with a graphical user interface
has recently been developed; however, this release does not support run automation, for
which reason all of the SPiM models that were created for the research were specifically for
v.0.05. SPiM uses the Gillespie algorithm (Section 3.2.3) to choose the channel or delay
on which a reaction occurs, as well as the duration of this reaction.
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3.2.2 Rule-based modeling in SPiM
A rule specifies features of a reactant that are either required for or are affected by reactions,
and how these features are to be “rewritten”, in case the reaction is chosen for execution
[52, 53]. Rules can thus be viewed as generalized reaction patterns that permit reactant
recognition, a mapping of reactants to products, and an association of a rate law with this
mapping [53]. The view of a rule is very local – that is, it often represents a local pattern
of a site or a state (Figure 3.1). For instance, given a pair of proteins P and Q that may
interact only when P is phosphorylated at site x, a rule would permit any such reaction,
regardless of whether P or Q are bound to other proteins or not – thus, the rule only looks
at x, and not the whole P and Q – and has the potential to encompass a lot of reactions
that would have otherwise been treated as occurring between distinct molecular species
[52].
Rule
Reactions
Sunday, March 11, 2012
Figure 3.1: Rule based modeling uses patterns to identify possible reactions, and to map all
the reactions encompassed by these patterns into products. In this figure, the reactions that
can be encompassed by the illustrated rule are shown. By reducing the number of reactions
that have to be defined, rule based models can significantly reduce the combinatorial
complexity that features frequently in models of biological systems.
The benefits of a rule-based approach is most evident when dealing with multistate
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protein modifications, a frequent feature of signaling pathways. Consider the case of epi-
dermal growth factor (EGF) signaling, which involves a network of at least 211 reactions
and 322 interactants. Each interactant generally has more than one state that deter-
mines its possible binding partners [54]. However, the reactions can be categorized into
more general classes such as state transitions, including phosphorylation; association and
dissociation; or translocation-type reactions [54]. Assuming that n of the state transi-
tion reactions are phosphorylation reactions, and a general pattern of phosphorylase |
substrate→ substrate− P , where substrate− P is a state of the substrate process, then
these n reactions can be recognized using a single rule, and would not have to defined
individually.
In addition to rules, SPiM also implements programming language-like constructs such
as if − then statements, which permit the inclusion of reaction preconditions on top of
patterns. These constructs could also be used for defining rules in an alternative manner.
This is particularly advantageous for problems that could not be represented as chemical
reaction-type models.
The strength of combining some logic-based operations of programming languages with
a rule-based modeling becomes evident when we need to define thresholds. Suppose that
P has two attributes, a and b, and Q interacts with P with a rate f(a) if a ≤ b and f(b)
if b < a. A SPiM code representation is very straightforward:
let P(a:int, b:int) =
if a <=b then
delay@f(a); !react
else
delay@f(b); !react
and Q() = ?react; PQ()
and PQ() = ()
Assuming further that a and b can each range over values 1..n and 1..m, respectively, a
plain Gillespie implementation that is able to track all reactions of P (a : 1..n, b : 1..m) will
result in a reaction matrix where the n ∗ m reactions of P have to be explicitly defined.
Overall, these features of SPiM eliminate redundancies often required when ODEs, or even
a direct implementation of Gillespie, are used.
3.2.3 The Gillespie algorithm
The stochastic simulation algorithm (SSA) of Gillespie addresses the general question of
the time evolution of N reactive chemical species in a fixed volume V , given the numbers
of each of the N species, as well as their M reaction channels. More specifically, it was
conceived to describe fluctations in the molecular population levels of reacting systems that
cannot be captured by reaction rate equations [55]. In SSA, reaction constants are treated
as probabilities than rates, and the temporal behavior of the system is a Markovian random
walk in N dimensions of the N species. The time evolution of the probability p(x, t) that
the system will be in state x at time t is described by the master equation.
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The physical basis for the stochastic formulation of chemical kinetics lies in the premise
that collisions in a well-stirred system in equilibrium occur essentially at random. For such
a system, it is possible to calculate the probability P (R1,2) of all pairwise collisions 1, 2,
occurring in V within an infinitesimal time interval [t, t+ δt]:
P (R1,2) = X1X2V
−1pir212v¯12δt (3.1)
where X1 and X2 are the concentrations of molecules S1 and S2, respectively; r12 is
the sum of the radii of S1 and S2; and v¯12 is the average relative velocity of the molecules,
assumed to follow a Maxwellian velocity [55]. It is further asserted that a stochastic reaction
constant c1, solely dependent on the physical properties of the reacting molecules and the
temperature of the system, exists, such that the probability of the collision within the time
interval [t, t+ δt] is:
P (R1,2) = X1X2c1δt (3.2)
This can be generalized for chemical species Si, i = 1..N that react through M reaction
channels Rµ, µ = 1...M , for which there must be M constants cµ, µ = 1...M . These yield
an expression for the average probability that a particular combination of Rµ reactants
will react within[t, t+ δt]:
P¯ (Rµ) = cµδt (3.3)
The next step would be actually describe the stochastic time evolution of the system,
which is traditionally done by setting up the master equation – in this case, directly
derivable from the sum of probabilities of the M + 1 ways by which the system can arrive
at a state (X1...XN) at time t+ δt:
P (X1, ..., XN ; t+ δt) = P (X1, ..., XN ; t)
[
1−
M∑
µ=1
aµδt
]
+
M∑
µ=1
Bµδt (3.4)
where aµδt is the probability that a reaction Rµ will occur, given the state of the system
at time t:
aµδt ≡ cmuδt×RµC (3.5)
Here, RµC is the number of distinct Rµ molecular combinations in the state. Bµδt in
Equation 3.4, on the other hand, gives the probability that the system is one reaction Rµ
removed from the state (X1...XN) at time t, and then undergoes the reaction Rµ at t+ δt.
However, solutions to such equations are intractable. In its stead, Gillespie proposed
the simulation of this time evolution, which answers the two critical questions to make the
system move forward in time: (1) when will the next reaction occur? and (2) what kind (or
which) reaction will it be? To this end, a function P (τ, µ)δt, which gives the probability
of the next Rµ reaction occurring within the time interval [t+ τ, t+ τ + δt] was defined; τ
and µ answer the two questions posed previously. To assign τ and µ, the following steps
are taken:
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1. For each Rµ, define the hazard function, hµ:
(a) For reactions of the form S1 + S2 → Product:
hµ = X1X2 (3.6)
(b) For reactions of the form 2S1 → Product:
hµ =
1
2
X1(X1 − 1) (3.7)
2. Calculate P (τ, µ) from the product of (P0(τ)), the probability that no reactions will
occur within [t + τ, t + τ + δt] state of the system at time t; and aµδt, which is the
probability that reaction Rµ occurs:
P (τ, µ)δt = P0(τ)aµδt (3.8)
Noting that the probability that no reaction will occur at δt is 1 −∑ νaνδt′ within
time δt′, then:
P0(τ + δt
′) = P0(τ ′)
[
1−
M∑
ν=1
aνδt
′
]
(3.9)
Integration of which yields:
P0(τ + δt
′) = exp
[
−
M∑
ν=1
aντ
]
(3.10)
so that Equation 3.8 can be rewritten as:
P (τ, µ)δt =
{
aµexp−a0τ , 0 ≤ τ <∞, µ = 1...M
0
(3.11)
where aµ ≡ hµcµ and a0 ≡
∑M
µ=1 aν ≡
∑M
µ=1 hνcν . It is noteworthy to mention that
P (τ, µ) depends on all reaction constants, as well as the count of all reactant species [55].
With this background, the stochastic simulation algorithm can be algorithmically defined
as follows:
1. Initialize t = t0, the system state X = X1...XN , and specify the reaction constants
cµ, µ = 1...M . Set the reaction counter to 0.
2. Calculate the values of a1 = h1c1 ... aM = hMcM (Equations 3.6 and 3.7), as well as
the value of a0, given by the sum of av values
20
3. Modeling stochastic cellular processes: dealing with compartments and
complex networks
3. Generate two random numbers, r1 and r2, taken from a unit interval
4. Generate values for τ and µ as follows:
τ =
1
a0x
ln
1
r1
(3.12)
µ =
µ−1∑
ν=1
aν < r2a0 ≤
µ∑
ν=1
aν (3.13)
5. Update the time as t + τ ; update the system state, and recalculate the reaction
hazards for species whose states have changed. Increase the counter by 1.
6. Return to step 2, and iterate until t ≥ tend
Several methods exist for the Gillespie algorithm, including the direct method [55], and
subsequent alternative solutions, which attempt to improve the performance of the algo-
rithm such as the next reaction method [56], the slow-scale stochastic simulation algorithm
[57], and tau-leaping [58, 59]. SPiM v.0.05 implements the direct method [50].
3.3 Brane calculi: modeling stochastic membrane pro-
cesses
While pi calculus provides a possibility of representing compartments as processes (Ta-
ble 3.2) between which other processes or channels are passed, the fact that it does not
have specific reduction rules for these compartment processes could limit its expressivity,
given that the consequences of a compartment transformation is not limited to itself, but
extends to its contents – in this case represented as attributes. As an example, we can take
a fusion-type reaction between two compartments modeled as processes that have different
contents. This can be roughly modeled in SPiM using the following commands:
let Compartment_A (a:Proc) =
!fuse(a)
and Compartment_B (b:Proc) =
?fuse(a’); (Compartment_AB (a, b) )
and Compartment_AB(a:Proc, b:Proc) = ()
Now, supposing Compartment_AB itself can merge with other compartments, the code
has to be modified as follows:
let Compartment_A (a:Proc) =
!fuse(a)
and Compartment_B (b:Proc) =
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?fuse(a’); (Compartment_AB (a, b) )
and Compartment_AB(a:Proc, b:Proc) =
!fuse(a,b)
and Compartment_X(x1:Proc ... xn:Proc) = ()
?fuse(a’,b’); Compartment_ABX(a,b,x1 ... xn)
and Compartment_ABX(a: Proc ,b: Proc ,x1 ... xn: Proc) = ()
One problem that becomes evident in this example is that it is not possible to create a
single rule for fusion. This limitation arises from the fact that pi, and particularly SPiM,
semantics neither permit the use of process list structures as attributes, nor have native
operators that tell the machine what to do with this list. Consequently, a pi implementation
that involves topological operations on compartment processes with deeply nested content
suffers from a degree of combinatorial complexity.
Brane calculus was introduced for explicitly handling these effects of membrane-bound
compartments, and more specifically, of the topological changes that these can undergo,
in models of biological systems [45]. Cardelli’s brane calculus introduces the concept of
branes as dynamic wrappers that contain other branes or (pi) processes. Actions refer to
the rules that define how branes may interact, and the consequences of these reactions; these
are directly inspired by the actual topological transformations that biological membranes
undergo. Actions include uptake-type reactions in the form of phago and pino; fusion-type
reactions in the form of mate and exo; and split-type reactions in the form of bud and drip.
Figure 3.2 summarizes the rules of the calculus, while Tables 3.3 and 3.4 provide details of
the syntax and reduction rules. Note that the fusion-type reactions, exo and mate result
in the mixing the branes, or of both the branes and their content, respectively.
Object Syntax Description
System [ σ ](| P |) Parallel compositions of Branes and their
contents
Brane [ σ ] Membrane bound compartment that can
contain other Branes or (pi processes)
Action σ, τ ∈ {phago, pino, Names of brane calculus rules; each action is
exo,mate, bud, drip} associated with a channel to delineate inter-
action specificity
Process P , Q Agents/objects that
Operations Syntax Description
Parallel, Systems [ σ ](| P |) ◦ [ τ ](|Q |)
Parallel, Actions σ|τ
Series τ.σ
Choice σ + τ
Table 3.3: Objects and operations of Brane calculus
As indicated previously, pi processes could be incorporated in a brane model as brane
contents, with its availability being restricted by the brane topology, thus providing a
22
3. Modeling stochastic cellular processes: dealing with compartments and
complex networks
Action Reduction rule
phago [ σ|phago!x ](| P |) ◦ [ τ |phago?x ](|Q |)→ [ τ ](| [− ](| [ σ ](| P |) |)Q |)
pino [ σ|phago!x|phago?x ](|Q |)→ [ σ ](| [− ](| − |)Q |)
exo [ τ |exo?x ](| [ σ|exo!x ](| P |)Q |)→ P ◦ [ τ |σ ](|Q |)
mate [ σ|mate!x ](| P |) ◦ [ τ |mate?x ](|Q |)→ [ σ|τ ](| P ◦Q |)
bud [ τ |bud?x ](| [ σ|bud!x ](| P |)Q |)→ [ τ ](| [ σ ](| P |)Q |) ◦ [ τ ](|Q |)
drip [ σ|bud!x|bud?x ](|Q |)→ [ σ ](| − |) ◦ [ σ ](|Q |)
Table 3.4: Reduction rules of Brane calculus
language that sufficiently captures most features of a cellular system. Going back to the
example given at the start of this section, the whole can be re-written simply in brane
as follows; note that there are no explicit specifications of the product, given that this
would be resolved by the reduction rules, with the order of reactions being determined as
in Section 3.2.3:
[ mate!x|bud?x|bud!x ](| A [− ](| a |) |) ◦ [ mate!x ](|B [− ](| b |) |) (3.14)
Danos and Pradalier extended the calculus by introducing the concept of sidedness
– that is, that the outer and inner layers of a biological membrane can be specified to
have different interaction capabilities – in order to create a language closer to biological
membranes (Figure 3.3, [60]). The calculus essentially has the same objects and actions as
Cardelli’s brane calculus, and has the difference in the syntax that reflects the sidedness of
a brane: [ 〈σ ; τ〉 ](| P |), with σ representing the actions on the outer leaflet, and τ , of the
inner leaflet.
3.4 A Projective Brane calculus with activate, bud and
mate as primitive actions (PABM)
In our work [44], we further extended projective brane calculus by introducing the concept
of domains, or brane patches. Unlike in previous calculi where branes are treated as con-
tinuous objects, domains allow portions of membrane to behave autonomously (Tables 3.5
and 3.6). The use of domains imbues greater control over how membranes are merged and
split. This is most evident in the case of bud, where the extruded membrane is derived
exclusively from the domain that received the trigger to bud (Figure 3.4).
Additionally, it could be use for more detailed modeling of the molecular events that
govern the topological changes in the first place. In recent research, it was shown that
transport vesicle formation may be driven by the steric pressure arising from membrane
protein interactions; more specifically, asymmetrically distributed luminal proteins within
the vesicle could alter the physical properties of a membrane and influence its curvature [61].
In this particular example, the use of domains to represent the asymmetric distribution
of the proteins, and to use sidedness to represent the fact that these proteins are in the
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Object Syntax Description
System [ ~ρ ](| P |) ◦Q System of Branes
Brane [ ~ρ ] Membrane bound compartment
that can contain other Branes or
(pi processes)
Domain ~ρ ≡ 〈σ1 ; σ2〉 Discrete part of a membrane containing
functionally-related actions
Action σ ∈ bx,mx, !x ; reduced to mate and bud, with its
corresponding activator
Process P , Q Agents/objects that make up a system
Operations Syntax Description
Parallel, Systems [ ~ρ ](| P |) ◦ [ ~ρ ](|Q |) Systems [ ~ρ ](| P |) ◦ [ ~ρ ](|Q |) occur concurrently
Parallel, Domains 〈σ1 ; σ2〉|〈τ1 ; τ2〉 Domains 〈σ1 ; σ2〉|〈τ1 ; τ2〉 occur concurrently
Parallel, Actions σ, τ Actions σ and tau occur concurrently
Parallel, Processes P | Q P and Q are processes executed concurrently
Series σ.τ Indicates that σ can only be executed
after σ
Choice σ + τ Indicates that either σ or τ can occur;
selection of one results in the elimination of
other option
Replication, Parallel (n)σ, (n)~ρ n instances of action σ or domain ~ρ
Replication, Series σ(n) n instances of σ executed one after
the other
Table 3.5: Objects and operations of PABM calculus
interior would be very natural:
[ bx.(n)〈− ; ProteinA〉|!x.(m)〈− ; ProteinB〉 ](| ER |) (3.15)
Here, n and m represent the critical numbers of ProteinA and ProteinB, accumulated
on separate domains, that have to be present before a transport vesicle from the endoplas-
mic reticulum (ER) is formed with bud.
Apart from extending brane, we also provide a generalization of its rules, which we
reduce from six to two. This is possible by using the concepts of projective invariance and
projective equivalence, which first appeared in projective brane calculus [60]. Briefly, pro-
jective invariance postulates that the physics of an interaction does not make a distinction
between inside and outside. Given the following system:
[ 〈− ; mx〉 ](| [ 〈!x ; −〉 ](| P |) ◦ [ 〈mx ; −〉 ](|Q |) ◦ S |) (3.16)
Assuming that S is projected to infinity, Eq. 3.16 becomes transformed as follows,
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Action Reduction rule
bud (Type I), b P ◦ [ ~ρ1|〈σ2 ; bx〉 ](| [ ~ρ2|〈!x ; σ2〉 ](|Q′ |) ◦R |) −→
P ◦ [ 〈σ1 ; −〉 ](| [ ~ρ2|〈− ; σ2〉 ](|Q′ |) |) ◦ [ ~ρ1 ](|R |)
bud (Type II), b [ ~ρ1|〈bx ; σ1〉 ](| P |) ◦ [ ~ρ2|〈!x ; σ2〉 ](|Q′ |) ◦R −→
[ ~ρ1 ](| P ◦ [ 〈σ1 ; −〉 ](| [ ~ρ2|〈− ; σ2〉 ](|Q′ |) |) |) ◦R
mate (Type I), m P ◦ [ ~ρ1|〈!x ; σ1〉 ](|Q |) ◦ [ ~ρ2|〈mx ; σ2〉 ](|R |) −→
P ◦ [ ~ρ1|~ρ2|〈− ; σ1, σ2〉 ](|Q ◦R |)
mate (Type II), m [ ~ρ1|〈σ1 ; mx〉 ](| P ◦ [ ~ρ2|〈!x ; σ2〉 ](|Q |) |) ◦R −→
[ ~ρ1|~ρ2|〈σ1 ; σ2〉 ](| P |) ◦Q ◦R
Table 3.6: Reduction rules of PABM
effectively transmuting inside to outside:
[ 〈mx ; −〉 ](| [ 〈!x ; −〉 ](| P |) ◦ [ 〈mx ; −〉 ](|Q |) ◦ S |) (3.17)
Projective equivalence is defined as the least equivalence relation that produces this
transmutation; using this principle, mate and bud can be viewed as inverse actions, result-
ing in the generalization of Brane reduction rules from six to mate- and bud-type reactions
in PABM (Figure 3.5, Table 3.5). Note that the notation, and the subsequent pairing of
actions, was also changed. While previous calculi required the strict pairing both actions
and channels, such as bud!x/bud?x and mate!x/mate?x, PABM uses just the channel name
and type for a pairing, so that bx and mx can both be executed by a single !x trigger.
As with pi calculus, PABM will use the Gillespie algorithm for choosing the next reaction.
Currently, an executor for PABM is being developed by an external collaborator using the
term-rewriting language MAUDE. Further details of features and possible applications of
PABM are discussed in Paper B.
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P Q QP
QP P Q
Q Q
P Q P Q
QP P Q
Q Q
phago!x
phago?x
pino!x | pino?x
exo?x
exo!x
mate!x mate?x
bud?x
bud!x
drip!x | drip?x
Phago
Pino
Exo
Mate
Bud
Drip
Figure 3.2: Graphical representation of the reduction rules of Cardelli’s brane calculus,
which generalize the topological changes of biological membranes. Sender (black) and
receiver (red) branes and their respective contents are colored to demonstrate the origin of
newly-created branes in the product, as the case is in phago, pino, bud and drip; or brane
or content mixing, as seen in exo and mate. Figure adapted from [45].
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P Q R
mate!x mate?x
exo!x
exo?x
P Q R
mate!x | exo?x mate?x
exo!x
P Q R
exo!x mate?x
exo!x
mate?x
A
B
Figure 3.3: Differences between Brane (A) and Projective Brane (B) Calculi. The use of
Projective Brane Calculus provides richer semantics that incorporate the effect of protein
insertion onto membranes. In this example, a brane calculus system (A) could be more
unambiguously expressed (B); note that the two options in (B) will have very different
system evolution paths, with the second option being a terminal state.
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!x bxσ1 σ2
σ3
4
σ5 σ6
σ
σ1
σ3
4σ
σ2
σ5 σ6
σ1
σ3
4σ
σ2
σ5 σ6
Figure 3.4: PABM domains delineate discrete regions of a brane on which operations can
be performed autonomously. While a bud-type reaction in calculi without domains would
result in an extruded membrane that would also include σ5 and σ6, bud with domains
would cause the extrusion of the brane defined by the domain locally involved in the bud
reaction.
Figure 3.5: Graphical representation of PABM reduction rules. These rules generalize
endo, pino and exo reactions (top) and mate, bud and drip reactions (bottom) as mate
and bud type reactions.
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Chapter 4
Modeling gold NP uptake and
intracelluar distribution
Creating a general model for NP uptake and intracellular distribution is an important
complementary approach to experimental investigations in NP efficiency and cytotoxicity
evaluation. For efficiency estimation, we are mostly interested in finding out how much time
is needed for endosomal escape as a function of the physico-chemical features of the NP. In
establishing the first model, we wanted to have an idea of how much of the particles localize
in the nucleus, based on empirically measured aggregation, uptake, endosomal escape,
cytosolic transport and nuclear entry rates, as well as known physical constraints provided
by the cell. The model should, of course, capture experimentally-derived intracellular NP
distribution before it is extended for cytotoxicity modeling, but extensibility should be an
expected feature. Specifically, we need to at least incorporate details on how NPs interact
with or influence the transcription of genetic material, perhaps going as far as identifying
specific genes and gene products, and detailing the signaling pathways that influence its
expression, for which experimental evidence exists [62, 41]. Compatibility with existing
models of signaling and gene expression pathways, mostly written in SBML [63], is also
a non-trivial considerations in modeling. There is a program that converts SBML models
into SPiM which should allow for a possibility of integration with pathway models [64].
Most NP cytotoxicity models are quantitative structure-activity relationship (QSAR)
models. These are essentially regression models that describe the relationship between
biological activity and the physicochemical and structural characteristics of compounds of
interest, or related compounds that have been characterized [65, 5]. It should be noted
that QSAR may also be used to predict physicochemical properties themselves [4], al-
though there is no current synthesis on how far this has been exploited and how successful
it has been for NPs, which possess different physical properties from its source materi-
als. It is rather clear, however, that the results from QSAR do not answer why an NP
is cytotoxic or not, but rather which categories of NP characteristics are most likely to
influence its toxicity; validation experiments are directed towards evaluation of the robust-
ness of these categories [4]. Categories that have been proposed for “nano-QSAR” include
size distribution, agglomeration state, shape, porositiy, surface area, chemical composition,
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structure-dependent electronic configuration, surface charge, and crystal structure [4, 7].
Executable biological models, on the other hand, are expected to yield testable mechanistic
scenarios of how a particular NP causes cytotoxicity; in this sense, results from QSAR can
be viewed as complementary, rather than competing. In this chapter, we discuss how we
built our generic model using gold NP data, highlighting the advantages of creating it in
pi calculus.
4.1 Choice of gold nanoparticles as a case study
One of our first considerations in setting up a generic model of NP uptake and intracellular
movement is data availability, particularly with respect to kinetic parameters. This mini-
mizes the need for parameter estimation, in turn increasing the probability that disparities
between experimental and model-derived data result from the model structure itself, and
not from wrong parameter estimates. Gold NPs are fairly well-characterized, given its wide
array of existing and potential biological applications, including its use as contrast agents,
drug and gene delivery vectors, and as a heat source in anti-cancer hyperthermia therapy
[66]. This implies that data exist on its uptake [67, 68] and aggregation [69] characteristics,
as well as its potential cytotoxicity [41, 70, 71]. These assays have involved both modified
and unmodified gold NPs of different sizes, tested on different cell types [67].
4.2 Nanoparticle aggregation, uptake, and combinato-
rial explosion
The influence of NP size on uptake, which is effectively determined by NP aggregation
characteristics is challenging to model using ODEs, especially if aggregates of different
sizes have to be tracked explicitly during a simulation. This is foreseeably the case in
toxicity [72, 73] and degradation-related problems [74], where size plays a major role. For
instance, a 4 nm NP, as well as 4 nm NP clusters with diameters ranging from 15 - 20 nm,
appear to enter nucleus easily Paper C, [70, 71], where it could interact with the DNA, and
cause cytotoxicity [75]. The moment, however, that it forms an aggregate with a diameter
of between 9 [33] and 26 nm [76], which are the limits for passive diffusion and signal-
mediated transport into the nucleus, respectively, then nuclear entry would no longer be
physically possible, unless mitosis occurs [18]. In order to capture these in an ODE model
it is necessary to define m ∗ n equations, each describing the evolution of 1..n aggregate
sizes through the m states or locations that these could take. The aggregation reaction
itself, however, is a reaction that can be generalized as NP(size1) + NP(size2) → NP(size1
+ size2), with the base case being NP (1) – that is, an unaggregated NP. This possibility of
generalization makes the pi calculus model significantly less cumbersome. It also permits
easier expansion to include other reactions involving aggregates of a particular size. It is
noteworthy to mention at this point that the way that processes are implemented in SPiM
precludes the possibility of an instantiation of the NP process from reacting with itself.
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4.3 Pi calculus model of gold NP uptake and intracel-
lular distribution
In Paper C, we describe a pi calculus model for nanoparticle aggregation, size-restricted
uptake and movement within the cellular compartments. Briefly, we defined the follow-
ing rules, detailing inter-NP interaction and NP-cell interaction; the rules are written as
reaction-type statements for readability:
1. Aggregation: NP(size1) + NP (size2) → NP(size1+ size2)
2. NP-cell Binding and internalization: NP(size) + Cell → NP(size)-Cell → Cell +
Endosome(NP(size))
3. Endosome-Endosome fusion: Endosome(NP(size1)) + Endosome(NP(size2))
→ Endosome(NP(size1), NP(size2))
4. Transcytosis: Endosome(NP(size)) + Basolateral membrane → Basolateral mem-
brane1
5. Endosome lysis: Endosome(NP(size)) → Cytosol(NP(size))
6. Nuclear entry: Cytosol(NP(size)) → Nucleus(NP(size))
Cell compartments were treated as processes that can send and receive the number of
NPs or NP aggregates that enter it. The initial runs were performed without incorporating
the effect of aggregate size on the uptake rate. The main results from the model are in
the form of spatio-temporal distributions of NPs (Figure 4.1). The model results, however,
feature generally higher nuclear translocation of NPs. In order to improve the data fit, as
well as to demonstrate the ease by which one could implement changes in a pi model, we
introduced a simple restriction of optimal uptake rates for aggregates of size 43 - 125 NPs.
Although uptake is several steps upstream of nuclear entry, this modification already has
a large impact on predicted nuclear entry, as well as the number of clusters that can be
found in the nucleus.
What this work primarily demonstrates is how rule-based models can be used in un-
derstanding delivery information better. Using this base model, it becomes possible to
ask questions as ‘What is the effect of having n cytosolic NPs on a signaling pathway P ,
considering that NPs release ions that react with proteins X and Y in P?’ Similarly, we
could use the model to ask to what extent does inter-NP variability have an effect on NP
efficiency – a question that we answer in the next chapter.
1Transcytosed NPs are assumed to be unable to reenter the cell, and are treated as lost
32 4. Modeling gold NP uptake and intracelluar distribution
Figure 4.1: Predicted spatio-temporal distribution of gold NPs across 500 cells. Model
results are generally consistent with reported NP intracellular distribution up to five hours;
the average number of nuclear NPs at 10 hours, however, is higher than expected. We
subsequently reduced this number by imposing a limit to the aggregate sizes that are
taken up at an optimal rate, based on known size effects in literature [68]. Figure from
Paper C.
Chapter 5
Experiments and modeling of
endosomal escape events
Endosomal escape has been identified as the main bottleneck in gene and drug delivery
[27, 19]; it has been consequently of interest to develop both experimental techniques
and complementary modeling techniques that would allow us to analyze endosomal escape
characteristics of different vectors, including the elucidation of the mechanisms that permit
some vectors to perform better than others. There are, however, few real-time, single
endosome lysis studies because of difficulties in detecting the events reliably. Previous
studies of vector or viral tracking involved labeling of multiple cellular and vector/viral
components, and used confocal laser scanning microscopy was used [77, 78, 79, 80, 81]. In
Akita et al., at least 20 z-slice images for each of 30 cells were reported to yield statistically
meaningful tracking results [77]. If this method were applied to a 30-hour transfection
experiment [18], this would entail the capture, consolidation and analysis of 216,000 images.
Due to these technical limitations, studies have mostly concentrated on spatial distribution
of the material, without the temporal aspect [79, 80]. Endosome escape efficiency is only
inferred from a minimal amount of sampling points [77]. Having a direct method for
analyzing uptake and endosomal escape will not only yield time distributions of the escape
events, but also information on other factors that might influence the time distribution
such as the vector load per endosome and cell-specific endosome size distributions. Such
a method will be powerful in exploring the performance of a delivery vector, especially if
information is obtained for different cell types.
To accomplish this, we needed a reporter system that could either be co-delivered with
other vectors, or be used as a vector itself. The ideal system should have different signals
for each target component, and should not diffuse so easily in the cytosol. We chose the
recently characterized colloidal mesoporous silica (CMS) particles, developed in the lab
of Prof. T. Bein, as the reporter system core, to which lytic agents such as PpIX and
dyes such as ATTO633 covelently linked to a quencher QSY21 can be attached [82]. PpIX
is a photolytic agent that produces reactive oxygen species (ROS) on activation, which
oxidize double bonds in the both the vector membrane and the endosome membrane. On
vector movement to the cytosolic milieu, the bond between ATTO633-QSY21 is reduced,
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resulting in fluorescence that is localized to the NP. As with our previous work, we need to
complement the data with a model from which mechanistic assumptions can be derived.
In this chapter, we discuss experiments performed using the CMS reporter system, as well
as a mechanistic model that we have generated in order to describe all the data obtained.
5.1 Characterization of endosomal release of a lipid-
coated nanoparticle reporter system
5.1.1 Generation of lipid-coated nanoparticles
To deposit a lipid bilayer on the CMS particles, we developed a solvent-exchange based
protocol that gradually moves from amphiphatic ethanol solution to pure aqueous solution
(Paper D). Some previous protocols have either used a film-hydration method [83] or a
similar principle of solvent exchange [84], but are limited either by the difficulty of the
protocol, or the incompatibility of the final solvent with biological samples. Our protocol
directly uses dehydrated lipid that is resuspended from ethanol to water. We have shown
that the protocol generates fluid liquid bilayers on a flat surface as shown from a continuous
bleaching protocol (Paper D, [85]). Additionally, correlation experiments show that the
method yields intact bilayers on CMS particles for several lipid compositions [86]. A lipid
coat deposited in this manner also provides better stability against CMS NP aggregation
in aqueous medium [86].
5.1.2 Reporter system characterization and experiments
The reporter system in the lipid-covered form has been extensively characterized in the
work of A. Sauer from the group of Prof. C. Brauchle, as well as by H. Engelke, with the
membrane quality being assessed using confocal microscopy and correlation spectroscopy
[86]. Here, as well as in Manuscript F, we provide further characterization of the system
using single-cell uptake experiments and single-endosome lysis experiments.
As a proof-of-concept experiment, we used a release-on-demand system PpIX, for which
the endosome lysis time distribution is expected to be narrow. A typical experiment to
obtain the endosome lysis times is shown in Figure 5.1. Briefly, cells are incubated with
PpIX-decorated ATTO633-QSY21 NPs and ATTO633-QSY21 NPs negative controls for 12
hours. Uninternalized antibodies were washed off and excess fluorescence is quenched prior
to PpIX excitation with a 405 nm laser. Excitation results in the production of reactive
oxygen species (ROS). ROS-mediated oxidation of double bonds in lipid tails destabilize
both the NP and endosome membrane. Experiments were performed on a fibroblast cell
line, which is expected to take up a fairly high amount of NPs, as opposed to the carcinoma
cell line against which it was tested. Apart from cell-related effects, we also tested the ef-
fect of the lipid membrane composition, as well as the duration of activation. Fluorescence
images were taken every second over two minutes at on three emission channels. Endo-
somes were semi-automatically detected using an in-house ImageJ plugin [87]; undetected
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endosomes are segmented manually Figure 5.1. Since PpIX activation halts the movement
of endosomes, it is only at the first frame that segmentation is performed.
Statistics from single-endosome PpIX-mediated lysis with different lipids, cell
types, and PpIX activation times
Time distributions of DOPE@CMS exhibit marginally earlier lysis times than DOPC@CMS,
indicating that kinetically, the fusogenic effects of DOPE are superseded by PpIX. Our
results also suggest that the activation time appears to play a more prominent role in
Renca-LacZ than in 3T3, as evinced by the bigger shift in the distribution when the ac-
tivation time is decreased (Figures 5.2C and 5.2D). Furthermore, the distribution of lysis
times after a two-minute PpIX activation is considerably more spread than in 3T3, which
could either be an experimental artefact, or an indication of cell-specific dependence of
endosome lysis.
To check if there were cell-specific differences that influenced lysis timing, we obtained
the endosome size distribution based on the regions of interest in the AlexaFluor Dextran
488 channel. We also obtained the corresponding intensity at the red channel as a rough
approximation of the endosome load. The disparities in the endosome area (Figure 5.3A)
and endosome load (Figure 5.3B) are relatively marked between the two cell types, with
Renca-LacZ cells displaying more size variation, and tending towards larger endosomes.
This is could be due to a higher expression and/or a longer lifetime of Rab5 in Renca-
LacZ, a protein that controls endosome fusion, and consequently endosome size distribution
[88]. The observations are consistent with a recent theoretical study that shows that the
endosomal escape time increases with the endosome size, and decreases as the net amount
of membrane disruptive material increases [21].
Cell-type dependence of nanoparticle uptake
Due to the unexpected disparities in the lysis results, we wished to quantify the uptake
differences between 3T3 and Renca-LacZ, as well as two other cell lines that we have not
previously used. These include Beas2B, a normal human bronchial epithelial cell line; and
Huh7, a hepatocarcinoma cell line. Parallel uptake experiments were performed on the
cells, which were incubated with NPs at two hour intervals up to eight hours. Our results
confirm that 3T3 cells take up more DOPC than Renca-LacZ cells on average. Additionally,
the cell-to-cell variability of uptake, as evinced by the distribution width, is approximately
twice as high for Renca-LacZ than 3T3 (Table 5.1).
Cell type uptake dependence of non-functionalized NPs has been reported previously
[89]. There have also been recent reports on uptake differences resulting not only from
cell surface properties, but also cell type-specific cytoplasmic and nuclear pore penetration
constraints [90]. These results altogether show the need for investigating this phenomenon
more closely, especially in the context of NP design and dosage.
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Sample Mean Width
DOPC@CMS, 3T3 675.7 ± 0.3 17.2 ± 0.2
DOPC@CMS, Renca-LacZ 644.5 ± 1.7 41.7 ± 2.4
DOPC@CMS, Huh7 673.9 ± 1.2 20.9 ± 1.1
DOPC@CMS, Beas2B 726.9 ± 9.4 132.5 ± 14.3
Latex, 3T3 1314.1 ± 29.9 227.8 ± 43.3
Latex, Renca-LacZ 1603.5 ± 19.3 1065.7 ± 31.6
Latex, Huh7 613.4 ± 69.4 1314.5 ± 102.0
Table 5.1: Selected gauss fit parameters of cell-type specific NP uptake profiles at eight
hours post-incubation
5.2 Stochastic pi calculus model of PpIX-enduced endo-
somal escape
To model the endosome lysis data, we extended our gold NP model to take cell-dependent
uptake, NP variability in terms of PpIX load per particle, and the PpIX-mediated endosome
lysis reaction into account. The structure of the model is shown in Figure 5.4. For our
runs, we made the initial assumptions that the rates from the gold NP model hold; given
that the CMS particles are 100 nm, while the gold NPs for which the model was written
are 4 nm, we changed the limits of optimal uptake from 43 - 125 NPs per aggregate to
a maximum of 15 per aggregate. We also preceded the uptake process with a delay that
generically represents cell-specific uptake differences. Each of 10000 NPs was initially
assigned a different PpIX load based on a normal distribution centered at 50 PpIX/NP
and a width of 5.
For the first version of the model, we omit effects brought about by the choice of lipid.
As a base case for the fit, we consider the data for DOPC-covered particles in 3T3 cells.
Simulations indicate sensitivity to endosome-specific parameters, specifically, the number of
net PpIX per endosome required to cause endosome lysis (Figure 5.5). However, changing
this parameter is not expected to be sufficient to capture the behavior in Renca cells,
for which the influence of heterogenous endosome size on this minimum number probably
requires explicit representation. The current model is limited by the fact that it is not
possible to use a random number generator within a running SPiM code; this would be
necessary for assigning a size attribute to the dynamically created endosome process, which
we infer would have an influence on the lysis time [21]. This feature is currently pending
as a request for integration into SPiM.
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Figure 5.1: Our reporter system is an NP comprised of a colloidal mesoporous silica
(CMS) core to which the photosensitizer protoporphyrin IX (PpIX), as well as ATTO633
quenched by covalently-attached QSY21 (A1). The system is co-introduced with a fluid-
phase marker, Alexa-Fluor Dextran 488, which delineates the bounderies of the endosome
(A2) The whole NP is sealed by a lipid bilayer. On activation by a 405 nm laser, reac-
tive oxygen species are produced and oxidize double bonds in the lipid tails, resulting in
membrane destabilization. The corresponding microscopy images prior to (B) and dur-
ing (C) lysis are shown. The corresponding segmented images in (B) are shown; not all
endosomes are successfully detected, and these have to be manually defined (arrow). A
typical signature of endosome lysis is shown in C, where a drastic drop in the red and green
channels, and a gradual rise in the ATTO channel, is detected. Automatically detected
discontinuities, indicative of lysis are recorded for different lipid coats and different cell
types.
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Figure 5.2: Time distributions of endosome lysis events after PpIX activation in 3T3 (A and
B) and Renca-LacZ (C and D) cells. PpIX-functionalized DOPC@CMS and DOPE@CMS
were incubated overnight, then activated for either one or two minutes. Results generally
show marginally earlier lysis times for DOPE@CMS. It is interesting to note that lysis
appears to be more concentrated towards earlier times for 3T3 cells than for RencaLacZ;
furthermore, the shift in the lysis times when activation is shorter is less prominent in 3T3.
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Figure 5.3: Endosome size distribution (A) and NP colocalization intensities per unit area
in an endosome (B) in 3T3 and Renca-LacZ cells.
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Figure 5.4: SPiM model structure for PpIX-mediated endosomal escape. Each NP process
is initially assigned a PpIX load attribute from a normal distribution centered at 50 with a
width of 5, as well as a parameter representing the number of activated PpIX, Act_PpIX.
NPs can bind to a cell or form aggregates. Cell binding can trigger uptake, whose rate
is adjusted to reflect differences in cell type. Each uptake event results in the generation
f an endosome; endosome fusion can occur as long as Act_PpIX = 0. On activation, a
subset of the net PpIX associated with the endosome is activated. If this is greater than a
threshold n, then lysis occurs. Otherwise, activation continues until n is reached.
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Figure 5.5: SPiM model fit of lysis data for DOPC-covered particles in 3T3 cells (A) and
the corresponding parameter sensitivity analysis (B). The models is most sensitive changes
to the minimum number of PpIX per endosome (marked by an asterisk). Variations in NP
batches have the potential to affect the results significantly as well, but our fit indicates
that inter-NP variation is less than 10%.
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Chapter 6
Design considerations for nanoparticles
with protein or peptide modifications
for targeted delivery and controlled
release
The previous chapter has dealt with a release-on-demand system that is suitable for de-
livery of cargo to tissues for which light penetrance is not an issue. For other tissues, it
would be interesting to develop NPs that do not suffer from this limitation. As indicated
in Chapter 2, viruses have been the main source of inspiration for such modified NPs.
Current hybrid vector designs frequently include targeting and lytic peptides, rather than
full proteins, to improve uptake and endosomal escape, while minimizing the likelihood of
an immune response [25]. These peptides sometimes bear mutations that are known to
enhance its function. Peptides, nonetheless, can still be immunogenic, and some work has
been done both in terms of defining the minimum peptide length that still results in fusion
[91, 92]. In comparison with the full protein, however, the performance of peptides is often
not as efficient. For instance, the transduction domain of the TAT protein of HIV-1, which
is sufficient to mediate viral material transfer into the cell in its native protein form [93, 94],
needs to be coupled with another fusogenic peptide from influenza hemagglutinin (HA) to
escape micropinosomes [95]. Similarly, longer cell penetrating peptides have been reported
to generally display higher uptake than shorter counterparts, even if uptake is receptor
independent [96]. Frequently, the structural features of a peptide, which are necessary for
fusion, are omitted in the use of shorter peptides, or peptides with modified sequences [97].
Finally, larger-scale structures such as the fusion pore also have to be taken into account
in hybrid vector design. Studying the mechanisms of action of a native targeting or fusion
protein is consequently a core feature in this area.
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6.1 Modeling minimal requirements for HA-mediated
endosomal release
Although it is not currently possible to precisely control the number of engineer surface
functionalizations or preassembled fusion pore structures on NPs, the incorporation of a
minimal number of targeting ligand is of particular interest, since high ligand densities
could lead to non-specific interactions with non-target tissue, as well as increased im-
munogenicity [25, 98]. As a starting point, we started looking at the mechanistic details of
HA-mediated endosomal release, specifically the minimal number of HA molecules required
to form a fusion pore. Perhaps not so surprisingly, the reports that we found on these are
contradictory at first glance [99]. To understand these results better, we compared the
experimental methods, data analysis and experimental results; in the six studies consid-
ered, we found that the experiments could generally be classified into cell-cell and virus-cell
fusion setups, which expectedly yield results that are not directly comparable. Limiting
our analysis to virus-cell fusion setups showed that the data are almost the same. The
interpretations differed based on the phenomenological model used. There were also cases
when different results are interpreted to yield the same minimum mechanistic requirements
for fusion because different phenomenological models were used to analyze them; of course,
this implies that using one model to analyze the other set of data would have resulted in
conflicting, rather than converging conclusions. To resolve these inconsistencies, we created
a rule-based model, detailed in Paper E, that was first specified in PABM, then executed
using the model-checker, PRISM [100].
The different possible combinations for the pore size, which ranges from six to eight; and
number of fusogenic HAs in a pore, which was reported to be between one and three, makes
it practical to first reduce the solution space and limit the model testing to the most feasible
scenarios. To achieve this, we first ran simulations using the fastest reaction possible for
pore sizes ranging from five to nine. The closest to the data was a pore size of six, which
we then used for testing all the possible combinations of fusogenic and non-fusogenic HAs.
We obtained the best fit using a fusion pore size of six, of which three are fusogenic; of
these three, two are free HA, and one is bound. These results were subsequently verified
by using the same rates obtained from virus-cell fusion data fits, together with HA and
sialic acid (SA) density estimates in the cell-cell fusion scenario to fit cell-cell fusion data
[99]. These results may eventually be used in designing NPs with preassembled fusion
pore-forming units, which would not only allow the NPs to escape from the endosome,
but possibly to enter the cell by direct fusion. Again, if it becomes possible to control the
number of surface functionalizations in an NP, it would be interesting to test uptake and
fusion kinetics using such minimally-modified vectors.
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6.2.1 NP uptake insights
Our understanding of interactions between NPs and cells, as well as the effect of serum
protein association with NPs, particularly those that form the corona, on cell-specific
responses, is probably just at the surface of the knowledge that is necessary to design
NPs with more predictable behavior. For instance, the experiment and model results in
Chapter 5 show how much cell-type specific characteristics, and not inter-NP variations
such as PPIX load, define the spread of endosome lysis events. However, we can only
speculate on why the uptake is varied, and our data an modeling results indicate the
possible involvement of Rab5 expression levels and lifetime as a contributor to the difference
between CMS performance in Renca-LacZ and 3T3 cells. Nonetheless, this does not tell
us why uptake among the different cell types is different.
We next asked the question of how much CMS NP uptake patterns will change by
functionalization. In a proof-of-concept experiment, we took filamentous HA from B.
pertussis, a heparin binding protein which induces lipid destabilization and mixing [101,
102], and resuspended it with the DOPC cover of the CMS NPs [103], effectively co-
introducing it with the NPs. We chose the protein because of its targeting and destabilizing
properties, its possible structural similarities to other fusogenic peptides such as influenza
HA and integrins [104], as well as its commercial availability. These uptake profiles could
also be considered as an indirect measure of the availability of the binding partner in the
target cell, and could be used as a starting point for evaluating the targeting peptides
that would work better for specific cell types. Uptake results without (Figure 6.1A) and
with (Figure 6.1B) HA are shown for the same cell lines tested previously. Interestingly,
fibroblast cells still show the least cell-cell variability in terms of uptake, but not the highest
average NP load, which is now associated with Huh7. There is, however, a general uptake
increase and spread for all cells, giving us again an idea that uptake may be generally
improved with the use of targeting proteins, but would significantly magnify the uptake
response variability.
In future work, it would be interesting to analyze the performance of arrays of NPs with
different functionalizations, deposited in a controlled manner, against different cell lines.
A study where an NP library, comprised of NPs modified with 146 small chemical groups,
was constructed and tested on five cell lines, may serve as a template for further assays
[105]. The information that can be derived from such an experiment include information
on surface modifications that change the affinity of particles; material that discriminate
between functional states of a cell and ad hoc identification of disease-specific agents with-
out knowledge of the target [105]. If the study is modified to use peptide, rather than
small molecule functionalizations, the study would also yield information on surface pro-
tein expression profiles across different cell types; this is, by itself, is an important result,
given that information is fairly scarce with respect to protein profiles for cell lines. The
use of the NP library could be extended to characterize the protein coronas for different
NPs. It would be interesting to see how much uptake characteristics are affected by the
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Figure 6.1: Uptake of DOPC@CMS NPs in 3T3, Renca-LacZ, Huh7 and Beas2B cells in
the absence (A) or presence (B) of filamentous HA from B. pertusis. Note that even with
non-specific insertion into the membrane, there is at least a two-fold increase in uptake.
The larger spread of data could be partly expected, both as a result of the variation in
the cell surface expression of heparin across the different cell types, as well as the varied
quantities of HA inserted per membrane.
corona, and how NP functionalization affects the corona itself.
6.2.2 Future work in nanoparticle design
The successful design and testing of a protocell, which combines the properties of lipo-
somes and nanoporous NPs, was recently reported [25]. This protocell was comprised of a
lipid-covered CMS NP to which a modified influenza HA lytic peptide and a human hepato-
cellular carcinoma targeting peptide have been incorporated. The targeting peptide makes
uptake highly specific and more efficient, with an increase of internalized protocells by an
order of 102 in target cells. Uptake saturation is observed at t = 1 hour post-incubation,
which is five hours earlier than what we have generally observed for unmodified particles.
Interestingly, DOPC protocells show improved surface binding to its target cells indepen-
dent of peptide density, which has been reported to range from 6 - 2048 peptides per
particle. This is attributed to the enhanced bilayer fluidity, which permits peptide re-
cruitment to the binding site. A problem with this, however, is that the extremely high
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membrane fluidity results in cargo leakage; stable formulations for drugs require bilayers
comprised of saturated lipids such as DSPC, and high cholesterol concentrations [25, 106].
For such less fluid formulations, more peptide would be required to generate equivalent
uptake effects [25]. Since the endosomal escape of HA-modified DSPC protocells was not
covered in the study, it could be speculated that this would be significantly lower than for
DOPC protocells, if not completely absent, especially for lower HA concentrations. This
is because of the requirement for membrane fluidity to assemble the fusion pore-forming
unit [99].
In cases such as this, the use of pre-assembled pore-forming complexes might be an
interesting option (Figure 6.2). While artificial pores that have been created so far are
limited to lipid nanotubes [107], the creation of preassembled protein or peptide pores
using DNA origami [108, 109, 110] might be a viable option. It is in cases as these where
combining results obtained from modeling, as in Paper E, and experimental techniques,
might prove practically beneficial.
pH-sensitive lipid 
dye
Targeting 
peptide
Preassembled lytic 
peptide cluster
Quenched 
Atto633
Figure 6.2: Design for a CMS-based NP tracker and delivery system with pre-assembled
pore-forming complexes. This inclusion of these pre-assembled pore-forming complexes
would facilitate endosomal escape even if the encapsulating bilayer is not fluid, as the case
would be when lipids such as DSPC are used. Less fluid bilayers are often recommended
for drug carriers, as these prevent premature cargo leakage [25]. Note that the design also
incorporates a pH-sensitive lipid dye, possibly enabling real-time tracking from incubation,
rather than after incubation. The targeting peptides might be dispensed with, if these are
pre-assembled with the pore-forming cluster as well.
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ABSTRACT: In non-viral gene delivery, the variance of
transgenic expression stems from the low number of plas-
mids successfully transferred. Here, we experimentally
determine Lipofectamine- and PEI-mediated exogenous
gene expression distributions from single cell time-lapse
analysis. Broad Poisson-like distributions of steady state
expression are observed for both transfection agents, when
used with synchronized cell lines. At the same time, co-
transfection analysis with YFP- and CFP-coding plasmids
shows that multiple plasmids are simultaneously expressed,
suggesting that plasmids are delivered in correlated units
(complexes). We present a mathematical model of transfec-
tion, where a stochastic, two-step process is assumed, with
the first being the low-probability entry step of complexes
into the nucleus, followed by the subsequent release and
activation of a small number of plasmids from a delivered
complex. This conceptually simple model consistently pre-
dicts the observed fraction of transfected cells, the cotrans-
fection ratio and the expression level distribution. It yields
the number of efficient plasmids per complex and elucidates
the origin of the associated noise, consequently providing a
platform for evaluating and improving non-viral vectors.
Biotechnol. Bioeng. 2010;105: 805–813.
 2009 Wiley Periodicals, Inc.
KEYWORDS: mathematical modeling; gene transfer; single
cell; transfection/gene expression
Introduction
Non-viral gene delivery systems have evolved over the last
decade into widely used vectors for exogenous DNA delivery
to eukaryotic cells. Synthetic cationic lipids and polymers, in
particular, are used in molecular biology for transgene
expression, and are being further refined for use in DNA-
based therapies (Ferber, 2001; Patil et al., 2005; Roth and
Sundaram, 2004). Despite considerable progress in the
efficiency and characterization of vectors, important aspects
of the delivery pathway and transfer kinetics remain poorly
understood, including how artificial vectors are taken up,
transported to the nucleus, and how these factors collectively
influence the expression characteristics of a cell population.
Current understanding from intracellular studies of
transgene delivery includes the following steps: DNA–
vector complex uptake via the endosomal pathway, followed
by endosomal escape and cytoplasmic transport, nuclear
entry, vector unpacking and transcription initiation (de
Bruin et al., 2007; Kircheis et al., 2001; Lechardeur et al.,
2005; Roth and Sundaram, 2004; Safinya, 2001; Suh et al.,
2003). These processes are accompanied by a huge loss of
material and temporal delays. It is therefore not surprising
that transfected cells in a culture respond very hetero-
geneously over time, notably in terms of the expression
onset time (ton) and the maximum expression levels
attained. It is generally accepted that the expression behavior
of a single transfected cell is stochastic, yet cell culture
averaged expression levels are reliable indicators of gene
transfer efficiency.
Flow cytometry is commonly used to measure fluores-
cence distributions over a population at a rate of up to
10,000 cells/second (Longo and Hasty, 2006). High-
content single cell assays, in contrast, are particularly
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suitable for investigating the dynamics and heterogeneity
of clonal cell populations, since individual cells can
be followed with a high temporal resolution. In addition,
quantitative image analysis has been successfully improved
to reliably convert fluorescence intensities into copies of
molecules, hence paving the path to follow ‘‘gene expression
by numbers’’ (Rosenfeld et al., 2005).
In this article, we analyze gene expression following non-
viral gene delivery, with focus on the variance of expression
levels. The expression of genes exhibits all-or-nothing
characteristics (Hume, 2000) and additional stochasticity
exists in transcriptional regulation (McAdams and Arkin,
1999; Rao et al., 2002). Elowitz et al. (2002) have analyzed
noise in bacterial gene expression and elucidated the
distinction between extrinsic and intrinsic noise, that is, the
contribution of fluctuations in cellular components
and inherent stochasticity of the biochemical processes
during gene expression. The extrinsic variance of gene
expression within a clonal population of eukaryotic cells has
been investigated in the light of stochastic theories
(Blake et al., 2003; McAdams and Arkin, 1997; Raser and
O’Shea, 2004; Volfson et al., 2006). It was only recently that
attempts were made to generate models for transgene
expression following non-viral gene delivery (Dinh et al.,
2007; Varga et al., 2000, 2001; Zhou et al., 2007).
Computational modeling might greatly enhance our under-
standing of gene transfer and aid in elucidating the nature of
the underlying transport barriers. Many of the issues
regarding cell entry and intracellular transport are shared
with attempts tomodel viral infection (Douglas, 2008; Varga
et al., 2005).
In this article, we used quantitative single cell time-lapse
microscopy combined with mathematical modeling to
analyze the variability in transgene expression (Fig. 1).
From the synthetic delivery agents currently being evaluated
for therapeutic use, we chose polyethyleneimine (PEI)
(Boussif et al., 1995) and the commercial Lipofectamine
2000, as cationic polymer and lipid model systems,
respectively. Both synthetic vectors are able to condense
plasmid DNA into DNA-nano particles, denoted as cationic
lipid (cationic polymer)–DNA complexes or just ‘‘com-
plexes.’’ Distributions of the expression onset times and
expression steady state levels were evaluated for both
vectors.
Data are well described by a stochastic delivery model,
which is based on the assumption that in a decisive step,
only a small number of complexes enter the nucleus
through a stochastic process. Out of these complexes, only a
fraction of the plasmid load is expressed (Fig. 1). The
theoretical model is further corroborated by a cotransfection
analysis, that is, the case of the simultaneous transfection
using two distinguishable plasmids encoding for CFP and
YFP. It is shown that this model consistently describes the
fraction of transfected cells and the observed expression
level distribution. As a consequence the effective size of a
stochastically delivered unit of plasmids (complex) can be
determined.
Materials and Methods
Cell Culture
A human bronchial epithelial cell line (BEAS-2B, ATCC)
was grown in Earle’s MEM supplemented with 10% FBS
at 378C in a humidified atmosphere, 5% CO2 level.
Transfection was performed on both non-synchronized
and synchronized cultures. A thymidine kinase double-
block was performed to synchronize cells.
Transfection
BEAS-2B cells were grown to 80% confluence from an initial
seeding density of 1 105 cells/well in six-well plates 24 h
before transfection. Cells were washed and the medium is
replaced with 1mL OptiMEM/well immediately before
transfection. Optimized transfection procedures were
performed using either 2% (v/v) LipofectamineTM2000/
OptiMEM or PEI (N/P¼ 8)/HBS; 1mg of pEGFP-N1 or
pd2EGFP-N1, is used for transfecting each batch of cells.
The transfection medium was prepared either by adding the
Lipofectamine or the PEI solution to the plasmid solution.
After the transfection media were allowed to stand for
20min the cells were incubated with 200mL/well
Lipofectamine or PEI transfection medium for 3 h at
378C, 5% CO2 level. After 3 h of incubation the medium was
removed, and cells were washed with PBS. Cells were
reincubated with Leibovitz’s L-15 Medium with 10% FBS
prior to EGFP expression monitoring.
Cotransfection
Cotransfection was performed with two kinds of pre-
parations containing the same molar amount per
plasmid. For one preparation, ECFP/Lipofectamine,
EYFP/Lipofectamine, ECFP/PEI and EYFP/PEI were
complexed separately. For the other, a mixture of ECFP
and EYFP hetero-complexes were complexed with
Lipofectamine or PEI. Transfection using either the
hetero-complexes (pre-mixed) or a mixture of homo-
complexes (post-mixed) was performed as previously
described. Cells were reincubated in growth medium and
CFP and YFP expression was monitored by fluorescence
microscopy after 24 h.
Data Acquisition and Quantitative Image Analysis
Images were taken at 10 magnification, with a constant
exposure time of 1 s, at 10min intervals for at least 30 h post-
transfection. Fluorescence images are consolidated into
single image sequence files. Negative control images were
taken to assess lamp threshold values and autofluorescence,
and were subtracted from corresponding image sequence
files to eliminate autofluorescence effects. To capture cell
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fluorescence over the entire sequence, regions of interest
(ROIs) were manually defined around each cell (Fig. 2).
Changes in total gray measurements in individual ROIs were
determined for each time point.
Results
Time Lapse Microscopy and Single Cell
EGFP Expression
A cell line of lung epithelium cells was transfected with a
plasmid encoding for the green fluorescent protein (EGFP).
Transfection protocols for PEI- and Lipofectamine-
mediated delivery followed standard procedures and
are described in detail in the Supplementary Online
Information. We denote the time of the gene vector
administration to the cell culture as t¼ 0 h. Transfection
medium was removed and cell growth medium added at
t¼ 3 h. Single-cell EGFP expression was monitored by
automatically taking sequences of fluorescence micrographs
from 25 view fields at 10-min intervals. Figure 2a shows a
representative sequence from a Lipofectamine transfection
experiment, with the initial bright field image, as well as the
EGFP fluorescence at t¼ 4, 8, and 12 h post-transfection.
These images demonstrate heterogeneity in both the
expression onset times and levels of exogenous gene
expression. It is observed that the number of fluorescent
cells increases with time; at the late stage (30 h), the ratio of
fluorescent to non-fluorescent cells is about 23% and 30%
for PEI- and Lipofectamine-mediated transfection, respec-
tively. A total of 500–1,500 cells were monitored in parallel
within one time-lapse experiment. Individual time courses
of the total fluorescence per cell were evaluated by image
processing from data stacks as shown in Figure 2b and
described in the Supplementary Online Information.
Figure 2c shows a series of representative time traces
from one transfection experiment, illustrating the signi-
ficant variance in both the expression onset time and EGFP
expression level. The typical sigmoidal shape of the
time courses is well described by the phenomenological
function
IðtÞ ¼ Imax
2
1þ tanh t  t1=2
trise
  
(1)
which allows the determination of the maximal fluorescence
plateau value (Imax) the time of half-maximum (t1/2) and the
characteristic rise time, trise. The fluorescence intensities
were converted into molecular units using EGFP standard
beads for calibration (see Supplementary Online Informa-
tion). In the remainder of the text we will give the
fluorescence intensity Imax in units of EGFP numbers G.
Equation (1) proved to be robust for automated data
analysis, facilitating the accumulation of statistics for a large
number of individual cells. In order to determine the time
points of expression onset, ton, we use t1/2–trise as an
approximation due to the lack of a well-defined point of
onset as shown in Figure 2d. Since the timing of gene
expression is expected to be dependent on the cell cycle, we
investigated the distribution of ton for synchronized and
non-synchronized cells. To this end, cells were arrested at
the G1/S-Phase transition using a thymidine kinase double-
block (Merrill, 1998).
Distribution of Expression Onset Times
Figure 3 summarizes the measured distribution functions of
ton and Imax for GFP expression after transfection of non-
synchronized and synchronized cultures with PEI- and
Lipofectamine-based complexes respectively. Expression
onset times range from 5 and 25 h for both PEI- and
Lipofectamine, indicating the existence of a time window
during which plasmids are successfully transcribed in the
nucleus. The distribution for Lipofectamine clearly peaks at
an earlier time (8 h) compared to PEI (16 h). On cell
cycle synchronization, the distribution of onset times
sharpen and become peaked at about t¼ 15 h for both
PEI and Lipofectamine. Bright field images reveal that most
synchronized cells divide 12 h after transfection. This is
consistent with the fact that transfection was carried out in
mid-S-phase, 3 h after release from the thymidine kinase
Figure 1. Experimental setup for single cell transfection experiments (upper
part) and key elements of the theoretical model (lower part). EGFP-encoding plasmids
and cationic agents form complexes, which are administered to eukaryotic cell
cultures. Automated single cell microscopy yields statistics on phenotypic expression
of EGFP. For the delivery of plasmids to the nucleus, stochastic effects are important,
while the following expression of fluorescent proteins can be described in a
deterministic fashion.
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double-block. This shows that plasmid activation occurs
about 3 h after the M-phase. Furthermore, since cell cycle
synchronization suppresses expression at earlier times, there
is evidence that the delivery process depends on the cell cycle
dependent breakdown of the nuclear membrane. This is
consistent with previous studies claiming that mitosis
enhances transgene nuclear translocation in cationic lipid
gene delivery (Brunner et al., 2000; Mortimer et al., 1999;
Tseng et al., 1999). We also find that synchronization leads
to a twofold higher steady state expression for PEI-mediated
(from 2.6 106 to 4.3 106 average EGFP molecules per
cell) and Lipofectamine-mediated (from 2.9 106 to
5.1 106 average EGFP molecules per cell) transfection,
consistent with earlier observations on ensemble averaged
data (Brunner et al., 2000).
Modeling Steady State Gene Expression
In order to analyze the distribution of expression steady
states, we introduce a mathematical model that describes
EGFP expression after transfer and nuclear translocation
of complexes containing exogenous EGFP plasmids.
Stochasticity due to nuclear translocation of the plasmid
complexes and the intra-nuclear activation will give rise to a
probability distribution P(X) for X successfully expressed
plasmids (see Fig. 4a). In the first stage of analysis,
we describe the expression of EGFP from a single activated
plasmid in a linear deterministic model and neglect any
cell–cell variability. Based on the biochemical reactions
describing transcription, translation and maturation as
shown in Figure 4b we denote the ensuing rate equations.
Here, R denotes the number of RNA molecules, U the
number of unfolded polypeptide chains, and G the number
of folded EGFP proteins:
_R ¼ sAX  dRR (2)
_U ¼ spR ðkM þ dUÞU (3)
_G ¼ kMU  dGG (4)
sA, sP, and kM denote the rate constants for transcription,
translation and EGFP maturation, dR, dU, and dG denote the
degradation constants of each product, respectively. The
degradation rates of folded (dG) and unfolded protein (dU)
are assumed to be equal, since the same proteases are
involved (Leveau and Lindow, 2001). A plasmid degradation
term was omitted, since its occurrence is predicted to be
negligible within the time frame considered (Subramanian
and Srienc, 1996). Literature values for the individual kinetic
rates are summarized in Table I. Equations (2)–(4) can be
solved analytically. For the steady state value, a linear
relation
Imax ¼ Gðt !1Þ ¼ kMsPsA
dGdRðkM þ dGÞX (5)
Figure 2. Acquisition of single cell time series. a: Microscopy view fields from a Lipofectamine transfection experiment. The first frame is a bright field (BF) control image.
Fluorescence image sequences are taken automatically at 10-min intervals for at least 30 h. b: Definition of regions of interest (ROIs), total gray value measurement and conversion
to the number of EGFP molecules. c: Representative time-courses of EGFP expression in individual cells following PEI-transfection. The population average (red) is plotted to
demonstrate its linear increase in contrast to the sigmoidal shape of the individual traces. d: Characteristic parameters of expression are obtained by fitting the heuristic function 1
(red) to the recorded fluorescence time course (black). The time of expression onset, ton, is calculated from the time of half-maximal expression t1/2 and the slope at that point.
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between the expression level Imax¼ [GFP] and the number
of expressed plasmids X¼ [plasmids] is obtained:
½GFP ¼ kexp½plasmids (6)
Here kexp denotes an effective expression factor, corre-
sponding to the number of proteins expressed per transcribed
plasmid in the steady state. With the values given in Table I,
we find kexp 4 106 molecules/plasmid, which compared
to the experimental number of molecules (1–15 106),
results in the remarkable finding that the number of
plasmids X is of order 1. This implies that most of the
variance in expression level originates from stochastic
variations in the small number of plasmids, such that the
distribution of GFP expression is determined by the
distribution of successfully delivered plasmids, P(G) P(X).
To further substantiate this conclusion, we designed
an experiment where the expression factor kexp is
deliberately modified through the use of destabilized
EGFP. It has a 14-fold higher degradation rate (ddesG)
due to an additional amino acid sequence (PEST), which
makes it more susceptible to proteolysis (Kain, 1999).
Figure 3e and f display the shift in the steady state
distribution of Imax, shown in a logarithmic scale. As
predicted above, the shape of the distribution function is
almost unchanged for both PEI- and Lipofectamine-
mediated transfection. In addition, the peak positions
shifted by a factor 12.5, which is close to the value 14.3
predicted from Equation (5).
Modeling Transfection Noise
Unlike in chromosomal DNA, which contains a fixed
number of genes, the transfection experiments discussed
here result in the delivery of a variable number of genes per
vector. We model gene delivery as a two-step stochastic
process as shown in Figure 4a. As we will argue in the
following, a two-step model is the simplest model that is in
accordance with the experimental data. The model consists
of (i) the nuclear translocation with probability m of
complexes containing an average of m plasmids and (ii)
intra-nuclear activation of plasmids, with probability q.
Whereas the probability q subsumes all phenomena
promoting or interfering with transcription such as DNA
methylation or complexation. We assume that the first
process, the delivery of complexes to the nucleus, is rare and
statistically independent, yielding a Poisson distribution for
the number of delivered complexes C:
PðCÞ ¼ m
C
C!
em (7)
characterized by its mean value m. Secondly, the indepen-
dent activation of a plasmid in the nucleus is described
by a Bernoulli process with success probability q. The
concatenation of both processes results in an expression for
P(X) which retains the characteristics of a Poissonian.
Mathematical details of its derivation can be found in the
Supplementary Data. Figure 5 shows the calculated
distribution of activated plasmids, P(X) (red bars), to the
measured experimental protein distribution, Pexp(G) (green
bars). In addition a theoretical protein distribution is shown
as black lines. Ptheo(G) is obtained from P(X) by additionally
accounting for noise in gene expression, where we have used
a relative magnitude of 0.3 for post-transfectional noise
from the literature (see Supplementary Data). Note that the
x-axis of the distributions P(G) is rescaled by the factor kexp
according to Equation (6). The agreement between
Figure 3. EGFP expression statistics for PEI- and Lipofectamine-mediated
transfection. Distributions of expression onset times ton (a and b) and maximal
expression values Imax (c and d), for PEI-mediated (red) and Lipofectamine-mediated
(dashed black) transfection depict strong variability within the cell cultures. The total
number of expressing cells was 23% out of 560 for PEI and 30% out of 502 in the case of
Lipofectamine. b and d: Thymidine kinase-synchronized cultures with 40% out of 1981
and 30% out of 1797 cells expressing EGFP for PEI and Lipofectamine, respectively. For
synchronized cells, expression onset time distributions coincide for Lipofectamine and
PEI, indicating that transfection is more likely to happen in specific phases of the cell
cycle. Distributions for Imax (given in units of EGFP molecules) cannot be explained by
post-transfectional sources of fluctuations alone. e and f: Effect of the altered
expression rates on the distribution of maximal expression levels Imax. Distributions
for d2EGFP (gray) and EGFP (red) transfected with Lipofectamine (e) or PEI (f) are
shown. d2EGFP, which has a higher degradation rate, exhibits a systematic shift of the
Imax distribution compared to EGFP, independent of the vector used. Besides this shift,
a change in the number of proteins per active plasmid, kexp, preserves the shape of the
distribution. This suggests that the shape is determined during plasmid delivery prior to
expression.
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experiment and model is remarkable considering that there
is only one free parameter in the fit. This is due to the fact
that two additional experimental constraints have to be met.
These are the measured fraction of transfected cells, TR,
defined as the percentage of cells expressing one or more
plasmids, and the average number of GFPmolecules per cell,
hGi, determined by calibration. The parameters m and mq
are fixed by these constraints. The remaining unknown is
the expression factor, kexp, which is determined by the fit
shown in Figure 5. We obtain kexp 1 106, meff 3, and
m 0.3–0.5.
The red curve in Figure 5 represents the distribution of
successfully expressed plasmids. This distribution, which is
directly related to the number of expressed GFP protein
though Equation (6), has a well defined mean value given by
h½plasmidsi ¼ mmq (8)
The transfection ratio, TR, is related to this mean plasmid
number. It depends on the average number of complexes
delivered m and the effective probability ~q that from any
given complex at least one plasmid is transcribed (we
present a complete derivation of these quantities in the
Supplementary Data).
TRðm;m; qÞ ¼ 1 expf  m~qg (9)
For the data shown in Figure 6, TR is of order 20%.
Cotransfection and Correlated Delivery
One important ingredient of our model is the delivery of
DNA in units or complexes and the subsequent correlated
coexpression of multiple plasmid copies. This assumption is
closely related to the question of whether DNA-complexes
fully dissociate before nuclear entry or complexes enter the
nucleus as a whole. To elucidate this issue, we studied
cotransfection of two distinguishable plasmids (CFP and
YFP) and analyzed the outcome of transfection using pre-
mixed and post-mixed complexes. Pre-mixed complexes
Figure 4. Theoretical model for transfection and gene expression. a: Our model of plasmid delivery consists of several stochastic components. The number of complexes
C delivered per cell is Poisson-distributed, with mean m. Each complex carries a random number of plasmids, described by a Poisson distribution with mean m. Finally, each plasmid
has an activation probability q, resulting in a Binomial distribution of active plasmids X out of the total number of delivered plasmids. With this approach, the overall distribution, P(X),
of actively expressing plasmids can be derived. b: Deterministic model of EGFP expression including transcription (sA), translation (sP) and protein maturation (kM). mRNA (R),
unfolded proteins (U) and GFP (G) are degraded with rates dR, dU and dG, respectively. Solving the corresponding rate equations, the steady state distribution of fluorescent proteins,
P(G), can be related to that of active plasmids, P(X).
Table I. Literature values for the kinetic rates of the linear gene expression model
Rate Best estimate in h1 Literature values in h1 References
sA (transcription) 180 145–240 Hume (2000)
sP (translation) 100 60–180 Molecular Biology of the Cell 3rd Edition (1995)
kM (fluorophore maturation) 1.0 0.96–1.28 Sniegowski et al. (2005)
dM (mRNA degradation) 0.10 <0.14 Sacchetti et al. (2001)
dP (protein degradation) 0.035 0.03–0.04 Sacchetti et al. (2001)
ddesG (destabilized protein degradation) 0.5 0.5 BD Biosciences Clontech
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contain both CFP- and YFP-plasmids in a single complex,
whereas post-mixed complexes contain either CFP- or YFP-
plasmids (for clarity see Fig. 6a and b). The steady-state
CFP/YFP expression was analyzed at 24 h post-transfection
for approximately 15,000 cells. We define the cotransfection
ratio, r, as the number of cells expressing both CFP and YFP
divided by the number of cells expressing either CFP or YFP.
We find that the cotransfection ratio increases from 12.9%
for post-mixed complexes to 21.9% for premixed com-
plexes. The significant difference could not be explained, if
complexes were completely dissolved in the cytosol and
delivery of plasmids was independent from the complexes.
The two-step delivery model, however, naturally explains
the discrepancy between pre-mixed and post-mixed com-
plexes. Based on our model, an analytical expression for the
cotransfection ratio can be derived (see Supplementary
Data) which predicts correctly the measured cotransfection
ratios, if the same parameters are used as determined from
the EGFP distribution function.
Discussion
We have measured the distribution of expression onset
times and steady-state expression levels derived from single
cell fluorescence time courses. Distributions of onset times
of PEI and Lipofectamine collapse on a single curve for
synchronized cell cultures, suggesting a universal cell cycle-
dependent gene delivery mechanism. Synchronized cells
exhibit a broad Poissonian distribution in expression levels
and cotransfection experiments reveal correlations in the
delivery probability for plasmids contained in one complex.
Invoking Occam’s razor, we analyzed the findings in
terms of an idealized minimalist model of gene transfection,
which describes gene delivery as a two-step stochastic
process. Yet our model proves to have considerable
predictive power by relating measurable quantities such
as the overall transfection efficiency, the cotransfection
probability and the shape of the gene expression distribution
with each other. Thus, the model allows the derivation of the
expression factor, the number of activated plasmids per
complex and the average number of delivered complexes
from the measured single cell transfection statistics. The
model also elucidates the origin of expression variance,
separating the noise due to small number fluctuations of
complexes, which is inherent to the delivery process and
extrinsic sources of noise due to cell–cell variability.
In our gene expression model, we refer to complexes as
units of coherently delivered plasmids. Those indirectly
inferred complexes are consistent with but not necessarily
identical to the complexes described in many physico-
chemical studies of PEI and lipofectamine mediated
transfection. Cationic-lipid complexes are known to form
multi-lamellar aggregates that contain a large number of
plasmids (Lasic et al., 1997; Ra¨dler et al., 1997; Zabner
et al., 1995). Following endocytotic uptake and release,
the complexes slowly dissociate in a stepwise, unwrapping
mechanism (Kamiya et al., 2002; Lin et al., 2003). PEI
complexes are torroids or rods with a typical hydrodynamic
radius of 100 nm (Boussif et al., 1995; DeRouchey et al.,
2005), which have been seen to be actively transported inside
cells (de Bruin et al., 2007) and to accumulate in the
periphery of the nucleus (Suh et al., 2003). Both scenarios
describe a situation where numerous small complexes have
equal chances of entering the nucleus during the course of
mitosis, which is consistent with our model assumptions.
Microscopy studies have argued favorably for complexes
being at least not fully dissolved at the final delivery stage
(Lin et al., 2003; Tseng et al., 1999). However, single nuclear
entry events have not been documented explicitly. The
probability of transgene expression in the nucleus again
depends on the nature of the transfection agent. Pollard et al.
(1998) reported that cationic lipids, but not PEI prevent
gene expression when complexes are directly injected in the
Figure 5. Comparison of single-cell data with the theoretical model. The the-
oretical EGFP distribution (black) is intimately connected with the underlying distribu-
tion of expressing plasmids (red). To facilitate comparison, the protein distribution has
been scaled down by the average number of proteins per active plasmid in steady
state, kexp. a and b: For synchronized cultures the measured protein distribution
(green) is fitted very well by our theoretical model (black). The fit for PEI transfection
(a) yields an average number of delivered complexes, m¼ 0.53, and an average
number of activated plasmids per complex, meff¼ 3.2. In the case of Lipofectamine
(b), we find m¼ 0.37 and meff¼ 3.2.
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nucleus. Such findings can only be consolidated with our
model, if the delivered complexes transform during the
course of the delivery, rather than being the same physical
complexes as originally prepared under in vitro conditions.
Within the context of our model we restrict ourselves to a
narrowed meaning of ‘‘complexes’’ as units of plasmids that
are co-delivered. In this framework, we determine the
average number of successfully delivered complexes and
the effective number of activated plasmids per complex from
the analysis of single cell statistics. It will be interesting to
corroborate the physical fate and the expression outcome of
single complexes by high resolution studies in single cells (de
Bruin et al., 2007).
The method to use transfection assays based on
automated high-throughput microscopy combined with
image processing might evolve into a routine tool for the
assessment of transfection efficiency. In contrast to ensemble
averaged fluorescence or luminescence data, single cell
assays yield precise distribution functions and single cell
expression dynamics, which allow a more detailed compar-
ison to theoretical models. As shown here, the analysis of
steady state expression levels provides access to the
probability of successful plasmid delivery (P(X)) and yields
an absolute number for the expression factor (kexp). In
forthcoming work we will discuss in more detail the
distribution of expression onset times and the expression
dynamics. We expect that our particular mathematical
model can be adapted to a wider class of transfection agents
and different types of cells. Their distinct transfection ratios,
rate constants and numbers of effective complexes will
become even more meaningful in the context of
comparative theoretical modeling. A combined experi-
mental and modeling approach will hence help to identify
rate-limiting barriers to gene transfer and will result in
improved data comparability, making it a versatile tool in
the continuous evaluation and improvement of existing
synthetic vectors.
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Abstract. We modify and extend Cardelli’s Brane Calculus and Danos
and Pradalier’s Projective Brane Calculus (PBC) to improve consistency
with biological characteristics of membrane reactions. We propose a Pro-
jective Activate-Bud-Mate (PABM) calculus as an alternative to the
Phago-Exo-Pino (PEP) basic calculus of L. Cardelli. PABM uses a gener-
alized formalism for Action activation with receptor-ligand type channel
construction that incorporates multiple association and aﬃnity similar
to Priami’s beta binders. Calculus elements are ﬁnite. Volumes are asso-
ciated with systems for more realistic compartment-based reaction prob-
abilities. PABM also uses Brane domains that partition membranes into
controllable, independent groupings of projective actions. Domains elim-
inate the need for parameters in Phago and Bud and allow lateral and
cross-membrane interactions. We show that PABM can emulate bitonal
membrane reactions. PABM also realizes the idea of L. Cardelli (Cardeli,
2004) on modeling molecules as systems.
1 Introduction
Cellular organization plays a key role in biological systems through the physi-
cal regulation of reactions. Enzymes, for instance, are typically sequestered in
membrane-bound systems to which access is only made possible through cascades
of equally regulated and timed signals. Most current formalisms for modeling,
however, do not possess an explicit functionality for modeling compartmental-
ization. In deterministic models, compartmentalization is modeled with the use
of additional variables that diﬀerentiate a species S that is within some com-
partment X from S that is within another compartment Y . While this has been
used with some success, S in X is actually not diﬀerent from S in Y , unless it
has already reacted with other species in either compartment. It has only been in
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recent years that several calculi were developed so that membrane compartmen-
talization: (a) becomes an inherent part of computations and (b) is emphasized
in simulating reactions[1, 2, 3, 4].
Brane calculus is a formalism that can be used to describe systems as
mem-brane-bound compartments that may contain other systems[3]. These com-
partments can merge, split or be hierarchically reorganized through uptake
(phagocytosis) or extrusion (exocytosis) mechanisms, based on the capabilities,
known as actions, of the membranes that enclose them[3, 5]. An important aspect
of these actions — directly adapted from pi calculus — is that they are triggered
via highly speciﬁc channel-based communication. Nevertheless, the mapping be-
tween channels is not necessarily one-to-one, with some channels having more
than one communication partner. Although the original concept of channels in
pi calculus was for mobile telecommunication systems, it is compatible with the
representation of biological interactions, from enzyme-substrate systems that in-
teract to form a chemically distinct product to receptor-mediated intermembrane
communication that leads to membrane reorganization.
Another formalism that includes compartments is Priami’s beta binders[4].
Here, much emphasis is given to the promiscuousity of the channels (“beta
binders”) through which the compartments interact, as well as its eﬀects on the
dynamic evolution of the compartment contents, interactions, and interfaces. As
in Brane calculus, compartments can merge and split as a result of binder-based
communication. While inherent in Brane Calculus, beta binders needed an ex-
tension to include hierarchical construction of compartments. Recent extensions,
however, only permit intuitive representation of static hierarchical structures,
but still forbid the explicit nesting of compartments[6]. The main advantage
of beta binders over Brane calculus is its natural representation of aﬃnity to
channel pairings, a concept that is adapted in the proposed extension in this
paper.
The uniqueness of Cardelli’s Brane calculus lies in the representation of all
computations on membranes. This is important, particularly since it is actually
the dynamic property of membranes that determines its capability to interact
with other membranes and its general environment in vivo. Consequently, this
property also determines how a membrane-bound system would evolve. Structure
hierarchy can likewise be easily represented in Brane calculus, where nested
systems are eﬀectively organized in tree structures[3, 5].
Brane calculus has been previously extended by Danos and Pradalier to in-
corporate the idea that the inner and outer surfaces of a membrane are not
identical[5]. In vivo, it could be frequently observed that the membrane protein
domains exposed to the extracellular matrix are diﬀerent from the domains ex-
posed to the cytosol. It is even possible for membrane proteins to possess either
an extracellular domain or a cytosolic domain. As a result, the deﬁnition of the
inner and outer membranes are diﬀerent. Additional physical restrictions are in-
troduced on which reactions could take place, in particular only directed actions
on membrane surfaces that could “see” each other are allowed to interact. This
extension using directed actions is known as projective Brane calculus (PBC).
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Nevertheless, there are a number of aspects in both calculi that involve con-
cepts not observed in biological system. The purpose of this paper is to introduce
further modiﬁcations and extensions combining the strength of both Brane cal-
culi, with the aim of making it even more consistent with the biological charac-
teristics of membrane reactions. Speciﬁcally, we introduce the following changes
that result to the proposed extension, the Projective Activate-Bud-Mate calculus
(PABM):
1. Use of the minimal set Smin ≡ {bud,mate, !, 0} instead of the set S ≡
{phago, exo, pino,mate, bud, drip} for the possible actions a ∈ Smin (see §2).
All other actions in S are realized using only the actions in Smin together
with directed Actions of PBC.
2. Abstraction of speciﬁc send-receive channel pairing into less speciﬁc chan-
nel name equality, eliminating the distinction between input and output
channels. Together with the previous revision, it allows generalized repre-
sentations in the form ax for Actions and Coactions, where x is a named
channel.
3. Introduction of Brane domains, which are autonomous groups of directed
Actions within a Brane. The use of Brane domains would also allow inter-
domain interactions within and across the same membrane.
4. Removal of the parameters for Bud and Phago, allowing the dynamic nature
of membranes to be reﬂected in the calculus.
5. Inclusion of volume information as a system attribute to reﬂect its eﬀects on
the probability at which collisions will occur inside a compartment.
6. Association of rates to channels emulating an aﬃnity feature similar to beta
binders.
7. Treatment of Brane constituents and contents as ﬁnite quantities.
8. Elaboration of molecules as systems, a concept previously introduced by L.
Cardelli[3].
These modiﬁcations are also geared towards the development of a machine for
Brane calculus that can handle large-scale biological models.
2 Modified Notations
Table 1 summarizes the proposed notation and conceptual changes to the current
Brane calculus, provided as a quick reference to the detailed explanations for
these changes in the succeeding sections.
2.1 Actions
Notations and terms. In the documentation for the design of a machine for
Brane calculus[7], stochastic pi calculus notations for input and output chan-
nels are used to distinguish between actions and coactions. At this point, it is
important to make a distinction between an action (small ‘a’), a and an Action
(capital ‘A’), σ. An action is an element of the set, a ∈ S currently deﬁned as:
S ≡ {phago, pino, exo,mate, bud, drip}; (1)
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Table 1. Comparison of the currently-established Brane calculus (Cardelli’s Brane
calculus and PBC) with the proposed calculus. Note that a, ai ∈ S σ, σi, τ ∈ A,
i = 1, 2, with a¯ as the coaction of a. Conventions for parallel composition from PBC
[5] are used.
Definition Brane/Pi Calculus PABM
Channel (x ∈ C) !x ←→ ?x x ←→ x
Set of actions (a ∈ S) S ≡ {phago,pino, exo, Smin ≡ {0,bud,mate, !}
mate, bud,drip, . . .}
Action (σ, τ ∈ A) a!x ←→ a¯?x !x ←→ ax (a 6= !)
Brane domain undeﬁned ρ ≡ 〈σ1 ; σ2〉
Brane 〈σ1 ; σ2〉 [ ρ ]
Directionality σ1 is outside, σ2 is inside σ1 is outside, σ2 is inside
System 〈σ1 ; σ2〉(| P |) [ ρ ](| P |)
Parameter σ(τ ) τ.σ and ρ (see text for details)
(bud and phago)
Choice σ1 + σ2 σ1 + σ2
Series σ1.σ2 or σ1σ2 σ1.σ2 or σ1σ2
Parallel σ1|σ2 σ1, σ2
ρ1|ρ2
P ◦Q P ◦Q
Replication !σ
.
= σ, σ, . . . (inﬁnite) (n)σ
.
= σ, σ, . . . , σ; n parallel
(σ)n
.
= σ.σ. . . . .σ; n series
(n)ρ
.
= ρ|ρ| . . . |ρ; n parallel
!P
.
= P ◦ P ◦ . . . (inﬁnite) (n)P .= P ◦ P ◦ . . . ◦ P ; n parallel
while an Action is an element of the set, σ ∈ A currently deﬁned as:
A ≡ {ax; a ∈ S, x ∈ C}, (2)
where the set C contains all possible channels. These notations are used through-
out the text. In PABM, we use the following (minimal) set:
Smin ≡ {m, b, 0, !}; (3)
where m is Mate, b is Bud, and two new actions, 0 and !, as the null and activate
actions, respectively. The set A remains the same but with S replaced by Smin.
We demonstrate that all other elements a ∈ S (Eq. 1) can be derived from a
combination of these modiﬁcations with the directed Actions of PBC. Note that
with the changes, the action becomes a passive entity (i.e. an action waits for
an activation signal) by default.
Since the deﬁnitions of mate and bud were not changed and have been dis-
cussed elsewhere [3, 5, 8], we will only review these deﬁnitions brieﬂy.
Activate action, ! Cardelli’s Brane calculus requires two levels of matching
before an Action could be executed/activated: (a) input and output channels;
and (b) action and co-action. The use of an activation signal is expected to
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improve the symmetry of form for the Actions with respect to channel and ac-
tivation pairings. Here, we introduce an activate action, ‘!’, to approximate the
input/output channel functionality of stochastic pi calculus, consequently pre-
cluding the need for an explicit distinction between actions and coactions within
Brane. The Action in the form !x acts as an initiator of membrane interaction
through channel x. This Action may be interpreted as a binding event, analogous
to the required output signal from the intiating membrane or molecule before
any non-activate Action can be executed/activated.
The use of an activation signal, instead of a more strictly-bound action-
coaction pair with matching channels, is based on the fact that a single com-
pound, modeled here as a communication channel, can interact with more than
one substance, which may range from proteins to oligosaccharides, on the cell
membrane. As discussed in §2.2, typical biological interactions involving recep-
tors, logically corresponding to channels, are one-to-many relationships, rather
than one-to-one pairs. Nevertheless, such cardinality does not imply that reac-
tion speciﬁcity is lost.
Another biological characteristic taken into account is the dependence of the
kind of reaction that occurs on the receptor type, rather than on the ligand (i.e.
it is the receiver that determines which eﬀect will occur). This characteristic
is particularly marked in cells of the immune system, as well as antibodies,
which have diﬀerent eﬀector functions associated with each class and subclass.
The proposed form emphasizes that interaction speciﬁcity is conferred by the
channel, but the receiver determines the type of action to execute.
The null action, 0. The null action, 0, blocks actions that precede it; an Action
in the form σ.0x0 can thus be used to model a blocked Action, σ. The null
action can be deactivated with !x, making σ accessible. Biologically, blocking
occurs in the event of temporary receptor internalization [9], binding-induced
conformational changes [10, 11], and binding-induced physical blocking of other
available binding sites. The use of 0 will be useful for modeling bind-and-release,
molecular functionality switching, and other membrane-bound mechanisms.
Bud. Bud refers to the arbitrary splitting of a membrane, resulting in two
membrane-bound compartments[3]. Cardelli makes a distinction between bud
and drip; bud occurs when the split occurs with one internal membrane, while
drip refers to the separation of zero internal membranes. In PABM, this distinc-
tion is not made.
Mate. Mate causes the irreversible mixing of actions of membranes that fuse
either horizontally (i.e. membranes at the same level of nesting) or vertically
through an exocytosis-type process[3].
2.2 Choice, Parallel, and Series
All discussions of choice, parallel and series compositions are made with reference
to Actions, unless otherwise indicated. Parallel and series compositions are not
valid for actions and channels.
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Choice. The concepts of parallel composition, choice and preﬁx(series) are re-
tained from pi calculus. The notation for choice will be retained (‘+’). Choice
could either be between actions a1 and a2 or channels x1 and x2. These are
equivalent to having a choice between two (or more) Actions in the basic form,
ax. In particular, the following choices within action-channel pairs (Actions)
would be equivalent to their respective choices between Actions:
(a1 + a2)x ≡ a1x + a2x (4)
a(x1 + x2) ≡ ax1 + ax2 (5)
(a1 + a2)(x1 + x2) ≡ a1x1 + a2x1 + a1x2 + a2x2 (6)
These equivalences remove the need of implementing Actions in their non-basic
forms. Hence, implementing choice in actions and/or channels will be unnecessary
since all cases can always be reduced to a choice between (at least) two Actions.
Aside from simplifying the implementation of Actions, Eqns. 4 and 5 reﬂect
biological phenomena. For instance, Eqn. 5 is illustrated by membrane-bound
receptors that have multiple ligands, with each ligand binding with a diﬀerent
aﬃnity. At least three virus families, Orthomyxoviradae, Paramyxoviradae and
Reoviradae, for example, use sialic acid in cell surfaces to enter via the endocytic
pathway(s)[14]. A biological phenomenon that illustrates Eqn. 4, on the other
hand, is the receptor for advanced glycation of end products (RAGE), expressed
in a wide variety of cell types. RAGE is characterized by its ability to recognize
numerous ligands, each of which result in diﬀerent eﬀects[15]. This is equivalent
to having several actions associated with the same channel. Although the reac-
tions of RAGE do not involve membrane structure deformations, a feature that
would allow the direct modeling of such events may be of interest. Furthermore,
Eqn. 5 implies that several receptors (or channels), can be used to initiate the
same actions. Diﬀerent receptors, for instance, are used by diﬀerent viruses to
enter the cell. Equation 6 is included for the purpose of completeness, but may
not have any biological signiﬁcance.
Parallel. Parallel pi processes and Actions, as indicated in Table 1, are repre-
sented following the notations in Danos and Pradelier and Cardelli.
Preﬁx/Series. The original notation will be maintained for the series. A recur-
ring series of the same Action would be used instead of replication to indicate
the ﬁnite reusability of an Action.
2.3 Rates
PABM incorporates rates by associating a real number, rx, to the channel of
each Action ax. When rx is associated with !x, it corresponds to the rate with
which !x reacts on average with its receiver — the basic rate. When this real
number is instead associated with ax, a 6= !, rx is a factor of the basic rate which
reﬂects the eﬃciency of the reaction. A value of 1.0 indicates that the speciﬁc
reaction rate with a particular receiver is the same as the basic rate. Association
of rates to channels is adapted from beta binders[4].
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2.4 Aﬃnity
Aﬃnity describes the strength of non-covalent interactions between a ligand to
its speciﬁc binding site on the receptor surface; this value is independent of the
number of binding sites[12]. Higher aﬃnities are associated with factors such as
the exposure of large, interactive amino acid side-chains, highly electronegative
groups, or the deformability of a surface; these characteristics generally enable
a ligand to form more non-covalent bonds with the receptor[13]. Empirically, a
value known as the aﬃnity constant (Ka) is used to approximate aﬃnity for
ligand-receptor systems1. It is determined by measuring the concentration of
free ligand required to ﬁll half of the binding sites on the receptor. When half
the sites are ﬁlled, [Ligand ·Receptor] = [Ligand] and Ka = 1/[Receptor], where
‘[X ]’ is used to indicate the molar concentration of X ; common Ka values range
from as low as 5× 104 to as high as 1011 liters/mole[12].
The use of aﬃnity in process calculi for biology has been proposed by C.
Priami and P. Quaglia as a feature for beta binders[4]. Aﬃnity is incorporated
as a probability P (a, b) that an interaction between two diﬀerent interfaces a
and b can take place, eﬀectively relaxing the requirement for an exact matching
of interface[6] — a distinct digression from pi calculus, where interactions occur
on syntactically identical ports (lock-and-key model).
In PABM, aﬃnity is inherent with choice. Since channels in PABM represent
receptor-ligand functionality, the execution of a single action a can be associated
with its interaction through more than one channel, say x1, x2, . . . , and xn, n >
1, resulting to the Action: a(x1+x2+. . .+xn) that reduces to ax1+ax2+. . .+axn
(Eqn. 5). When a = !, this results in multiple rates of execution, which depends
on the Action a′xl that is activated (a′ ≤ ! and l ≤ n). A similar situation occurs
when a 6= ! and a′ = !, albeit with a diﬀerent biological implication. Table 2
summarizes the diﬀerence between this approach and Priami’s implementation
in beta binders.
Table 2. Comparison of aﬃnity in beta binders and PABM
Beta Binders PABM
Association each reduction each channel
reaction probability P (a, b) multiple channels
Implementation between two non-identical using choice
interfaces a and b
2.5 Branes and Systems
The deﬁnition for Systems as sets of nested Branes is retained, and notations for
these are adapted from PBC[5]. Null Systems are represented as . Notations for
parallel composition of Systems are also retained. The same replication rules are
1 Notably for antibodies and antigens.
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applied to both Actions and Systems (Table 1). Branes however, are redeﬁned as
a composition of Brane domains; a Brane consisting of a single domain reduces
to the original deﬁnition (Table 1).
Directed Brane domains and directed Actions. In this section, the concept
of directed actions in PBC is extended to Brane domains. A Brane domain,
represented as a vector, ρ, is a grouping of directed Actions that approximates
the occurrence of composition and functional non-homogeneity (“patchiness”)
observed in biological membranes. Consequently, a Brane is now deﬁned as a
parallel composition of Brane domains. A Brane deﬁned using a single domain
is homogenous, and reduces to a Brane in PBC.
Brane domains were introduced to facilitate greater control in processes like
membrane budding. As opposed to Cardelli’s calculus where a parameter is used
to deﬁne the characteristics of the Brane that will be budded out, the proposed
calculus makes these characteristics entirely dependent on the current, dynamic
state of the parent membrane. Budding processes, however, are highly localized,
and the derived system should not have all the characteristics of the parent
membrane. In the proposed calculus, only speciﬁc Brane domains are transferred
in budding processes, unless the parent membrane is homogenous.
Alternately, a Brane domain can be visualized as a set of directed Actions oc-
curring proximally in a membrane. As an example, a system with Brane domains
is subsequently represented as follows:
[ ρ1|ρ2 ](| [ ρ3 ](| P |) ◦Q |) (7)
where ρn is of the form 〈σ1 ; σ2〉 (Table 1). As in the original Cardelli calculus,
both ρ1 and ρ2 are visible to ρ3. Using the rules of PBC, only the “outside”
Actions of ρ3 can interact with the “outside” Actions of both ρ1 and ρ2. The
advantage of this feature is relevant in modeling competition between parallel
membrane processes (§3.6).
It is important to note that Brane domains represent active or functional sites
on membranes or molecules and not the molecules themselves. Nevertheless, since
at least one active site is associated with proteins, these can be represented as
Brane domains. Brane domains can be used to model membrane proteins that
function together such as lipid rafts[17] and SNARE complexes[18].
Lateral and cross-membrane interaction. Since interactions are now be-
tween two Brane domains, apart from the interaction of a domain from one
membrane with another in a diﬀerent membrane, domain-domain interactions
within a membrane is now possible. Actions can now be activated by Activate
Actions on a neighboring domain (lateral membrane interaction). Activations by
Actions on opposite sides of a single membrane (cross-membrane) can also be
facilitated, provided that one of the Actions is translocated to the other side of
the membrane by a mechanism similar to diﬀusion or channel-mediated trans-
port. This capability can be used to model ligands that interact with receptors
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on the same membrane surface or on the opposite side of the same membrane.
Spontaneous membrane and in-membrane operations such as pinocytosis, drip,
inversion, and fusion of proteins to form rafts and complexes[17, 18] can now be
easily modeled.
The following equation shows the competition between a1x and a2x since
lateral- and cross-membrane interactions are allowed.
[ 〈!x ; a1x〉|〈a2x ; −〉|〈− ; a3x〉 ](| · · · |) ⇒ a1 or a2 (8)
Note that a3 cannot be activated since cross-membrane interaction are allowed
only within the same Brane domain. With PABM, the transport of functional
particles (e.g. molecules) through the membrane without introduction of atonal
reduction rules can also be modeled (see §3.7).
Volume information. A single enzyme-substrate experiment in a controlled
nanoenvironment has shown that the frequency of collisions between two
molecules is inversely proportional to the size of the vesicle where these molecules
are contained[19]. Consequently, volume information will be associated with each
System, representative of a compartment, allowing adjustments to be made in
the probabilities at which the contained reactions will occur.
2.6 Replication
For the purpose of a calculus geared towards discrete biological system modeling,
PABM uses a more controlled form of replication for Actions (also applicable to
Brane domains and Systems), where the cardinality of replication is indicated
(see Table 1). For instance, even if the initial counts of cellular components
that are in the order of & 104 to ∼ 1010 [16] are large enough to warrant
the use of ∞, these are still ﬁnite quantities that may be critical determinants
of biological system viability, especially in simulations that run for relatively
prolonged periods of time (≥ 24 hours). Finite replication also reﬂects the ﬁnite
lifetimes, masses and/or energies of both the components of biological systems
and the systems themselves, appropriately manifested in the calculus in the form
of ﬁnite Brane or Action usage. The numbers representing the ﬁnite number of
replications can also be made stochastic to mimic the heterogeneity of membrane
domains in terms of the absolute numbers of its constituents. Finite replication
is conceptually similar to energy in beta binders [4], since the special entity Ej
(with j ∈ <+) can be mapped to the cardinality of replication in PABM.
2.7 Sample Notation: Mitogen-Induced Proliferation of Schwann
Cells
Cell proliferation induced by an external signal is one of the simplest biolog-
ical examples that is, nevertheless, diﬃcult to express in an intuitive manner
without the use of spatial information. Mitogens, which induce cell division, are
typically associated with one or more cognate receptors through which it can
enter a cell. In Schwann cells, which form the insulation for vertebrate neurons
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in the peripheral nervous system and which are critical for axon regeneration,
proliferation is induced by the following mitogens in the neonatal stage: glial
growth factor (GGF), platelet-derived growth-factor B (PDGF-BB) and basic
ﬁbroblast growth factor (bFGF) [32].
For purposes of illustration, a coarse-grained model of the system can be
deﬁned in the above notational changes as follows:
[ 〈!xG ; !xa〉 ](|X |) ◦ [ 〈!xP ; !xa〉 ](|X |) ◦ [ 〈!xbF ; !xa〉 ](|X |) ◦
[ 〈mxG,mxP ,mxbF ; bxb〉 ](| SC ◦ [ 〈!xb.0xa ; −〉 ](| R |) |)
where each X represents a growth factor associated with some channel !xs,
where s represents the part of X that binds to the GGF receptor (G), the
PDGF-BB receptor (P ) or the bFGF receptor (bF ). The corresponding recep-
tors, mxG,mxP ,mxbF are all associated with the Schwann cell (SC). R repre-
sents the inactive replication machinery of the cell. This can only be activated on
the fusion of one of the growth factors with SC, removing 0xa, and making !xb
available for interaction. The availability of !xb in R allows SC to bud through
its interaction with Action bxb.
3 Projective Activate, Bud, and Mate Calculus
In this section, we demonstrate that all Actions in S (Eq. 1) can be expressed
as the actions in Smin (Eq. 3) combined with the directed Actions of PBC. The
use of Smin as primitives has similarities to the basic Mate-Bud-Drip (MBD)
calculus [8], which is one of two possible basic calculi for membrane interactions,
together with the Phago-Exo-Pino (PEP) calculus. It has been shown [3, 8],
however, that an encoding of MBD can be obtained with PEP, but not the
opposite, because the maximum level of membranes (i.e. the membrane nesting)
cannot grow during computation in MBD. Furthermore, the same articles prove
that PEP calculus is Turing complete and Turing powerful, as opposed to MBD.
Given these limitations, the use of a Bud- and Mate-based basic calculus ap-
pears counterintuitive. However, events indicated in the derivation of the MBD
primitives using PEP (Fig. 1A) are not observed in biological systems (Fig. 1B).
Although it is partly superﬂuous to observe that the derivations of MBD were
previously qualiﬁed as performed for computational purposes only, it is clear
that in vivo membrane fusion is characterized by membrane perturbances rather
than a series of phagocytosis and exocytosis events[20]. Speciﬁcally, the preva-
lent hypothesis regarding membrane fusion involves the reduction of the distance
between the fusing membranes, followed by the local perturbation of the lipid
structure and merger of proximal monolayers. Stalk formation and stalk expan-
sion, and ﬁnally, pore formation are postulated to follow. Furthermore, there is
a requirement that each of these steps has to be driven by an energy gradient
towards lower energies. The stalk hypothesis is mainly based on the observation
that the merger of proximal monolayers precedes the merger of distal monolayers.
These events are followed by the intravesicular solvent exchange[20].
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Fig. 1. PEP derivation of Mate [3] (A) and the latest model of how membrane fusion
occurs [20] (B)
The succeeding discussions focus on the proposed PABM calculus as an en-
compassing calculus that conforms better with biologically observed phenomena.
3.1 Mate and Bud as Inverses of the Other
We consider Bud and Mate membrane actions as the primitives of this calculus,
together with the Activate action, which controls their execution. Figure 2(top
to bottom) shows a local deformation of the membrane separating the spaces
labeled as P and Q ◦ R resulting from its interaction with Q. The increase in
local curvature is then followed by the movement of Q towards the newly formed
protrusion. On the fusion of the initial points of deformation, a new membrane-
bound space containing Q is formed within P (Fig. 2, bottom), completing Bud.
The reverse process, Mate, can be obtained using an opposite perspective. Here,
the membrane separating Q from P merges with the membrane separating P
and R (bottom to top). Colors are used to indicate tonality; in these processes,
bitonality is conserved, as in PBC[5]. Since Bud and Mate are opposite opera-
tions, it would be possible to think of these as belonging to a single operation.
3.2 Projective Equivalence
Projective equivalence arose from the introduction of directed actions by Danos
and Pradalier [5]. Brieﬂy, projective equivalence refers to the idea that the nature
of membrane interactions is such that one does not make a distinction between
top and bottom, or in this case, outside and inside. Consequently, by using a
simple point-of-view change (i.e. what one considers inside before, which is a
bounded space, is now viewed as the outside, which is unbounded), one reverses
the process. If one uses a pointed bitonal tree representation for the structure, the
equivalence is simply a change in the distinguished vertex [5], which is a change in
the root of the tree. One can then generalize phago and bud as a single budding
action, and exo and mate as a single mate action.
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Fig. 2. Mate and Bud as inverse actions of the other. Bud is shown as a sequence from
top to bottom while Mate as the reverse. Note that a distinction is not made between
“inside” and “outside” spaces. A bilayer is used to illustrate directionality.
3.3 Basic Reduction Rules
The basic reduction rules of PABM are entirely based on Bud and Mate. Reduc-
tion rules are applied between interacting Brane domains, where the location
of the activation signal with respect to the receiver (i.e. the directionality of
the Action) determines if a Bud will be inward or outward, or if a Mate will
be horizontal (i.e. membranes at the same level will merge) or vertical (i.e.
the membrane of a content will merge with the membrane of its parent); this
is conceptually similar to what has been done in PBC[5]. In the design of a
Brane model, the directions at which Bud and Mate proceed are naturally inte-
grated.The reduction rules of PABM are as follows, with “∼” used for indicating
projective equivalence[5].
– Bud:
P ◦ [ ρ1|〈σ1 ; σ2, τ2.bx〉 ](| [ ρ2|〈σ4, τ4.!x ; σ3〉 ](|Q′ |) ◦R |)
−→ P ◦ [ 〈σ1 ; σ2, τ2, τ4〉 ](| [ ρ2|〈σ4 ; σ3〉 ](|Q′ |) |) ◦ [ ρ1 ](| R |) (9)
∼[
ρ †1 |〈σ2, τ2.bx ; σ1〉
]
(| P |) ◦ [ ρ2|〈σ4, τ4.!x ; σ3〉 ](|Q′ |) ◦R
−→
[
ρ †1
]
(| P ◦ [ 〈σ1 ; σ2, τ2, τ4〉 ](| [ ρ2|〈σ4 ; σ3〉 ](|Q′ |) |) |) ◦R (10)
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– Mate:
P ◦ [ ρ2|〈σ1, τ1.!x ; σ2〉 ](|Q |) ◦ [ ρ1|〈σ′1, τ3.mx ; σ′2〉 ](| R |)
−→ P ◦ [ ρ1|ρ2|〈σ1 ; σ2〉|〈σ′1, τ1, τ3 ; σ′2〉 ](|Q ◦R |) (11)
∼[
ρ †1 |〈σ′2 ; σ′1, τ3.mx〉
]
(| P ◦ [ ρ2|〈σ1, τ1.!x ; σ2〉 ](|Q |) |) ◦R
−→
[
ρ †1 |ρ2|〈σ2 ; σ1〉|〈σ′1, τ1, τ3 ; σ′2〉
]
(| P |) ◦Q ◦R (12)
Note that Q in Mate is equivalent to [ σ4, τ4.!x ](| σ3 |)Q′ in Bud. Odd-even sub-
scripts and primed Actions are used to illustrate bitonality preservation. For
directionality to be conserved, note the need for the reversal of ρ1 to ρ
†
1 when
the perspective is changed.
In the case of Mate, interchanging the locations of mx and !x results in slightly
diﬀerent Brane domains. Eq. 11 results in:
P ◦ [ ρ1|ρ2|〈σ1, τ1, τ3 ; σ2〉|〈σ′1 ; σ′2〉 ](|Q ◦R |) ; (13)
while Eq. 12 results in:
[ ρ1|ρ2|〈σ1 ; σ2〉|〈σ′1, τ1, τ3 ; σ′2〉 ](| P |) ◦Q ◦R. (14)
It is only in the absence of τ1 and τ3 that the location of mx and !x does not
result in diﬀerent succeeding states.
3.4 Non-primitive Actions with Bud and Mate
As shown in Eqs. 9 to 12, congruence exists between an inward and outward Bud,
and between a horizontal and vertical Mate. This is more clearly illustrated in
Fig. 2, where one sees that a simple perspective shift makes the same Bud or
Mate operation inward or outward, or vertical or horizontal. For instance, when
one chooses P as the “inside”, Q can be viewed as budding in towards P , or that
the membrane containing Q is mating with the membrane separating P and R.
As a result, PABM considers a ∈ S, a /∈ Smin as membrane operations congruent
to either Bud or Mate operation or its speciﬁc cases.
Phago and Exo. Fig. 3(top) shows how Q is exocytosed from R or endocy-
tosed into P via Mate and Bud, respectively. This is congruent to the Mate-Bud
reactions in Fig. 2, with R as the outside and P as the inside. Phago is expressed
as Bud in Eq. 10 and is congruent to the usual bud in Eq. 9.
Pino and Drip. Pino and Drip may be spontaneous or induced Bud actions (see
Eq. 10), where a null System (Q = null) is created inside or outside the bounded
space P . The activation may also be induced by an appropriate Activate Action
outside or inside P , or within-membrane activations (see §2.5). Pino and drip
are obtained when Q = null in Fig. 3.
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Fig. 3. Speciﬁc cases of Mate and Bud: (top, forward) Exo and (top, reverse) Phago;
(bottom, forward) Cardelli’s Mate and (bottom, reverse) Bud operations
3.5 Enhanced Membrane Dynamics
A fundamental diﬀerence of the proposed calculus from the Brane calculus of
Cardelli is the dynamic nature of the reacting membranes. In Cardelli’s version,
the properties of budded membranes are speciﬁed as parameters to provide con-
trol; the same is true for the “endosomes” formed during Phago. In biological
systems, however, the characteristics of the budded membrane are necessarily
dependent on the state of the parent membrane at the time of budding or phago-
cytosis. Fig. 4 reﬂects this particular case of budding, when a sequential action
is associated with the activation Action on an initiating membrane (σ1, green).
Note the incorporation of σ1 in the budded membrane. Also note that only a
portion of the membrane is budded out.
This dynamic property of the membrane generally implies that systems in-
volved in a Mate followed by a Bud (b.m) will not evolve equivalently when
Bud is performed before Mate (m.b). For instance, consider the following initial
system:
Q0 ≡ [ 〈σ4, τ4.mxM ; σ3, τ3.bxB〉 ](| [ 〈σ1, τ1.!xB ; σ2〉 ](| P2 |) ◦ P3 |)
◦ [ 〈σ6, τ6.!xM ; σ7〉 ](| P1 |) (15)
Depending on which operation occurs ﬁrst, the system will evolve in two diﬀerent
ways. First, on performance of b.m, the system will evolve as:
Q0
m−−−−−−→ Q′0 ≡ [〈σ4, τ4, τ6 ; σ3, τ3.bxB〉|〈σ6 ; σ7〉](|
P1 ◦ [ 〈σ1, τ1.!xB ; σ2〉 ](| P2 |) ◦ P3|) (16)
Q′0
b−−−−−−→ Q′1 ≡ [ 〈σ6 ; σ7〉 ](| P1 ◦ P3 |)
◦ [ 〈σ4, τ4, τ6 ; σ3, τ1, τ3〉 ](| [ 〈σ1 ; σ2〉 ](| P2 |) |) (17)
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Fig. 4. Budding as a dynamic process. Note that a new action, σ1, associated with the
‘!’ is incorporated into the budded membrane. Domains are illustrated as line segments;
only selected domains proximal to the activated action are budded out.
Second, with m.b, the system will evolve as:
Q0
b−−−−−−→ Q′′0 ≡ [− ](| P3 |) ◦ [ 〈σ4, τ4.mxM ; σ3, τ3, τ1〉 ](| [ 〈σ1 ; σ2〉 ](| P2 |) |)
◦ [ 〈σ6, τ6.!xM ; σ7〉 ](| P1 |) (18)
Q′′0
m−−−−−−→ Q′′1 ≡ [− ](| P3 |) (19)
◦ [ 〈σ4, τ4, τ6 ; σ3, τ3, τ1〉|〈σ6 ; σ7〉 ](| P1 ◦ [ 〈σ1 ; σ2〉 ](| P2 |) |)
Clearly, Q′1 6= Q′′1 . This asymmetry example (b.m 6= m.b) is depicted in Fig. 5.
The diﬀerence disappears when the Mate and Bud are placed in separate do-
mains, 〈σ4, τ4.mxM ; σ3〉 and 〈σ′4 ; σ′3, τ3.bxB〉.
3.6 Competition of Parallel Membrane Processes
Using the concept of Brane domains, competition of two or more parallel mem-
brane processes can be easily modeled. Given the following system (longhand),
the interactions of !x is restricted to bx associated with σ1 or that associated
with σ3. If it interacts with bx in 〈σ1 ; bx〉, then the system reduction will be in
the form:
[ 〈σ1 ; bx〉|〈σ3 ; bx〉 ](| [ 〈!x ; σ5〉 ](|Q′ |) ◦R |)
−→ [ 〈σ1 ; −〉 ](| [ 〈− ; σ5〉 ](|Q′ |) |) ◦ [ 〈σ3 ; bx〉 ](|R |) (20)
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Fig. 5. Diﬀerences in ﬁnal system states based on the order at which reactions occur.
(top) Initial conﬁguration; (middle) Mate then Bud; (bottom) Bud then Mate.
On the other hand, if it interacts with bx in 〈σ3 ; bx〉 instead, then the system
reduction will be as follows:
[ 〈σ1 ; bx〉|〈σ3 ; bx〉 ](| [ 〈!x ; σ5〉 ](|Q′ |) ◦R |)
−→ [ 〈σ3 ; −〉 ](| [ 〈− ; σ5〉 ](|Q′ |) |) ◦ [ 〈σ1 ; bx〉 ](|R |) (21)
Competition can also be realized in lateral and cross-membrane processes
(see Eq. 8).
3.7 Molecules as Systems
Molecules can either serve as ligands or receptors. In this proposed modiﬁcation,
Molecules can be modeled as null Systems containing Activators associated with
Actions or other Activators. It may also be in the form of blocking functions,
σ.0x, which could only be activated by !x. A molecule can be modeled as:
Molecule : [ 〈σ1, (n)(!xname+!xgeneric) ; σ2, (m)(!xname+!xgeneric)〉 ](|  |) (22)
where τ may be a null Brane and the “name” could be the name of the molecule
making the channel unique for the molecule and “generic” refers to the generic
channel of the molecule. For example, “RNA” can be a generic channel having
the name of the protein that it encodes for its speciﬁc name.
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Together with cross-membrane interactions, molecule diﬀusion through a
membrane can be modeled without atonal reduction. This is illustrated in the
reduction below, where the molecule on the left-hand side enters the system
P . Note the change in the replication coeﬃcient, reﬂecting the reduction of the
active sites in both the molecule and the membrane surrounding P .[ 〈(!x)(n1) ; (bx.!y)(n1)〉 ](|  |) ◦ [ (n2)〈my ; −〉 ](| P |)
−→ [ (n2 − 1)〈my ; −〉|〈(bx.!y)(n1−1).bx ; (!x)(n1−1).!x〉 ](| P |)
−→ [ (n2 − 1)〈my ; −〉 ]
(∣∣ P ◦ [ 〈(!x)(n1−1) ; (bx.!y)(n1−1)〉 ](|  |) ∣∣) (23)
3.8 Mass and Energy Conservation
Since budding involves direct movement of Brane domains, mass (represented
by an Action) conservation is also simulated. The “consumption” of an Action
after reduction can be seen as the usage of the available energy used for and/or
transfer of mass during the process, i.e. transformation of the structure into
new ones.
4 PABM as an Extension of Existing Brane Calculi
Equivalent expressions for the multiple association of the activation action using
Cardelli’s original notations can be derived. Suppose there are three systems
that can interact via a generic action a, with coaction a. Multiple association
can be realized with:
a!x (|Q0 |) ◦ a?x (| P1 |) ◦ a?x (| P2 |) , (24)
where system Q0 can proceed with the action (a ↔ a) on both systems P1 and P2
through the same channel !x →?x. It is possible to eliminate the use of coactions
(a) through the following representation:
!x (|Q0 |) ◦ a?x (| P1 |) ◦ a?x (| P2 |) (25)
with !x possibly activating either P1 or P2 via a?x. This minor notation change
is immediately compatible with Pi calculus, and would require a minor code
translation for recognition by the Stochastic Pi Machine (SPiM) [21].
However, the proposed calculus also involves the removal of the sender-receiver
pairing (viz. !x →?x), apart from the action-coaction pairing. Moreover, in
Eq. 25, the notation is asymmetric, with the activator !x having a diﬀerent
form from a?x. It is possible to use α!x as a universal activator to conserve sym-
metry, but α will be underutilized. The use of a single “sender” is proposed for
all the other actions in the form !x, while simultaneously making the notation
symmetric with the use of the same form (ax, see Table 1). Both conceptually
and implementationwise, these major diﬀerences could be seen as improvements
over the current representation.
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Hence, the multiple association expressed as (24) would be written in
PABM as:
[ 〈!x ; −〉 ](|Q0 |) ◦ [ 〈ax ; −〉 ](| P1 |) ◦ [ 〈ax ; −〉 ](| P2 |) (26)
with x as the channel; “!” now belongs to the same class as a 6= ! (Table 1).
The choice of the symbol “!” for the activate action is directly inspired by the
Pi calculus notation.
As indicated previously, the other major departure from Cardelli’s Brane cal-
culus is the utilization of Brane domains in dynamic membranes to eliminate the
use of parameters in phagocytosis and budding. With these domains, a Brane
in PBC becomes a special case when a Brane in PABM is homogenous (i.e. is
comprised of a single Brane domain). For purposes of comparison, the reduction
rules of the original calculus [taken from [8]] are shown in Fig. 6.
Fig. 6. Cardelli’s Brane calculus reduction rules taken from [8]
The realization of non-primitive actions that were illustrated utilizes the same
concepts as in the projective equivalence of Danos and Pradalier [5], with the
exception that no arguments are explicitly used for the Bud action. Furthermore,
the simplicity of the current basis and reduction makes the calculus closer to
actual biological membrane operations. Finally, PBC becomes a subset of the
proposed calculus since PBC Branes can be simulated using homogenous PABM
Branes.
5 Summary and Outlook
We end this paper with brief discussions on a potential application of the calcu-
lus, as well as a strategy for its possible implementation.
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5.1 Application Example: Viral Infection
Inﬂuenza A causes highly contagious respiratory infections in humans that range
in severity from acute to lethal. New strains arise annually, which lead to 250,000
to 500,000 deaths worldwide[22, 23, 24]. It is particularly interesting for biologists
because of its ability to evolve very quickly, a trait that makes the development of
an eﬃcient vaccine against it particularly challenging[25, 26]. To date, a number
of qualitative studies have been performed to investigate its life cycle, but most
involved separate analyses of steps in the infection process [24, 26].
One of the recent most extensive quantitative models of inﬂuenza A in cell
culture is that by Sidorenko and Reichl[24]. It consists of 49 ordinary diﬀerential
equations (ODEs) that involve the use of additional parameters to approximate
the movement of viruses and its components across cell compartments. The main
results obtained from the model include the identiﬁcation of factors that limit the
growth rate of viral progeny; these results are particularly useful in molecular
engineering, where engineered viruses are created for vaccine production[24].
Nevertheless, it is clear that much is still not known about the inﬂuenza A life
cycle, primarily owing to the complexity of the virus. Some details, for instance,
that have not been included in the Sidorenko-Reichl model include the following:
1. Distinction between each of the eight strands of genetic material (vRNA),
complexed with three proteins (collectively known as vRNP), throughout
the replication cycle
2. Distribution of 11 protein-coding genes across the eight vRNAs
3. Indirect genetic material replication (vRNA → cRNA → vRNA), with the
intermediate cRNA being able to interact with the same proteins that vRNA
interacts with
4. Requirement for precise viral assembly
Accordingly, several key issues remain unanswered:
1. time it takes to assemble vRNPs
2. ratio of infective to non-infective viruses
3. instances of ‘infectivity recovery’ in the event that two complementary non-
infective viruses enter a cell
Since compartments can be naturally represented in Brane, its use for modeling
the inﬂuenza A life cycle is probably an elegant, quantitative alternative that
would allow the inclusion of details such as those enumerated previously. Fig. 7
is a general illustration for the possible usage of PABM to model the inﬂuenza
infection cycle. This particular model is an interesting application for Brane
calculus on account of its scale. Note that all operations used for modeling the
system are restricted to budding and mating, including the simulation of the
bind-and-release action in the nucleus. The position of activation signals are
not explicitly indicated in the ﬁgure, but could be deduced from the illustrated
processes.
In addition to these, it would also be possible to include details that are known
to aﬀect inﬂuenza infectivity, as well as eﬃciency[27]:
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Fig. 7. Inﬂuenza A infection cycle model being implemented using PABM. All opera-
tions are performed with Bud and Mate, including nuclear import and export through
the use of the NP protein, nuclear localization sequences (NLS) or nuclear export
sequences (NES). All processes are conformant with the actual events in inﬂuenza
infection.
1. cleavage eﬃciency of HA
2. distinction between transcriptionally active and inactive vRNPs
5.2 Implementation and Compatibility with SPiM
Previous eﬀorts have been made to implement Brane calculus[28, 29]. These
implement calculi based on the set S (Eq. 1) and were found useful for studying
events having the same scale as the Semliki forest virus life cycle, which was used
as the illustrative example in [3]. Nevertheless, these are not powerful enough to
handle models having the scale of the inﬂuenza A life cycle. It is consequently
of interest to develop an implementation that is both scalable and robust.
The stochastic pi machine (SPiM) was developed by Andrew Phillips, and
uses a simulation algorithm for stochastic pi calculus that is particularly suited
for simulating biological systems involving a large number of molecules. This
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simulation algorithm makes the execution cost dependent on the number of
species, rather than the actual number of molecules, unlike in direct implemen-
tations of the Gillespie algorithm [21]. SPiM has been used on a number of
occasions for a variety of biological problems [21, 30, 31]. Lately, the algorithm
in SPiM has been extended to include compartment-based computation, using
the Bioambients formalism [7]. SPiM also has a graphical interface, which sig-
niﬁcantly improves its ease of use.
PABM should be compatible with SPiM using the following equivalences:
!x ≡ (m!x + b!x + 0!x) (27)
ax ≡ a?x (28)
σ.!x ≡ a!x(σ) (29)
where a = m, b, 0 and a is the corresponding coaction. Encoding more speciﬁc
stochastic pi calculus constructs would only require the use of very speciﬁc chan-
nel names. For PABM to be implemented on top of SPiM, compartments, Brane
domains, and action directionality have to be appropriately represented. A sep-
arate implementation approach that focuses on the rewriting rules of PABM is
also currently being explored.
Acknowledgments. We wish to thank Luca Cardelli and Andrew Phillips for
helpful discussions.
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Abstract Computational modeling is increasingly
important to help understand the interaction and
movement of nanoparticles (NPs) within living cells,
and to come to terms with the wealth of data that
microscopy imaging yields. A quantitative description
of the spatio-temporal distribution of NPs inside cells;
however, it is challenging due to the complexity of
multiple compartments such as endosomes and nuclei,
which themselves are dynamic and can undergo fusion
and fission and exchange their content. Here, we show
that stochastic pi calculus, a widely-used process
algebra, is well suited for mapping surface and
intracellular NP interactions and distributions. In
stochastic pi calculus, each NP is represented as a
process, which can adopt various states such as bound
or aggregated, as well as be passed between processes
representing location, as a function of predefined
stochastic channels. We created a pi calculus model of
gold NP uptake and intracellular movement and
compared the evolution of surface-bound, cytosolic,
endosomal, and nuclear NP densities with electron
microscopy data. We demonstrate that the computa-
tional approach can be extended to include specific
molecular binding and potential interaction with
signaling cascades as characteristic for NP-cell inter-
actions in a wide range of applications such as
nanotoxicity, viral infection, and drug delivery.
Keywords Nanoparticles  Nanotoxicity 
Modeling  Process algebra  Delivery  Intracellular
distribution
Introduction
The growing use of nanotechnology in medicine and
many novel products for daily use underscores the
importance of studying the effect of nanoparticle (NP)
uptake on human cells and organs. NPs have been used
in a wide variety of biomedical applications (Stark
2011; Sperling et al. 2008; Murphy et al. 2008;
Alivisatos et al. 2005), but simultaneously present an
inherent risk to human health because of its ability to
penetrate human tissue, circulate in the blood stream,
and pass through cell membranes. Currently, there has
been an increase in the number of studies dealing with
the uptake and intracellular fate of NPs (Le´vy et al.
2010; Nativo et al. 2008), which are mostly found
enclosed within endo-lysosomal structures (Kneipp
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et al. 2006; Khan et al. 2007; Singh et al. 2010) and less
frequently, as free particles in the cytosol (Nativo et al.
2008), mitochondria (Singh et al. 2010; Li et al. 2003;
Xia et al. 2006), endoplasmic reticulum (Singh et al.
2010), or nucleus (Singh et al. 2010; Xia et al. 2006;
Garcia-Garcia et al. 2005; Alberola and Radler 2009).
Subcellular NP distribution data are good indicators of
both therapeutic efficiency (Le´vy et al. 2010; Sauer
et al. 2009; Boeckle and Wagner 2006) as well as
potential toxicity (Le´vy et al. 2010; Sauer et al. 2009).
There are also numerous reports on NP interference in
signaling pathways, including apoptosis (Muller et al.
2010; Zhao et al. 2009; Park et al. 2008), inflammation
(Muller et al. 2010), changes in gene expression, and
protein folding (Khan et al. 2007). Most of the progress
is in understanding the correlation between the com-
position of the adsorption layer of the NPs and uptake
(Dell’Orco et al. 2010; Nel et al. 2009; Lundqvist et al.
2008; Cedervall et al. 2007; Lynch et al. 2007).
As early as in the 1990s, the need for in silico
evaluation of adsorption, distribution, metabolism,
excretion, and toxicity (ADMET) of new drugs, now
naturally extended to NPs, was recognized (Haddish-
Berhane et al. 2007; van de Waterbeemd and Gifford
2003). The current influx of data, however, is not always
accompanied by a mechanistic understanding of the
processes behind these, further bolstering the need for
complementary quantitative and mechanistic models. A
key requirement for such models is the possibility to
cover broad spatio-temporal regimes that address all
aspects of NP-cell interactions. Finally, the model should
be able to handle stochastic behavior to account for the
inherent variability between the NPs, as well as the role
of the cell in response variability (Summers et al. 2011).
Currently, most NP-cell interaction models that
address NP subcellular distributions are formulated
using ordinary differential equations (ODEs) (Del-
l’Orco et al. 2010; Salvati et al. 2011; Dinh et al. 2007).
ODE models, however, have known scalability limi-
tations. Model extensions where variables with multi-
ple interdependencies have to be changed, for instance,
result in combinatorial explosion (Fisher and Henzin-
ger 2007). This limitation has major implications for
modeling multifunctional NPs, which are expected to
cross-react extensively with the biological system. The
inclusion of spatial information in ODE models would
also require the definition of additional variables for
each reactant in each of the specified compartments, is
similarly cumbersome and non-intuitive.
Apart from ODE models, statistical and phenom-
enological models have also been used for investigat-
ing NP-cell interactions (Summers et al. 2011; Puzyn
et al. 2011; Van Hoecke et al. 2009). Phenomenolog-
ical models, while useful in describing how NP-cell
interactions vary as a function of condition, do not
yield information on why these variations occur.
Furthermore, we have recently shown that the appli-
cation of two different phenomenological models to
the same data could result in radically different
interpretations (Dobay et al. 2011).
The application of concepts from concurrency
theory to biological modeling has opened a plethora
of possibilities for creating mechanistic models of
biological systems. Process algebra methods permit
the description of communication, specific interaction,
and synchronization between independent, mobile
objects known as processes (Milner 1999; Priami
2009). Communication between processes is done
through channels, with one process being the initiator
of an action and another being the receiver. Channels
have names, which allow communication to be
specific to subsets of processes. Finally, it is possible
to summarize reaction patterns as rules. These rules
specify how reactants can be recognized, which is
through channel names in pi; how the system is to be
written as a result of a reaction. Owing to these
characteristics, process algebra is particularly attrac-
tive for modeling biological systems.
In this article, we study the subcellular distribution
of gold NPs by transmission electron microscopy
(TEM), and use a stochastic process algebra model to
simulate their entry and intracellular movement in
living cells. Gold NPs have been chosen as a model
system due to their stability, ease of preparation, and
detection by TEM, as well as ready availability of
experimental data from other groups (Nativo et al.
2008; Bartczak et al. 2011; Chithrani and Chan 2007;
Chithrani et al. 2006). We develop a model scenario of
NP interactions, which specifically includes mem-
brane topology transitions via fusion and fission.
Specifically, we use an implementation of the sto-
chastic pi calculus, SPiM (http://research.microsoft.
com/en-us/projects/spim/), developed by Phillips and
Cardelli (2004), at Microsoft Research, Cambridge
which was developed for modeling biological pro-
cesses. SPiM uses the Gillespie algorithm to choose
the next reaction probability proportional to the base
rate of reaction and reactant availability, as well as for
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calculating its duration, insuring correct chemical
kinetics (Gillespie 1977). We use both the NP-as-
process and compartment-as-process abstractions,
which enable us to obtain the subcellular distribution
of NPs without the use of extra variables, as the case
would have been in an ODE model. Model results
demonstrate the potential of this technique for ana-
lyzing general NP-cell interactions, with a clear pos-
sibility of extension to more complex scenarios.
We discuss the use of stochastic process algebra for
general biological processes that involve particulate
objects and cellular membrane compartments.
The many parallels between NP uptake and other
cellular uptake processes would ultimately make such
models also useful in the areas of viral entry and gene
delivery.
Methods
Cell culture
Cells were grown in Earl’s MEM supplemented with
10 % FBS and 2 mM L-glutamine in a humified
atmosphere at 37 C with 5 % CO2 level. Cells were
maintained at 85 % confluence, trypsinized, re-sus-
pended in cell medium, and counted using a Neubauer
counting chamber.
Sample preparation for TEM
Human lung epithelial cells Beas-2B were seeded with
a density of 4 9 10 (Alivisatos et al. 2005) cells/well
onto Millicell polycarbonate porous membranes. One
day after seeding, 4-nm gold NPs 15 nM were added
and incubated in serum for 6 h to a final concentration
of 15 nM, following which cells were fixed overnight
with Karnovsky’s solution at 4 C. Cells were washed
with cacodylate buffer and post-fixed for 2 h with 1 %
osmium tetroxide in cacodylate buffer at 4 C. Eth-
anol was used to dehydrate the cells step by step before
embedding in EPON resin (Poly/Bed812-BDMA
Embedding Kit). Thin sections were stained using
uranyl acetate and lead citrate. Cells are sectioned
transversally with respect to the polycarbonate mem-
brane on which they are attached. Gold NPs were
kindly provided by Prof. Dr. W. Parak, AG Biophoto-
nik, Marburg, Germany.
Stochastic pi calculus model of NP entry
and intracellular movement
We created an executable pi calculus model using the
stochastic pi machine, v. 0.05 (SPiM, Phillips 2005,
freely available from http://research.microsoft.com/
en-us/projects/spim/). The model incorporates all
reactions illustrated in Fig. 3a; rates and restrictions
for each of the reactions are summarized in Fig. 3b.
Each run corresponds to the dynamics of a cell that can
take up a maximum of 2,000 NPs; results of 500 runs
were processed by a Perl script. Run automation was
facilitated by a simple shell script. The codes are
available from http://softmatter.physik.lmu.de/tiki-
index.php?page=Downloads.
Results
Subcellular distribution of gold NPs in epithelial
cells as seen by TEM
We performed in-house NP uptake experiments to
demonstrate the uptake mechanisms and subcellular
distribution of NPs. We studied lung epithelial cells
incubated with 4-nm gold NPs imaged using TEM
microscopy; these are visible in the cells as black
contrast-rich, electron-dense spots. Typically, NPs
aggregate after contact with cell medium (Fig. 1,
micrographs a, b, d, e, and f). Consequently, NPs occur
mostly as clusters inside cells: trapped in endosomes,
free in the cytoplasm, and in the cell nucleus.
Figure 1a shows an overview of a part of a cell where
NPs and NP clusters are found close to the cell
membrane and trapped in endosomes. We observe
NPs entering cells via diverse endocytotic pathways,
including macropinocytosis (Fig. 1b) and caveolae-
mediated pathways (Fig. 1c). Note the difference in
the magnification between micrographs 1b and 1c.
While micropinocytosis leads to big endosomes that
reach sizes up to 1 lm, caveolin-mediated endocytosis
leads to smaller endosomes of around 60 nm (Luc-
cardini et al. 2007). Since the different endocytotic
pathways lead to endosomes with different sizes, the
distribution of gold NPs in endosomes is non-uniform,
with some endosomes containing a high number of
NPs (Fig. 1d) than others, which can contain as little
as a single NP (Fig. 1c). Figure 1e shows NP clusters,
indicated by arrows, free in the cytoplasm. In the cell
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nucleus, NP clusters with diameters ranging from
15–20 nm are found. One such cluster close to the
nuclear membrane is shown in Fig. 1f. The histograms
in the lower panel of Fig. 1 summarize the number of
cells in terms of how much endosomes (Fig. 1g), free
NP clusters in the cytosol (Fig. 1h), and NP clusters in
the nucleus (Fig. 1i) they contain.
Implementation of NP interactions as a pi calculus
model
To understand this evolution of NP distribution inside
cells, we created a simulation that details NP uptake
and intracellular movement. Our choice of pi calculus
was motivated by scalability and expressivity and the
necessity of including stochastic aspects of the system.
To illustrate these points, we consider the first scenario
of NP interactions, namely the aggregation of NP and
their binding to the cell surface (see Fig. 2). An ODE
model requires as many variables as there are NP
species to distinguish between free NPs, NP clusters of
size 2, 3,… N, and their bound versions. This imple-
mentation is cumbersome, and involves an explosion
of the number of required variables as clusters of larger
size are included. Unlike in ODE models, where
locations and clusters of NPs are necessarily treated as
separate variables, in pi calculus, NPs are represented
Fig. 1 TEM images of 4-nm gold NP uptake. A 15 nM solution
of polymer-coated particles was incubated in with Beas-2B cells
complete medium for 6 h before fixation and TEM imaging.
a A typical overview of a part of a cell is shown. Cells are
attached on a polycarbonate porous membrane and are cut
transversally. NPs are found forming clusters outside and inside
of the cell. NPs use different modes of entry into the cells,
including pinocytosis (b) and caveolae-mediated pathways (c).
Inside cells, NPs are found localized in endosomes (d), free in
the cytosol (e) and forming small clusters inside the cell nucleus
(f). The number of endosomes (g), as well as the number of NP
clusters in the cytosol (h) and the nucleus (i) observed in the
examined sections are shown
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as processes the state of which can change as a result of
interactions with other processes. In any computational
implementation, many of these processes are generated
and concurrently updated in parallel (typically 2.000
processes in our simulations). NP processes have its
state and size as attributes, and could be passed as
parameters between processes representing location.
Specifically, NPs are modeled as processes that can
aggregate with each other through channels called
‘‘!aggregate’’ or ‘‘?aggregate’’ depending on whether it
is an output (!) or input (?) channel, respectively. When
an aggregation reaction occurs, the size attribute of the
sender NP is passed through the !aggregate channel,
and is added to the size attribute of the receiver NP. NP
adhesion to the cell surface is modeled using the
‘‘binding’’ channel, and results in the concurrent
updates of the state of NP processes in an aggregate
from ‘‘unbound’’ to ‘‘bound.’’ The corresponding code
is shown in Fig. 2. A process calculus simulator such as
SPiM executes the model by concurrently computing
the states of multiple NPs using a stochastic algorithm.
The program therefore keeps track of the fate of each
NP at any time. This attribute permits both NP
subcellular distribution and NP cluster size distribu-
tions to be easily obtained from the model. Process
algebra is thus fundamentally distinct from ODEs in
that the model of the system is not centered on
concentrations, their relationships, and how they
change over time. Instead, it is focused on the definition
of processes that capture the behavior of the biological
objects that they represent, and that can be directly used
as objects in a simulation.
Fig. 2 Scalability problems in modeling NP aggregation and
uptake using ODEs. An ODE model of NP aggregation and
uptake requires the separate specification of binding and entry
reactions for individual free (NP) and aggregated NPs of size 2,
3…N (NPA2, NPA3…NPAn). Note the need for extra variables to
track aggregates of different sizes. Apart from the obvious
scalability problems that would arise if reactions involving the
NP aggregates are introduced, one needs to have a priori
knowledge of particle sizes for which variables have to be
defined. In addition, a variable for NPs on the cell surface, NPB
has to be specified separately. If the size distribution of bound
NPs is needed, n additional ODEs, each representing bound
aggregates of sizes 1,…n, have to be specified. In contrast, the
equivalent pi calculus model only requires the definition of NPs
as processes that could aggregate or bind to a cell. When an
aggregate is formed, the size can be treated as an attribute of the
process. Further scalability problems in ODE models will arise
if the model is extended to include the intracellular location of a
particle (Fig. 3a). Rate constants for aggregation (rA), binding
(rB) are indicated in both models, and are assumed to be uniform
for all reactions, regardless of aggregate size. Communication
channels between processes (dashed lines) are similarly
indicated for the pi calculus model, and are colored by channel
name
J Nanopart Res (2012) 14:821 Page 5 of 12
123
Time evolution of NP uptake and subcellular
distribution in silico
We proceeded to extend our model to simulate the
entire gold NP cell uptake scenario. Including events
downstream of binding requires the definition of the
cellular locations as processes that can receive the NP
process as a parameter. Various extensions of pi
calculus which provide a more intuitive and elegant
description of dynamic compartments have been
developed. However, we developed the model using
pi calculus constructs. These processes are involved in
reactions that change the topology of cellular com-
partments and redistribute their contents accordingly;
these include endocytosis, fusion, exocytosis, and
dissolution-type reactions. Compartments may inter-
act with regular processes or with other compartments.
Figure 3a shows all the reactions that we considered in
our model. Reactions can be between processes, as in
NP aggregation; between a process and a compart-
ment, like in binding; or between compartments, as in
transcytosis. We assumed that both free and clustered
NPs could be internalized after a two-phase interaction
with the cell surface: the binding interaction results in
a state change of the NPs involved, while an interac-
tion on the ?uptake channel results in the creation of an
endosome process. The number of internalized NPs
per endosome is sent through the ?uptake channel. NPs
could then escape from the endosome into the cytosol
in a dissolution-type compartment reaction; NP
complexes that escape the endosome are assumed to
remain aggregated for simplicity. Alternately, the
endosome could be transcytosed in an exocytosis-type
reaction. Endosomes may also fuse with other endo-
somes, combining their NP contents. In all cases, an
output on any of the endosome channels passes the
number of NPs it contains onto the compartment with
which it interacts. This implies that possible reactions
per compartment are updated. All outputs on an
endosome channel also terminate the specific instan-
tiation of the endosome process, corresponding to the
physical dissolution of the endosome that occurs in the
cell. Of all the NPs, only those that are in the cytosol
can enter the nucleus through the !nuclear entry
channel; for clusters, a single output on this channel is
sufficient to translocate all the NPs in it into the
nucleus. Once in the nucleus, NPs can be eventually
modeled to undergo an activation reaction, which is a
generalization for diverse events that can range from
the release of NP cargo, or the initiation of an
interaction of NPs with the genetic material. Although
we do not include activation in our simulations, an
elaborated form of this reaction could be used in
evaluating either the efficiency of a NP designed to
deliver cargo to the nucleus or to evaluate the
cytotoxicity of a NP that can only be tolerated in the
nucleus at small amounts.
Figure 3b provides a list of all processes and its
corresponding channels corresponding to the model in
Fig. 3a. Each channel in it is associated with rates,
which, together with the number of processes bearing
the channel, determine the probability that the channel
event occurs. We endeavored to use realistic kinetic
rates obtained from experiments using gold NPs
reported in the literature, unless otherwise indicated
(Fig. 3b). The aggregation rate was estimated as
kagg = krC/W based on the theory of coagulation in
dilute dispersions (Hiemenz et al. 1997), where C is
the molar concentration of NPs and W is the stability
ratio. kr, the rate constant of rapid coagulation is given
by kr = 4kBT/3 g, where kB is the Boltzmann constant,
T is the temperature, and g is the viscosity of water.
Assuming W to be 5 9 10 (Alivisatos et al. 2005), as
taken from (Kim et al. 2008), this yields the approx-
imate aggregation rate of 12 NP h-1 at room temper-
ature. For the binding rate, we made the crude
assumption that binding is diffusion limited as well,
and the rate chosen was five times higher than the
aggregation reaction, taking the larger cell surface
area into account. The uptake rate was taken to be 20.0
NPs h-1, which was estimated from data for
50–74 nm gold particles (Chithrani et al. 2006).
We address the issue of size-dependence of uptake
rates more in detail at a later stage in this article.
The transcytosis rate was obtained for 15-nm gold
NPs, and was estimated to be of the order *0.2–1.3
NPs h-1; we took the lower limit of the rate. The
endosome–endosome fusion rate was treated as an
aggregation reaction, but with g replaced by local
cytosol viscosity, which is estimated to be 20 times the
viscosity of water (Leduc et al. 2011). This yields a
value of around 0.4 NP h-1, which is further reduced
to 0.1 NP h-1 given that most of these events occur
only around 40 min post-formation (Kjeken et al.
2004). For the rate of endosomal release, we took the
lower limit of 0.204 NP h-1 reported for a polyeth-
yleneimine (PEI) gene delivery vector, given that the
NPs do not exhibit the proton sponge effect that aids in
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PEI endosomal escape (de Bruin et al. 2008; Moore
et al. 2008). Finally, the nuclear entry rate, both for
NPs released was taken from HPMA copolymer
particles having hydrodynamic diameters ranging
from 2 to 4 nm (Callahan et al. 2009).
The model was run for 500 instances of cells, each of
which started with maximum of 2,000 NPs in the
extracellular milieu. The choice of 2,000 as the
maximum number of NPs that can enter a cell was
based on 14–74 nm gold NP experiments that placed
this number to be at the order of ten (Murphy et al.
2008; Chithrani et al. 2006). Subcellular distributions
obtained from this first model are shown in Fig. 4. The
most prominent feature is the inward shift of the
distribution over time. The first row of graphs shows
how the distribution of NPs on the surface shifts to
smaller values. At t = 30 s, approximately 800 NPs
have already had some interaction with the cell. Of
these, an average of 730 NPs are attached on the cell
surface, while around 60 are already in endosomes
(data not shown). After 5 min, most cells have an
average of 550 NPs attached on the cell surface, while
an average of 1,422 NPs are already in the endosome;
these include both free and clustered NPs. Uptake is
significantly higher than in Chithrani et al. (2006),
where this level is expected to be obtained at around
1 h. After 5 h, all the NPs are predicted to be
internalized. This is consistent with gold NP uptake
results reported in literature, where uptake saturation
for 14–74 nm particles begins at approximately 5.5 h
(Chithrani et al. 2006). The second row shows how the
NPs quickly fill endosomes. Endosomes then release
their cargo either to the cytosol or to the basolateral site
by exocytosis. Given that equal rates were assumed for
Fig. 3 Schematic drawing
of gold NP interaction and
movement in cells. Single
NPs can form aggregates of
unrestricted size, or bind to a
cell directly; NP aggregates
can likewise bind the cell.
On binding, both NPs and
NP clusters are taken up by
the cell into an endosome,
which can then either fuse
with other endosomes,
release its content to the
cytosol, or fuse with the cell
membrane on the basolateral
side of the cell. NPs can
enter the nucleus through the
entry of single NPs or NP
aggregates in the cytosol (a).
Both NPs and cell
compartments are treated as
processes in a pi calculus
model of the system. NP
processes are subsequently
passed through channels
between compartment
processes. An overview of
process channels and its
parameters are shown in (b).
Rates are taken from
literature derived from gold
NP, or equivalent
experiments. All rates are
associated with the output
channel
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these reactions, it is not unexpected that approximately
half of the particles are lost to transcytosis after 5 h;
only a very small percentage of the NPs are likewise
predicted to be in the nucleus, consistent with exper-
imental results (Fig. 1f, i). However, nuclear NPs are
predicted to increase at 10 h, which is not expected
from previous reports (Chithrani et al. 2006). Further-
more, our model predicts that the nuclear content is
widely distributed, whereas experimental data indicate
that nuclear clusters generally have diameters ranging
15–20 nm, roughly corresponding to complexes
formed from between approximately 25–50 NPs from
visual inspection (Fig. 1f). A likely reason for these
discrepancies could be the fact that the initial uptake
rates do not adequately discriminate between small
and large clusters, and hence overestimates both the
number of cell and nuclear entry events, as well as the
cluster size distribution.
Cluster size distribution and size-dependent rates
To account for size dependent uptake, rates can be
changed based on size conditionals. As a first mod-
ification, we simulated a significantly higher uptake
rate of 622 NPs h-1 for clusters of sizes 43–125 NPs,
approximately corresponding to 15–20 nm clusters,
which are known to be taken up optimally in
comparison to smaller clusters, or to clusters exceed-
ing a 100 nm diameter (Chithrani et al. 2006). Clusters
comprised of 1–42 NPs, as well as those greater than
125 were assigned a lower uptake rate of 1 NP h-1. In
Fig. 5, we demonstrate the outcome of size-dependent
Fig. 4 Simulation results of gold NP entry in 500 cells. The
diagram shows the NP distributions over 500 cells at five
different locations (surface, endosome, cytosol, baso-lateral
side, and nucleus) as a function of time. At t = 0, 2,000 free NPs
are assumed to be within the extracellular milieu of each of the
500 cells. At t = 5 min, most of the NPs (*1,500 per cell) have
been internalized, with around 25 % of the NPs remaining
bound to the cell surface. At t = 1 h, all the particles have been
taken up, 20 % of which have escaped into the cytosol.
At t = 5 h, cytosolic NPs reach a plateau of around 50 %.
Only *2 % cells are predicted to contain particles in the
nucleus. At t = 10 h, the number of nuclear entry events
increase significantly, and involve a wider size distribution of
clusters than those observed in experiments. Note that a column
sum of the averages for each location is equal to 2,000
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endosomal uptake. This refinement increases the
number of NPs per endosome from an average of
103 NPs/cell to 263 NPs/cell (Fig. 5a). Evaluating the
cluster size distributions of these endosomal NPs
reveals that there is indeed a significant increase in
larger NP clusters (Fig. 5b). The size-dependent
enhanced endosomal uptake also causes a correspond-
ing shift downstream in the number of nuclear NPs,
which now are now at an average of 50 NPs, down
from the 123 NP average when there are no size
constraints (Fig. 5c); this is now more consistent with
experimental data. To check if the nuclear clusters are
comprised of single clusters, or are comprised of more
than one set of clusters, we checked the number of
nuclear entry events. In both size-restricted und
unrestricted cases, most of the nuclear clusters result
from single entry events that mostly involve NP
clusters; size-restriction reduces the occurrence of
nuclear entry from 70 to 40 %, which is in agreement
with our data (Figs. 1f, 5d).
Discussion
In this work, we introduced the concept of process
algebra for modeling NP-cell interactions and high-
lighted the ease with which this approach allows
mapping of distribution of NPs across different
cellular compartments. At the same time, process
algebra prevents the problem of combinatorial
Fig. 5 Effect of size restrictions on uptake and nuclear
localization of NPs. Based on sphere packing calculations and
image analysis results, NP aggregates of size 43–125 were
assigned an uptake rate of 622 NPs h-1, while other aggregates
were assigned a suboptimal rate of 1 NP h-1, based on previous
experimental results. Incorporating the effect of aggregate size
on uptake rate, results in a significant reduction of single
particles and small clusters taken up in endosomes. These are
reflected in both the number of NPs in endosomes, which
increases from an average of 251 NPs/cell to 263 NPs/cell (a), as
well as the average cluster size, which increases from 26 to 55
NPs/cluster (b). The effects of cluster size restrictions on NP
uptake are also reflected in the sizes of nuclear-localized
clusters, which goes down from 123 to 50 NPs (c), a value more
consistent with experimental results, where clusters range from
15 to 20 nm. Size restriction, however, does not generally affect
the distribution shape of nuclear entry events, which indicate
that most nuclear NPs occur from single entry events of NP
clusters (d). Instead, restriction decreases the total number of
nuclear entry events from 70 to around 40 %, which is also more
consistent with TEM results. Endosome distributions were
obtained at t = 5 h, while nuclear distributions were obtained at
t = 10 h. The total number of aggregates was for 500 cells that
can internalize a maximum of 2,000 NPs each
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explosion, which occurs when NP aggregation is
considered. In particular, we described a stochastic pi
calculus model that simulates the subcellular distri-
bution of NPs as a function of its binding affinity, size,
(Milner 1999) and aggregation rate, as well as of the
topological changes of the compartments where it can
localize. Recent developments in NP research and
practical application has led to burgeoning amounts of
data, including subcellular distribution information,
but an understanding of the mechanisms governing NP
behavior does not appear as forthcoming. One of the
important first steps in this direction is the creation of a
computational model from which one could glean the
plausibility and/or adequacy of assumptions regarding
the system (Kitano 2002).
A critical step in creating any computational model
is parameter estimation; these parameters include both
reaction rates and reactant stoichiometry. When
possible, initial parameters are obtained from exper-
imental data. In this case, one could test the model
structure better, and deviations between the model fit
and the data could be attributed to the proper source of
error (Faller et al. 2003). It is rarely the case, however,
that all required parameters are available. Assump-
tions often have to be made about the order of
magnitude of the reaction rates, although it is possible
to calibrate the model to fit the experimental results in
a process called parameter estimation (Moles et al.
2003). Once parameters are estimated from the data,
these are statistical validated against all observed
dynamic behaviors of the system being modeled
(Faller et al. 2003).
For our model, we used rates for gold NPs, when
available, as well as from other particle as initial
values for our simulations. The first subcellular
distributions that we obtained from the model, how-
ever, were already generally consistent with experi-
mental data. A difference that we decided to address is
the result for nuclear NP cluster sizes. Given that it is
relatively straightforward to access parameters in the
model, we incorporated the non-linear dependence of
uptake rate on particle diameter. This modification
results in a significant reduction in the uptake of single
NPs and small clusters (Fig. 5), as well as a shift of the
average nuclear content size from 8 to 32 NPs, which
are now more consistent with data (Fig. 5c).
An important point that we made by comparing our
model with experimental results is that a pi calculus
model is very useful for testing hypotheses. Changes
are both easily incorporated and simulated; the states
of a process can also be accessed easily. We exploited
the latter feature to test the effect of having size-
dependent restrictions on uptake rates. This small
change in the model significantly improved the
consistency between simulation results and experi-
mental data. A remaining discrepancy, however, is the
breadth size distribution of NPs in the nucleus. Again,
this is possibly due to the absence of size restrictions
on the clusters that can enter the nucleus. If this is the
case, then a similar size exclusion condition based on
the nuclear pore diameter should be sufficient to
handle the discrepancy.
Models can be further extended by adding channels
for new interactions to existing processes, or defining a
new process with which old processes can interact
with. These do not often require extensive changes to
existing code. It must be borne in mind that the current
model is still comparatively simple, without details on
NP-surface properties, or its possible interactions with
proteins, most notably, corona formation (Cedervall
et al. 2007). Physicochemical properties, which can be
related to cytotoxic activity by the quantitative
structure-activity relationship (QSAR) method, are
not specified, either (Puzyn et al. 2011). Given that
these factors are very important in evaluating NP
cytotoxicity, it is particularly important that there is an
efficient way by which these could be incorporated
into a computational model of NP-cell and NP-protein
interaction. Furthermore, it is of interest in the medical
field to extend NP modeling to predictive simulations
of intracellular distribution of drug or gene-loaded
NPs. Gene delivery is a particularly appropriate
example for quantitative NP modeling since the
activity of successfully delivered NPs can be easily
followed by expression of GFP fusion proteins (Sch-
wake et al. 2010); this process could be included as the
activation endpoint indicated in Fig. 3.
For any of these extensions, stochastic pi calculus
models present a significant potential, as it allows
large systems to be modeled incrementally. The
specific implementation that was used to implement
the model, SPiM v.0.05, requires code written in SPiM
language, the syntax of which is slightly different from
pi calculus. A web-based, platform-independent appli-
cation prototype with a full graphical user interface
(http://lepton.research.microsoft.com/VisualSPiM/
frame_silverlight.html) is also available, but run
automation in this version is still under development.
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Similarly, a drag-and-drop interface for code genera-
tion is being developed in the group of Phillips to
preclude the need for users to learn the SPiM language
to create a pi calculus model (Service 2011). These
additional improvements to SPiM would make it even
easier to evaluate the potential of pi calculus models in
NP-related applications. As indicated previously,
there are other process algebras that were specifically
designed for handling compartments, such as Brane
calculus (Cardelli 2005) and its variants (Danos and
Pradalier 2005; David et al. 2009); BioAmbients
(Schwake et al. 2010; Regev et al. 2004) and Beta-
binders (Priami and Quaglia 2005). Currently, scalable
and automatable tools for these are under develop-
ment. These would eventually provide a more elegant
and intuitive way of writing more complex, compart-
ment-based models.
Conclusion
We demonstrated the potential of pi calculus for
modeling problems involving reactant state changes
and topological transformations, which are expected
to be key features in NP cytotoxicity modeling, and
which are likewise expected to be the source of
combinatorial explosion problems in equivalent ODE
models. The current gold NP model that we presented
sufficiently captures intracellular distribution patterns
from experiments. In the future, this can be easily
extended to detail how its distribution and properties
affect how it interacts with intracellular components.
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Controlled deposition of lipid bilayers plays a key role in creating supported membranes for
biosensing devices and biophysical cell studies. The authors adopt a solvent-exchange method in
order to deposit a phospholipid bilayer on solid substrates. The basic concept of deposition is to
dissolve phospholipids in isopropanol-water mixtures and to increase water content gradually.
Shortly before the onset of the micelle-to-vesicle transition, a lipid bilayer nucleates at the solid
surface. They investigate the bulk phase behavior and surface coverage using small angle x-ray
scattering and attenuated total reflection-Fourier transform infrared spectroscopy. They find a
sequence of transitions from inverted-monomeric-micellar and vesicle phases correlating with an
increasing amount of lipid on the adsorption layer. Supported lipid bilayers, prepared using this
approach, are homogeneous and fluid. © 2010 American Vacuum Society.
DOI: 10.1116/1.3319326
I. INTRODUCTION
Many of the structural and dynamical properties of lipid
bilayers, which characterize the unique properties of biologi-
cal membranes, can be preserved when deposited on solid
surfaces. As advocated in a seminal article by Sackmann,1
the scientific and practical applications of supported mem-
branes are versatile, and include applications such as bio-
physical model systems, biosensors or phantom cells. In gen-
eral, molecules and their molecular interactions are more
easily detected or imaged when anchored to surfaces. Sup-
ported membranes can be prepared as lipid monolayer or
bilayers. They can be chemically grafted to the solid or ad-
sorbed due to unspecific surface interactions. These have the
potential to be used in various ways in combination with
structured surfaces.2–8 For instance, it is possible to confine
fluid corals to chemically defined fields.6 This allows the
creation of integrated devices, such as lipid arrays or parallel
assays in lipid-based chips for analytical and diagnostic
applications.2,4,5 Moreover, supported membranes can be
combined with electrodes for monitoring membrane imped-
ance of pores,7,9 or with semiconductor technology for the
application of lateral fields for membrane based
electrophoresis.2,10,11 Since supported membranes remain
fluid, adsorbed macromolecules can easily be rearranged,
permitting DNA molecules to be prepared in a stretched
state.12 Setups required for observing and manipulating the
spatial organization of cell-model membrane interactions
benefit from supported membranes in that the interacting
components are well presented, such as those involved in the
specific immunological recognition processes of T-cells.13
An important role of lipids is also expected in future nano-
biosystems. Here, supported membranes can be designed
with nanoscale precision as nanofluidic lanes for transporting
and monitoring single molecules.8,14
There are various methods by which supported lipid bi-
layers SLBs can be deposited on surfaces. SLBs are com-
monly prepared by vesicle fusion, a method developed in the
McConnell laboratory,15,16 where sonicated vesicles in con-
tact with an appropriately cleaned glass surface rupture and
spread out to form a continuous bilayer.17 The difference in
surface free energy between a bare and lipid bilayer-coated
glass surfaces under water is the driving force that drags the
bilayer from an area of excess lipid to uncovered areas.18,19
Other methods to prepare supported membranes include the
Langmuir–Blodgett deposition,15 spin coating,20 evaporation
induced self-assembly,21 and more recently, dip-pen
technology.8 Each of these methods has inherent advantages
with respect to the applications in which they will be used.
For instance, the Langmuir–Blodgett deposition allows the
deposition of asymmetric bilayers,22 dip-pen technology fa-
cilitates the fabrication of biomolecular arrays,8 spin coating
enables the quick generation of highly oriented, homoge-
neous bilayer stacks with defined thickness,20 and evapora-
tion induced self-assembly permits the creation of patterned
nanocomposites of dissimilar materials.21 In some applica-
tions, exposure of the sample to air should be avoided, and
solution-based deposition of supported bilayers is
preferred;22 such procedures would also be suitable for a
wider class of surfaces, including hydrophobic surfaces23 or,
in principle, also solid particles such as silica or glass
beads.24,25 Tiberg et al.,26 for example, reported a simple
method of this kind for preparing model lipid bilayers by
coadsorption with a nonionic surfactant.
In this article, we present a solvent exchange method to
prepare supported membranes. In this process, the quantity
of the organic solvent, in which the lipids are dissolved, is
continuously varied by addition of water. The approach is
inspired by the reverse-phase evaporation method, where li-
posomes are produced through the slow removal of organic
solvent from a water-solvent mixture.27 Specifically, we in-aElectronic mail: joachim.raedler@physik.uni-muenchen.de
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vestigate the lyotropic phases of lipids in isopropanol-water
mixtures and the degree of lipid adsorption to solid surfaces
as a function of increasing water content i.e., solvent ex-
change, as schematically depicted in Fig. 1. Isopropanol was
chosen from the commonly used solvents because of its com-
plete miscibility with water. The lipids
1,2-dimyristoyl-sn-glycero-3-phosphocholin DMPC and
1,2-dimyristoyl-sn-glycero-3-trimethylammoniumpropan
DMTAP were chosen to investigate the effect of lipid
charges on structure formation on negatively charged sur-
faces. We present data obtained using small-angle x-ray scat-
tering SAXS and attenuated total reflection ATR infrared
spectroscopy to determine the bulk phase behavior and the
degree of surface adsorption. A micelle-to-bilayer transition
was found to occur at water contents between 80% and 90%.
It is shown that a continuous fluid lipid bilayer deposits at
glass surfaces when the water content of a lipid/alcohol/
water mixture is gradually increased across this transition
point.
II. MATERIALS AND METHODS
A. Reagents
DMPC and a cationic lipid, DMTAP, as well as its equiva-
lents with deuterated fatty acid chains d54-DMPC and d54-
DMTAP, were purchased from Avanti Polar Lipids Alabas-
ter, USA. A lipid with a longer chain,
l-stearoyl-2-oleoyl-sn-glycero-3-phosphocholine SOPC,
18:0/18:1—phosphatidyl choline, was also obtained from
Avanti Polar Lipids. All lipids were delivered dissolved in
chloroform. Isopropanol was obtained from Fluka Buchs,
Switzerland. All compounds were used without further pu-
rification.
B. Lipid preparation
Lipid samples were prepared by evaporation of the chlo-
roform under a nitrogen flow and subsequent storage of the
dried lipid in vacuum overnight. Degassed water and isopro-
panol were mixed by their volume properties and added to
the lipid. For Fourier transform infrared FTIR measure-
ments, the lipids were dissolved in a mixture with the final
water:isopropanol volume ratio. Samples for SAXS measure-
ments were prepared similarly in cylindrical tubes with an
outer diameter of 1.0 mm and wall thickness of 0.01 mm
Hilgenberg, Malsfeld, Germany.
For the continuous bleaching experiments, 2 mg lipids
were tagged with 0.25 mol % Oregon green Invitrogen and
dried overnight, as previously described.24 Lipids were then
initially dissolved in 1 ml of 50:50 volume ratio water:iso-
propanol solution and introduced into 100 l Ibidi bottom-
less chambers Ibidi, Munich fitted with a silicon oxide sur-
face Roth, Germany. These surfaces were prepared by
sonication in 2% Hellmanex for 15 min, followed by wash-
ing with sonication in distilled, de-ionized water Mill-Q,
Millipore Co., USA. All surfaces were dried under a nitro-
gen stream prior to use. Samples were slowly titrated with
water, with 10 min intervals prior to the addition of water
that changes the content 5% at a time, until a 90% content is
reached. After the last titration, this system was allowed to
equilibrate for 30 min prior to washing and measurement.
Samples were washed at least five times prior to measure-
ment to ensure the removal of remaining vesicles.
C. FTIR
ATR-FTIR experiments were performed with a Nicolet
60SXR FTIR spectrometer with a self-developed horizontal
ATR flow cell. The cell consists of a polycarbonate window
to avoid the formation of air bubbles and an aluminum crys-
tal holder for a water-based temperature control.
To imitate a glasslike substrate a silicon crystal with a
native SiO2 surface was used as the ATR crystal. The silicon
crystal’s surface was purified by storing it in a 2% sodium
dodecyl sulfate solution for one day and cleaning it in a
mixture of 70% nitric acid, 10% hydrogen peroxide, and
20% water for 1 h. The crystal was rinsed under water and
dried for one day. Infrared spectra IB of the dry cell, IR
of the water/isopropanol filled cell, and IS of the cell filled
with lipid and solvent were measured. The corrected spectra
were calculated by
I =
Is
IB
− 
IR
IB
.
The coefficient  was adjusted to minimize the water
bands in the spectra.28 For each lipid mixture, a part of the
sample and the reference measurements are used in order to
prevent the retention of any background after the correction.
Lipids used had a concentration of 1 mg/ml. A 15 min equili-
bration period is allotted after samples are placed in the mea-
surement chamber; this also allows the water vapor and CO2
in the chamber to be reduced.29 To determine the absorption
intensities, the spectra were matched against a sum of six
Gaussian curves, with their position and width determined
from reference measurements involving higher lipid concen-
trations. For the analysis, a prefactor was varied and data
were fitted with a Gaussian-type baseline correction.
FIG. 1. Color online Principle of solvent exchange-induced physisorption.
Lipids dissolved in pure alcohol are not adsorbed onto a SiO2 substrate. As
water content increases, micelles begin to form, which can also adhere to the
substrate. In pure water, lipid bilayers exist both on the substrate, as well as
in solution as liposomes.
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D. SAXS experiments
SAXS experiments were carried out at the high brilliance
beamline ID2 at the ESRF Grenoble, France. X-ray scatter-
ing intensity at 0.15 nm was measured by a multiwire pro-
portional gas-filled detector and radial integrated. The inves-
tigated q range for SAXS was 0.2–5 nm−1. The sample
environment allowed temperature control within 0.1 °C
through a Peltier water bath setup. The rotational symmetric
scattering data were integrated radially and fitted with a
model of three definite electron densities for solvent, acyl
chains, and headgroup. Scattering curves were fitted in the
wave vector range between 0.8 and 5 nm−1 without back-
ground correction. The headgroup of the lipids was assumed
to consist of an electron density H=0.45 e− /Å3 and acyl
chains of c=0.17 e− /Å3.30,31 The electron densities of
isopropanol-water mixtures range from 0=0.157 e− /Å3
0% water to 0.266 e− /Å3 100% water.
E. Determination of the lyotropic phases
The multilamellar phases were characterized by the posi-
tion of the Bragg peaks d=2 /q with no further analysis of
the structure and form factor.32–34 Isotropic phases were ana-
lyzed by fitting the intensity Iq=Fq2 with the theoretical
form factors Fq, corresponding to spherical micelles, ellip-
tical micelles, rodlike micelles, vesicles, and a planar lipid
bilayer. The geometrical parameters were optimized to fit the
data. In each case, the model with the best chi-square value
was chosen. The form factor of vesicles was derived from
the form factor of a sphere
Fs,0,R,q = 43R3 − 0
3 sinRq − Rq cosRqRq3  .
The form factor of a spherical micelle is than given by
FvH,0,R,D,q = FsH,0,R,q − FsH,C,R − D,q ,
where H, c, and 0 denote the electron densities of the lipid
head group, the alcyl chains, and the solvent, respectively,
and where R is the radius of the micelles. The form factor of
a vesicle consists of several shells,
Fvs,0,R,D1,D2,q = FsH,0,R,q − FsH,c,R
− D1,q + FsH,c,R + D1
− D2,q − FsH,c,R + D − D2,q .
D1 and D2 are the thickness of the headgroup and the mem-
brane thickness, respectively. Elliptical micelles were fitted
with the anisotropic form factor
F2c,s,0,Rc,Rs = 	
0
/2
Vcc − sfq,Rc + Vs + Vc
s − 0fq,Rs2 sin d ,
fq,R = 3sin X − X cos X
X3
,
X = qR
sin2  + 	2 cos2  ,
V = 4/3	R3,
where 	 denotes the anisotropy factor.
F. Continuous bleaching
The continuous bleaching method24,35,36 was used to char-
acterize the dynamics of the generated membranes. Accord-
ing to the theory of the method, the spatial intensity of a
fluorescently labeled membrane is described by simultaneous
photobleaching and replenishment of fluorescent molecules
as they diffuse in two dimensions. Briefly, we continuously
illuminate a defined region with an approximate diameter of
180 m, viewed at 63 magnification, Figs. 7a and 7e
of the SLB, resulting in the bleaching of the Oregon green
dye, whose fluorescence intensity at the center of the illumi-
nated area, Id/2, decays exponentially as a function of expo-
sure time according to the equation
Id/2t = It0e
−B0t = It0e
−

,
where It0 is the initial fluorescence intensity at the center of
the illuminated area, B0 is the bleaching rate, and 
=B0t is
the dimensionless time. Values for Id/2 and B0 were obtained
as previously described.31 When the fluorescence intensity at
the center of the illuminated region approaches background
fluorescence, the fluorescence intensity line profile Figs.
7c and 7g is fitted as a function of distance according to
the equation
Ix = Ix0 cosh
B0D x − d2 + A2,
where Ix0 is the fluorescence intensity at the edge of the rim,
D is the diffusion constant, and A2 is a constant used in
fitting. Diffusion constants are estimated from these fits
Figs. 7c and 7f. SLBs formed by controlled deposition
were compared to SLBs formed by vesicle fusion, as de-
scribed by Zantl.37
III. RESULTS AND DISCUSSION
A. Determination of volume phases by SAXS
We used SAXS in order to determine the lyotropic me-
sophases of lipids through the whole spectra of water:isopro-
panol concentration ratios, as well as through different tem-
peratures. Figure 2 shows the scattering intensities of the
lipid, DMTAP, dissolved in water:isopropanol mixtures
through increasing water concentration. In pure isopropanol,
we find a sharp Bragg reflection at 1.42 nm−1, corresponding
to a structural periodicity of 4.4 nm. The periodicity in-
creases to 4.7 nm when the water content is increased to
15%. These values lie within the bounds of typical values for
a lamellar phase. However, the detailed structure of the
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lamellar phase in isopropanol might be distinct from the
well-known lamellar phase of lipids dispersed in water.38
For 30% and 40% water contents Fig. 2, no notable
signals can be observed. These suggest a homogeneous scat-
tering medium. A light bending that occurs maximally at
1.8 nm−1 corresponds to a distance of 3.5 nm, which is the
characteristic correlation length for molecules at a concentra-
tion of 25 mg/ml. These features are both indicative of the
existence of lipid monomers. At 50% water content, a
slightly increased intensity can be observed at 1 nm−1,
which may be indicative of a small fraction of micelles in
solution. At 60%, the scattering profile exhibits a form factor
which can be attributed to spherical micelles. The data were
fitted to the form factor of a micelle in the range between 0.6
and 5 nm−1, as described in the experimental section. Micel-
lelike structures are known to occur in binary isopropanol-
water mixtures, without lipid, at 60% water content.38,39 It is
likely that in the ternary system, phospholipids will incorpo-
rate into these spherical aggregates. Our data are consistent
with a polydisperse, Gaussian distributed system of spherical
micelles with a radius of 2.5 nm1 nm and a headgroup
size of 0.2 nm. These data were derived from SAXS data
assuming a core-shell structure as described in the experi-
mental section.
At 70% and 80% water contents, Bragg reflections asso-
ciated with a multilamellar phase were detected again, with a
periodicity of 4.8 nm. At 90%, we find a form factor corre-
sponding to dispersed unilamellar vesicles Figs. 2 and 3b,
and as described in the experimental section. In this case,
the fitting analysis yields a range of possible fit parameters
dependent on the selected size distributions, as well as on the
electron density. However, values for the thickness of the
lipid bilayer varied around a value of 4.5 nm. The data are
consistent with an average vesicle radius ranging from 20 to
100 nm. The inaccuracy of the fit with respect to the vesicle
radius is possibly indicative of high polydispersity.
The abundance of DMTAP-isopropanol-water phases be-
comes even greater as the temperature is varied. As shown in
Fig. 4a, a region of inverted spherical micelles appears
when the temperature is changed. Here, the radius of a mi-
FIG. 2. DMTP scattering data for isopropanol-water solutions at 25 °C con-
taining different amounts of water. The system goes from a lamellar phase in
pure isopropanol and moves toward monomers and micelles, and eventually
to a liposomal phase as the water content of the solvent increases. Data are
plotted on a logarithmic scale.
FIG. 3. Scattering data and corresponding form factor fits for various lipid structures in a DMTAP solution, such as micelles and inverse micelles at 60% water
content a, lipid bilayers at 90% water content b, and multilamellar phases at 15% water content c. The monomeric phase, which has essentially no signal,
is contrasted with the multilamellar phase c.
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celle is around 2 nm, with a size distribution width of 0.1
nm. In Secs. III B–III D, we discuss phase behavior as a
function of water content, temperature and lipid composition.
B. Bulk phase diagrams
Complete phase diagrams of DMTAP, DMTAP/DMPC,
and DMPC as a function of water-isopropanol content and
temperature are shown in Fig. 4. All phase divisions have
degrees of uncertainty of 5 °C and 5% water content since
phase transitions were not measured along the full division;
measurements were instead made in representative points in
the phase diagram. Areas with a question mark could not be
described using commonly used form factors. The phase be-
havior reveals a general phase order: With increasing water
content, inverse micelles, monomer, micelles, and finally,
vesicles can be found. This behavior is clearly represented by
the phase diagram of DMPC. In all three phase diagrams,
regions where the lamellar phase occurs can be seen at lower
temperatures.
Upon the addition of DMTAP to DMPC, the phase behav-
ior becomes more complex. The phase diagram for a 1:1
DMPC-DMTAP mixture Fig. 4b differs from the DMTAP
diagram in terms of the absence of the lamellar phase at low
water content. Furthermore, higher water content is required
for the micelle phase to occur. In pure isopropanol, the lipid
mixture exists as inverted cylindrical micelles. On reaching a
water content of 15%, a transition to monomer phase is
achieved, which could in turn undergo a transition to cylin-
drical micelles once the water content is increased to 30%. It
is remarkable that vesicles at high water content but elevated
temperatures are no longer stable. In the same regime,
DMTAP exhibits phases that were not unambiguously deter-
minable. Since we are interested how one can enter vesicle
phases, it is remarkable that DMTAP/DMPC exhibits a
temperature-induced transition from monomer to vesicles at
water content of 50%.
C. Lipid surface coverage measured by ATR-FTIR
In this section, we discuss the adsorption of lipids from
the bulk phase described above to silicon oxide as a function
of water content. To distinguish the lipid from isopropanol,
we used phospholipids with deuterated alcyl chains, which
allow the determination of the degree of adsorption through
specific infrared adsorption bands from ATR-FTIR. Figure 5
shows a bulk infrared spectrum of DMPC and deuterated
d54-DMPC indicating the position of the C–H and C–D
FIG. 4. Color online Phase diagrams for DMTAP a, DMPC/DMTAP b,
and DMPC c with reference to varying isopropanol-water content and
temperature. Lipids used in these measurements had a constant concentra-
tion of 25 mg/ml.
FIG. 5. Color online Infrared spectra showing the C–H and C–D stretching
vibrations of DMPC red line and d54-DMTAP black line, inset. The C–D
stretching vibrations in the ATR mode are shown in the expansion as a
function of increasing water content.
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stretching bands. The position of the C–H bands overlaps
with the adsorption bands of isopropanol and cannot be used.
The C–D stretching bands of the lipid, however, can be de-
tected in the ATR mode, despite a broad background signal
arising from water and isopropanol in bulk solution. Conse-
quently, reference measurements were made for each sample,
and a corrected spectrum is obtained, as described in the
experimental section. The expansion in Fig. 5 shows typical
results from a series of ATR-FTIR measurements.
Surface occupancy is proportional to the intensity of the
alkyl bands. To determine this intensity, the spectra were
matched against a sum of six Gaussian curves, which match
the shape of the adsorption band fingerprint. In the fit, the
amplitude of this set of Gaussians was taken as a measure of
the degree of lipid coverage. The position and width of the
set of Gaussians were independently determined from refer-
ence measurements, where higher lipid concentrations were
used. Figure 6 shows the isothermal adsorption of DMTAP.
Results are normalized to 1.0 at 100% water content, corre-
sponding to the surface coverage obtained from vesicle fu-
sion, i.e., a single lipid bilayer. An arc-tan fit, which serves as
a visual guide, is overlaid across the adsorption isotherm as a
function of water content. For DMTAP, the point at which
half-surface coverage can be observed appears to be at 67%
water content.
In the case of DMPC, a significantly shallower isotherm is
observed, which does not have a defined transition point.
Half-maximum coverage is found at approximately 40% wa-
ter content; finite adsorption is observable even in pure iso-
propanol 0% water. In the case of the equimolar lipid mix-
tures of DMPC-DMTAP, the transition occurs between 63%
water content. In comparison with pure DMTAP and pure
DMPC, this approximates a behavior that is between the two.
Figure 6c also indicates the percentages of DMPC and
DMTAP separately. These data can be obtained if only one of
the lipid components is deuterated. More interestingly, there
is always a larger amount of DMPC than DMTAP adsorbed
to the oxidized silicon surface. Infrared spectroscopy results
indicate that the addition of water causes lipids dissolved in
isopropanol to adhere to the hydrophilic silicon oxide sur-
face. These ATR-FTIR results, however, do not reveal details
of the quality of the lipid coating, specifically its homogene-
ity and its lateral diffusion.
D. Adsorption behavior of a thermotropic system
SAXS results imply that lipid adsorption can be induced
not only through changes in solvent composition but through
temperature changes as well. This strong temperature-
dependent behavior is manifested through an increased de-
gree of coverage for lower temperatures. If DMTAP in a
90% water:isopropanol solution is heated to 45 °C, all the
lipids desorb. Upon cooling, a lipid bilayer is readsorbed,
with increased coverage compared to before heating. In order
to confirm if this effect on coverage is characteristic of the
system or if it is an artifact of the prolonged equilibration
period, DMTAP samples at different water contents are
warmed from 10 to 50 °C and then cooled to 10 °C again.
Surface coverage was checked at intervals of 10 °C during
the process of heating, as well as after cooling. Results con-
firmed the initial observation on the temperature-dependence
of coverage data not shown. In terms of the phase changes,
our hypothesis is that increasing the temperature at 90% wa-
ter content results in transitions from the vesicle/bilayer
phase to a mixed micelle and vesicle phase Fig. 4a, and it
is possible that the micelles generated impinge on the surface
on cooling, and is responsible for the increased coverage
observed Fig. 1. These observations are reasonably consis-
tent with previous reports correlating surface coverage and
temperature, where an annealing and cooling cycle results in
a saturated lipid film.40
E. Diffusion measurements
In order to evaluate the mobility and homogeneity of the
membranes on a microscopic-length scale, continuous
FIG. 6. Isothermal adsorption curves for d54-DMTAP a, d54-DMPC b,
and d54-DMPC/d54-DMTAP c at 28 °C under varying water content.
C–D stretching vibration intensities were normalized, and correspond to the
lipid concentration on the silicon surface. The error bars are taken from the
fits of the spectra; for multiple measurements, errors were calculated accord-
ing to the rules of error propagation.
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bleaching experiments were used. We directly compared sup-
ported lipid bilayers prepared using the solvent exchange
method to those prepared by vesicle fusion. Lipid bilayer
deposition onto a glass surface by solvent exchange was
achieved using a flow-through sample chamber filled with
lipid in an 8:2 water:isopropanol mixture. The water content
was subsequently increased by the slow titration of the lipid
solution. These were compared to membranes generated
through small unilamellar vesicle fusion according to stan-
dard protocols.12,37,41,42 A visual evaluation of the mem-
branes produced by solvent exchange and vesicle fusion
shows that both are homogeneous Figs. 7a and 7d. The
samples were subsequently bleached continuously to evalu-
ate its fluidity. In continuous bleaching, illumination is con-
centrated on a circular spot of the membrane using a field
aperture. If a membrane is fluid, the fluorescence signal at
the center of the illuminated area decays exponentially over
time, while a fluorescence rim forms at its periphery. The
latter results from the continuous diffusion of unbleached,
fluorescently labeled lipids from the surrounding nonillumi-
nated area. Both samples exhibit these characteristics of fluid
membranes Figs. 7b and 7e. Evaluation of the diffusion
data of the monolayer in contact with the surface indicate
that membranes formed through solvent exchange have dif-
fusion constants of 2.60.3 m2 s−1 comparable with those
obtained by vesicle fusion protocol, which is found to be also
2.6 m2 s−1 within experimental accuracy Fig. 7 for de-
tails, please refer to the experimental section. The measured
diffusion constant consistent with the value
2.00.4 m2 s−1 obtained for a DMPC bilayer prepared by
the vesicle fusion technique.41,42 For comparison, the reader
is reminded that in a free lipid bilayer, the diffusion constant
of DMPC lies at about 0.5–5 m2 s−1 at room
temperature.41 For this protocol, the washing steps to remove
excess alcohol are important; otherwise, the presence of a
significant amount of residual alcohol would tend to increase
membrane fluidity as a result of its H-bonding with the hy-
drocarbon chains, which then leads to a decrease its confor-
mation order.43
F. Conclusion
We have investigated the phase behavior of the tenary
system comprised of lipid, isopropanol, and water as a func-
tion of water content, temperature, and lipid head group.
From SAXS and ATR-FTIR measurements, the bulk phase
behavior was found to correlate with the amount of surface
coverage. With increasing water content, the system under-
goes phase transitions through the bulk phases: inverted
micellar-monomeric-micellar-vesicles. At the same time, the
coverage of lipid on the silicon oxide surface of the ATR
crystal increases monotonically, reaching the saturating level
of a single lipid bilayer coating. There are remarkable differ-
ences between the behavior of DMTAP and DMPC, with
DMTAP exhibiting a steep increase in coverage as opposed
to DMPC, which shows gradual deposition with increasing
water content. This indicates that DMPC has a higher affinity
for the solid than the cationic DMTAP, despite the fact that
the solid is negatively charged. We also argue that within the
transition regime from micelles to vesicles, the formation of
solid supported bilayer is energetically favored over vesicle
formation in the bulk phase due to the fact that surface in-
teractions enhance the relative concentration of lipids at the
surface. From this, we can define a protocol for depositing a
lipid bilayer, which involves the incubation of a surface with
a tenary mixture below this critical micelle-to-vesicle transi-
tion and gradually increasing the water content. A theoretical
basis for this can be taken from the thermodynamics of al-
cohols interacting with lipid membranes.44,45 We assume that
the lipid aggregates at the solid surface, either monomers or
micelles, are in thermodynamic equilibrium with the bulk
phase. As the solvent is varied toward a pure water phase, the
critical micelle concentration for the lipid is lowered and the
lipids bound on the surface close to form a bilayer. This is in
contrast to the vesicle fusion method, where lipid deposition
takes place via vesicle rupture, an event that is associated
with a high energy barrier. Additionally, lipids are required to
spread and anneal at the surfaces after vesicle fusion. Hence,
in special cases, where vesicle fusion or spreading is limited,
as the case is for hydrophobic or nanostructured surfaces, the
solvent exchange method might be advantageous for the for-
mation of a supported bilayer.24 Compared to vesicle fusion,
this method has a clear shortcoming in that incorporation of
proteins and precise control over composition are not guar-
anteed, and would require further investigation. For cases
where a one-component lipid coating is required, however,
the solvent-exchange protocol has advantages in terms of its
applicability to complex structures, such as nanocontainers,
FIG. 7. Color online Continuous bleaching showing lipid diffusion in Or-
egon green-labeled DMPC SLBs prepared using the solvent-exchange
method a and b and vesicle fusion d and e. Average background-
corrected intensity profiles from the edge to the center of a circular selection
made from the decagonal sample were used in obtaining the bleaching rate,
which was subsequently used in calculating the diffusion constant based on
fitting these profiles by the equations specified in the methods section c
and f. The diffusion constant obtained for both SLBs was
2.60.3 m2 /s. Micrographs a and c were taken at t=0, and micro-
graphs b and e were taken at t=1 min. For the experiments, illuminated
regions with an approximate diameter of 180 m were used. Continuous
bleaching experiments were also performed for longer-chain SOPC mem-
branes, and were found to have a diffusion constant of 2.30.4 m2 /s
data not shown.
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microfluidic devices with extended networks, or solid par-
ticles. In particular, the surface functionalization of microflu-
idic channels with solid supported bilayers, which aims to
reduce protein-wall interactions, is an example where the
solvent exchange technique can be applied.46 For this kind of
technology-driven applications, the ease of preparation is of
primary importance, and the method presented here might
have most impact.
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Conﬂicting reports in leading journals have indicated the minimum number of inﬂuenza
hemagglutinin (HA) trimers required for fusion to be between one and eight. Interestingly, the
data in these reports are either almost identical, or can be transformed to be directly comparable.
Diﬀerent statistical or phenomenological models, however, were used to analyze these data,
resulting in the varied interpretations. In an attempt to resolve this contradiction, we use PABM,
a brane calculus we recently introduced, enabling an algorithmic systems biology approach that
allows the problem to be modeled in a manner following a biological logic. Since a scalable
PABM executor is still under development, we suﬃciently simpliﬁed the fusion model
and analyzed it using the model checker, PRISM. We validated the model against older
HA-expressing cell-to-cell fusion data using the same parameters with the exception of three,
namely HA and sialic acid (SA) surface densities and the aggregation rate, which were expected
to be diﬀerent as a result of the diﬀerence in the experimental setup. Results are consistent with
the interpretation that a minimum aggregate size of six HA trimers, of which three undergo a
conformational change to become fusogenic, is required for fusion. Of these three, two are free,
while one is bound. Finally, we determined the eﬀects of varying the SA surface density and
showed that only a limited range of densities permit fusion. Our results demonstrate the potential
of modeling in providing more precise interpretations of data.
1 Introduction
Membrane fusion is one of the most fundamental biological
processes exhibiting mechanistic similarities across its diﬀerent
forms, from viral and bacterial entry to intracellular fusion.1,2
Most of what is known regarding viral fusion are derived from
structural and mechanistic studies of inﬂuenza virus fusion, as
mediated by hemagglutinin (HA). Hemagglutinin is a trimeric
protein anchored to the viral membrane via its C-terminal
domain.3 HA binds host cells through sialic acid (SA)-capped
proteins, which are particularly abundant in the respiratory
tract, as well as in red blood cells.4 Binding triggers internaliza-
tion into an endosome, the acidiﬁcation of which causes HA
trimers to aggregate and to undergo a conformational change
that extends its N-terminal fusion peptides and causes it to fuse
with the endosome membrane, and release its contents into the
host cell cytosol.3 In vitro experiments have expanded the view
of HA-mediated fusion through the deﬁnition of intermediates
between the conformational change step and content mixing.
These include the generation of the ﬁrst fusion pore (FP),
through which ions can pass between the virus and target
membranes; the lipid channel (LC), which permits the lipids
to mix between the two membranes; and the formation of the
fusion site (FS), which allows content mixing5 (Fig. 1).
In an attempt to characterize membrane fusion and its
intermediates better, several groups have designed experiments
to determine the minimum requirements for the formation of a
fusion pore. Viruses or virus-like systems, which have been
evolved to eﬃciently form such pores on the endosome
membrane through proteins such as HA, are consequently
ideal for such studies. Knowing these minimum fusion require-
ments is also of interest in artiﬁcial gene and drug therapy,
where eﬃcient endosomal escape remains one of the main
problems. We are particularly interested in designing HA-
decorated vectors for gene and drug delivery. These vectors,
a Faculty of Physics and Center for NanoScience, Ludwig-
Maximilians-University, Geschwister-Scholl-Platz 1, Munich,
Germany. E-mail: maria.pamela.david@physik.uni-muenchen.de;
Fax: +49-(0)89-2180-3182; Tel: +49-(0)89-2180-1453
b Institute of Evolutionary Biology and Environmental Studies,
University of Zurich, Winterthurstrasse 190, 8057 Zurich,
Switzerland
c Swiss Institute of Bioinformatics, Quartier Sorge Baˆtiment
Ge´nopode, CH-1015 Lausanne, Switzerland
dNational Institute of Physics, University of the Philippines, Diliman,
Quezon City, Philippines
e Institute of Mathematics, University of the Philippines, Diliman,
Quezon City, Philippines
w Published as part of a Molecular BioSystems themed issue on
Computational Biology: Guest Editor Michael Blinov.
z Electronic supplementary information (ESI) available. See DOI:
10.1039/c1mb05060e
y As obtained by Bentz.5
Molecular
BioSystems
Dynamic Article Links
www.rsc.org/molecularbiosystems PAPER
2742 Mol. BioSyst., 2011, 7, 2741–2749 This journal is c The Royal Society of Chemistry 2011
which could be even smaller than the viruses itself, should
contain at least the minimum number of fusogenic units, but
the least number of HAs that would still permit fusion, to
reduce their potential immunogenicity.6 In the case of HA,
these minimum requirements refer to the number of aggre-
gated trimers that comprise the fusion pore, o, which may be
comprised of both HA bound to SA (HAbound) and free HA
(HAfree). A subset of o, q, undergoes an acidiﬁcation-mediated
conformational change to a ﬁnal fusogenic form.z However,
despite the fact that the experiments were directed towards the
description of a single phenomenon, the results and interpre-
tations derived from these vary. Table 1 summarizes results
from diﬀerent experimental groups, together with information
on the experimental setup used, as well as the statistical
methods or phenomenological models used in data analysis,
when applicable. Fusion intermediates that are possible to
observe with each setup are also indicated. Typically, FP can
be observed through conductivity measurements, while LC
and FS are typically observed using video ﬂuorescence micro-
scopy (VFM).7 The results describe the process as either
being a cooperative8,9 or a non-cooperative process.10,11
Interestingly, a closer analysis of some of the data sets reveals
that the results themselves are not so much varied as the
analysis. For instance, a superimposition of fusion data from
Imai and Floyd, which use comparable experimental setups,
reveals that the experimental results are almost identical
(Fig. 2). However, the conclusions of the studies are diﬀerent,
with Floyd and his co-authors supporting the idea of q= 3 on
the basis of a G-ﬁt of their data, whereas Imai used an
additional set of experiments involving variable fusogenic HA
surface densities as the basis for a conclusion of q = 1.9,10
Fig. 1 Steps in HA-mediated viral fusion in vitro. An inﬂuenza virus binds to sialic acid-capped receptors of the cell through the HA trimers at its
surface. Changing the pH triggers the aggregation of other HA trimers at the contact site, as well as a conformational change in a subset of these
trimers to form a fusion pore that allows ion exchange between the virus and target. Note that the aggregate can be comprised of both bound and
unbound HA trimers (inset). Each of the steps are numbered to correspond to reactions in Section 2.2.
Table 1 Minimum number of hemagglutinin trimers required for fusion as a function of experimental and statistical methods
Paper o q
Virus strain(s)/
cell line(s)
Fusion
partner HA/contact area SA/contact area
Detection
method
Fitting and
statistical
methods
Observed
step
Melikyan
et al.12
8* n/a HAb2, GP4f Planar bilayer
with fused
RBC
61  103–95  103 1.4  106–7.2  106 Time-resolved
admittance
Exponential ﬁt FP
Blumenthal
et al.13
6 n/a GP4f RBC 61  103 1.4  106–7.2  106 VFM Empirical equa-
tion based on
pore-opening
kinetics
LC, FS
Danieli
et al.8
n/a 3 HAb2, GP4f,
gp4/6
RBC 37  103–479  103 1.4  106–7.2  106 Spectrometry
(bulk)
Hill ﬁt LC
Guenther-
Ausborn
et al.11
n/a 1 X-47, A
Shangdong
RBC 20–30 74–372 Resonance
energy transfer
(bulk)
Modiﬁed Hill ﬁt LC, FS
Imai et al.10 n/a 1 PR/8/1924 RBC 20–30 74–372 VFM Log–log plots
based on HA
surface density
and fusion rates
LC
Floyd et al.9 n/a 3 X-31 Planar bilayer
with pure
GD1a
20–30 74–372 VFM G-ﬁt of frequency
vs. time distribu-
tion of fusion
data
FP/LC,
FS
z The convention of using the notations o and q was taken from
Bentz.5
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Consequently, if the Imai data had been interpreted on the basis
of a G-ﬁt, as the case was in Floyd, then it would have been in
support of q = 3.
In contrast, there are also some studies where a similar
experimental design was used, and that have arrived at the
same conclusion that q = 1. Nonetheless, the experimental
data obtained from these studies were very diﬀerent, and were
likewise analyzed using diﬀerent techniques (Fig. 3).10,11
In Fig. 3, the lag time is deﬁned as the time interval between
the exposure to low pH and the onset of fusion, and Gunther-
Ausborn et al. postulated that the reciprocal of the lag time, as
well as the initial rate of fusion are directly proportional to the
surface density of fusion-competent HA trimers.11 Obtaining a
linear relationship consequently implies that the reaction is
ﬁrst order (viz. q = 1) with respect to HA, whereas a non-
linear relationship would imply q > 1. If the Imai data had
been interpreted based on this method as shown in Fig. 3, then
it would have resulted in a conclusion that qa 1. From these
reports, it is evident that statistical analysis and phenomen-
ological modeling are insuﬃcient to deduce the minimum
requirements for HA-mediated fusion.
Here, we attempt to resolve these apparent contradictions
through an algorithmic systems biology approach,14 which
mimics the logic of the biological system. In such an approach,
biological objects and processes are transformed into objects
and instructions in an executable program (Fig. 4). Such an
approach is especially suited to the current case, where the
knowledge of the steps involved is comparatively extensive.
To setup the model, we use PABM, a formal language inspired
by membrane processes.15 PABM permits the representation
of biological, membrane-bound objects as dynamic, nested
compartments that can merge or split, and from which con-
tents move in and out (Fig. 5A). Changes in compartment
topology result from speciﬁc interactions of processes on the
membranes of compartments; a biological example of such
speciﬁc interaction is the interaction of a fusion peptide with
its target, which precludes fusion (Fig. 5B). Given, however,
that a PABM executor is currently under development, we
mapped the model to PRISM reactions to check its behavior.
Our model yields o = 6, q = 3, where q is comprised of two
free and one bound trimers. Apart from providing a possible
resolution to the contradictions arising from data analysis,
we were able to perform in silico experiments of previously
untested scenarios, speciﬁcally, the eﬀect of varying the surface
density of SA. Our model yields a range of SA surface
densities at which fusion can still occur. This might be able
to explain the pathology of inﬂuenza in non-respiratory tract
tissue and also be used as a criterion for determining if some
individuals have a selective advantage against inﬂuenza.
These results demonstrate the potential of algorithmic systems
biology approaches in data interpretation and predictive
modeling.
2 Methods
2.1 Computational modeling in PRISM
PRISM is a probabilistic and symbolic model checker which
permits the analysis of all possible behaviors of the system.16
Apart from the advantages provided by its model checking
feature, it also has a simulation engine.17 Given that the
in vitro reactions we wish to model include one strictly
membrane-related event, it is possible to map all events to
biochemical-type reactions. We chose PRISM because it has
the combined model checking and simulation features. The
simulation feature permits us to quickly perform a sanity
check of the system behavior, and to adjust initial parameter
estimates. Model checking then allows us to explore all
possible states and transitions, and allows us to determine if
a certain property holds for a system.16 Furthermore, it allows
us to evaluate the eﬀects of parameter changes on the prob-
ability of having fusion events. Finally, there have been
numerous precedents for the use of PRISM in the modeling
and analysis of biological pathways, including a previous
mapping from another model involving compartments.18–20
Fig. 2 Superposition of the data reported by Imai et al.10 and Floyd
et al.9 indicates that the experimental results are almost identical.
Nonetheless, the groups used diﬀerent statistical methods for analysis.
Fitting the Imai data set with an approximation of a G function yields
a result of the same magnitude as in Floyd et al.; if this function is used
as a reference for a conclusion, the data of Imai can be interpreted to
support a conclusion of q = 3.
Fig. 3 Superposition of the data reported by Imai et al.10 and
Gunther-Ausborn et al.11 using a 1/lag time vs. fusogenic HA surface
density plot. Gunther-Ausborn et al. deﬁne the lag time as the interval
between sample exposure to low pH and the onset of fusion; they
postulated that the relationship between the reciprocal lag time with
the fusogenic HA surface density gives the order of the reaction
with respect to HA. Their results yield a linear relationship, supporting
q= 1. If the same analysis had been used on the results of Imai et al.,
they would have obtained a nonlinear curve that supports q a 1,
instead of q = 1.
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2.2 Biochemical processes
The biological processes associated with the HA-mediated
fusion setups are shown in Fig. 1, where each of the reactions
described below are indicated. These reactions were initially
formulated in the PABM formalism, then mapped into the
guarded commands required in PRISM; the properties ana-
lyzed, namely the probability of having VirusFP and VirusLC at
time t for virus–cell and cell–cell fusion setups were expressed
in continuous stochastic logic (CSL)16
(1) Virus binding and unbinding
HAFree þ SAUnbound !kb HABound þ SABound
HABound þ SABound are counted as HABound  SABound
ð1Þ
HABound  SABound !kub HAFree þ SAFree ð2Þ
Fig. 4 Modeling workﬂow based on an algorithmic approach. Biological systems, which are described in terms of qualitative models
(‘‘cartoons’’), as well as reaction stoichiometries and rates, are abstracted as objects, properties and algorithms that can be coded using a suitable
language and executed. The behavior and reliability of the model can be evaluated through model checking and veriﬁcation, respectively.
Fig. 5 An overview of PABM. PABM is a formalism that addresses the need to intuitively express biological processes involving membranes. The
basic operations of PABM on compartments, known as reduction rules, are fusion (mate) and ﬁssion (bud) (A). These rules are implemented in
response to speciﬁc communications between actions on membranes. Actions deﬁne which compartments can interact, as well as the fusion and ﬁssion
capabilities of the membranes they are associated with. (B) In a simple biological example, a fusogenic peptide FP on the surface of a biological system
Amay be represented as an action with an instruction for mate (designatedmxFP in PABM code). Following its interaction with another system B that
has the appropriate receptor for FP (designated !xFP in PABM code), mate is executed, and both the membranes and contents of A and B mix. Note
the one-to-one correspondence between the biological system and PABM code, where the objects corresponding to A and B are likewise combined (C).
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(2) pH-induced HA aggregation and conformational change
If i Z 1, where i is the number of HABound and k is the
number of HAFree:
iHABound !ka ðj þ 1ÞHABound;Aggregate; ði  1ÞHABound ð3Þ
kHAFree !ka ðl þ 1ÞHAFree;Aggregate; ðk 1ÞHAFree ð4Þ
where j and l are the number of bound and free HA trimers
in an aggregate, respectively, and where j and l= 0 at the start
of the simulation. Both aggregation reactions are preceded
by a synchronization guard of rate 1.0 to ensure that all
anchor points between the fusing membranes have been
established prior to HA clustering. If HABound,Aggregate Z
minHABound,Aggregate andHAFree,Aggregate Z minHAFree,Aggregate
and HABound,Aggregate + HAFree,Aggregate Z o, where min
HABound,Aggregate and min HAFree,Aggregate are user-deﬁned
and o is equal to the minimum aggregate size:
jHABound;Aggregate !
kf;bound ðmþ 1ÞHABound;Fusogenic;
ðj  1ÞHABound;Aggregate
ð5Þ
lHAFree;Aggregate !
kf;free ðnþ 1ÞHAFree;Fusogenic;
ðl  1ÞHABound;Aggregate
ð6Þ
where m and n = 0 at the start of the simulation. Note that
there is a concurrent addition to the number of trimers in an
aggregate and a subtraction from the corresponding pool of
trimers that were previously not associated with any aggregate.
This is denoted by the comma on the right-hand side of the
equation.
(3) Fusion pore (FP), lipid channel (LC) and fusion site (FS)
formation
If HABound,Fusogenic Z min HABound,Fusogenic and
HAFree,Fusogenic Z min HAFree,Fusogenic and HABound,Fusogenic +
HAFree,Fusogenic Z q, where min HABound,Fusogenic and min
HAFree,Fusogenic are user-deﬁned and q is a subset of o that
undergoes a conformational change:
VirusFP !klc VirusLC ð7Þ
VirusLC !kfs VirusFS ð8Þ
where VirusFP, VirusLC and VirusFS represent virus particles
containing a fusion pore, a lipid channel and a fusion site,
respectively.
2.3 Model assumptions and parameter estimates
2.3.1 Inclusion of binding step. Fusion experiments involve
pre-binding of viruses or HA-expressing cells to the target
membrane, making the virus binding reactions appear
unnecessary. However, pre-binding does not prevent additional
binding events from taking place in the gap between the pre-
binding step and the pH drop.21 Furthermore, the explicit
representation of bound and unbound HA trimers is necessary
for determining the subset of bound HA trimers in o and q.
2.3.2 HA and SA surface densities. The estimate of the
number of HA trimers/virion was taken from independent
reports by Imai et al., Saitakis and Gizeli and Taylor
et al.10,22,23 Other parameters, such as the HA and SA surface
density at the contact area (Table 1) were obtained from
information in the original papers, as well as estimates in a
previous modeling paper.24 We ﬁrst performed simulations
using these values; we then took the ﬁnal HA : SA values
obtained for successful fusions within the expected time scale
and used this ratio in model checking. Given computing
constraints in the model checker of PRISM, where values of
the order of a hundred molecules for this model result in an
out-of-memory error, we scaled down both the HA and SA
values to the order of 15 and 5, respectively, reﬂecting the
average 74 HA : 30 SA ratio that results in successful fusion.
2.3.3 Initial parameter estimates. Most rates for each of
these transitions, with the exception of kb and ka, are either not
available in the literature, or could not be estimated from
literature values (Table 2). Initial parameter estimates were
derived from known rates of diﬀusion,8 which presumably
aﬀects the aggregation rate, ka, as well as predicted rates of
binding, kb.
25 Initial values for the acid-induced conforma-
tional change, kf, and fusion pore formation, kfp, were based
on parameters obtained from ﬁts reported by Bentz.5 In the
case of kf, we make a distinction between kf,bound and kf,free to
allow us to test the cases kf,bound { kf,free and kf,bound = 0,
given that there is no conclusive experimental evidence
regarding the ability or inability of bound HA molecules to
undergo a conformational change.26,27 Nonetheless, if it is able
to undergo the conformational change, it could be reasonably
expected to be slower.26 Consequently, we have assumed that
it has a rate 1/100 of the original kf value. For simplicity, only
forward reactions were considered, although reactions (1)–(7)
are known to be reversible.
Since PRISM does not have a built-in parameter optimiza-
tion toolkit, derived parameters were obtained using diﬀerent
combinations of parameter ranges; these ranges were chosen
based on preliminary runs evaluating the model behavior when
a single parameter is varied, while the others are held constant
Table 2 Model parameters and rates
Reaction Parameters
Initial
rate/s1 Fitted rate/s1
Binding 74 HA, 223 SA for
virus–cell fusion
experiments; 15 HA,
5 SA for model-
checking 18 HA,
446 SA to 30 HA,
446 SA for cell–cell
fusion experiments;
15 HA, 5 SA for
model-checking
0.225 34.81
Unbinding n/a n/a 0.0001–0.25
HA aggregation o from 5 to 9 8308,25 100, virus–cell,
0.00225–0.00765,
cell–cell
Conformational
change
q from 1 to 3 — 6.25
Transition to FP n/a — 0.9025
Transition to LC n/a n/a 1.1025
Transition to FS n/a n/a n/a
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(data not shown). The data reported by Imai et al. were initially
ﬁtted; the set of parameters associated with the best ﬁts, with
the exception of the aggregation (presumed slower), were then
used in ﬁtting the data reported by Melikyan et al.
A summary of model parameters and model-derived rates is
presented in Table 2.
2.4 Reducing the solution space
To determine o, q, and the individual states (bound or
unbound) of each trimer within o and q, the user-deﬁned
parameters min HABound,Aggregate, min HAFree,Aggregate, min
HABound,Fusogenic and min HAFree,Fusogenic can be varied to
reﬂect all possible cases. For o, we initially tested the values
ranging from 5 to 9 (viz. 6  1 and 8  1). It is assumed that an
aggregate can be comprised of both bound and free HA
particles. We also assumed that q can include both bound
and free HA, though kf,free is signiﬁcantly faster than kf,bound.
Taken together, and eliminating cases that are not biologically
plausible (viz. cases where none of the HA molecules in o
are bound) the diﬀerent combinations result in a total of
roughly 235 test cases (39 possible combinations for min
HABound,Aggregate + min HAFree,Aggregate yielding a value from
5 to 9, each considered in the context of an average of 6
possible cases of min HABound,Fusogenic + min HAFree,Fusogenic
for the range from 1–3). Finally, to eliminate even more
unlikely scenarios, we used the fastest reaction for each test
set; for o = 8, for example, the fastest reaction occurs when
min HAFree,Aggregate = 7, and q = 1, where the only trimer
undergoing a conformational change is free. Using this
strategy, we initially determined the most probable value of o,
then used these values for determining q.
2.5 Parameter sensitivity analysis
Sensitivity analysis was performed to estimate the reliability of
the model predictions. Here, we used local sensitivity analysis
adapted for the stochastic case. Brieﬂy, parameter values were
changed one at a time, while keeping the rest ﬁxed. Sensitivity
indices Sa, which represent the sensitivity of the output to a
change in each parameter Pi, were calculated based on the
standard:28
Sa ¼ @Y
@Pi
ð9Þ
where qY is calculated as the changes in the output resulting
from the substitution of the reference parameter with new
parameters in incremental ratios, and qPi is the diﬀerence
between the reference and the new parameter. We compared
the full distributions of outputs obtained from model checking
for each of the parameters in order to account for changes in
the shape of the distribution.
2.6 Variable SA experiments
For the variable SA experiment, we changed the values of the
eﬀective HA : SA surface density at the contact area from an
original estimated value of 3.0, to values between 0.75 and
15.0, while holding the values of o and q, obtained using the
procedure in Section 2.4, constant.
3 Results
3.1 A minimum aggregate size of six trimers is required for the
fusion pore
To determine o, we initially took the range of 5–9 trimers as
possible minima required for the transitions in eqn (5) and (6)
to occur. As shown in Fig. 6 a requirement for o Z 8 and
above would not be able to account for the observed fusion
kinetics, although this does not mean that aggregates of this
size would not result in fusion. Rather, it simply indicates that
majority of the fusion events would have to involve complexes
of a smaller size. Presumably, it would require more time to
assemble an aggregate of this size. In contrast, o = 6 closely
ﬁts the data. Furthermore, this size is consistent with electron
microscopy-based approximations of the pore size formed by
the so-called HA rosettes, which can be generated by solubilizing
the viral membrane with detergent then sparsely redistributing
them across synthetic liposomes.29
3.2 A minimum of three trimers in the fusion pore have to
undergo a conformational change to become fusogenic
Using the results described in Section 3.1, we simultaneously
varied the values of minHABound,Fusogenic andminHAFree,Fusogenic
to determine q (Fig. 7). A value of q = 3, comprised of one
bound and two free HA trimers, ﬁts the data. Interestingly,
diﬀerent values of q do not signiﬁcantly aﬀect the level of
Fig. 6 Simulation of fusion data reported by Imai and Floyd (red)
with the assumption that o is 6 or 8, with at least one bound HA
trimer in each case. In the case of o = 8, fusion is still observed, but
does not ﬁt the data.
Fig. 7 Dependence of fusion kinetics on q for o = 6. Of all the
possible combinations, an aggregate comprised of at least one bound
and ﬁve free HA trimers, of which three (one bound, two free) must
undergo a conformational change, best describes the data.
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fusion as much as o, but instead causes a shift in the time at
which saturation is reached.
3.3 Model validation using cell–cell fusion experiments
We next tried to verify our results by using the predictions in
Sections 3.1 and 3.2 to ﬁt the data reported by Melikyan
et al.,12 which were obtained using cell–cell fusion measure-
ments, where HA-expressing cells are used instead of viruses.
Cell–cell fusion experiments diﬀer from virus–cell fusion
experiments in terms of the HA and SA surface densities at
the contact area. These are also characterized by slower
kinetics because of the lower HA surface density, as well as
the presence of other proteins that can inﬂuence the fusion
kinetics.8,11 Nonetheless, all mechanisms starting from the
point where the aggregate is assembled (3 and 4, Fig. 1) are
identical.5 It should thus be possible to capture the behavior of
both HA-mediated virus–cell and cell–cell fusion using a single
model. For this, we varied ka, which is presumably slower.
However, due to the memory constraints in PRISM, we had to
scale down values of HA and SA, such that the eﬀective
HA : SA surface density ratio is maintained (Table 2), instead
of using the actual values indicated in Table 1. The best ﬁts for
both data sets are still o = 6, with ka values ranging from
0.00225–0.00765 s1 (Fig. 8). Other cell–cell fusion measure-
ment data8,13 were presumed transformable to allow direct
comparison with the data reported by Melikyan et al., and
were no longer modeled in this paper.7
3.4 Parameter sensitivity analysis
Following model validation, we performed sensitivity analysis
on estimated parameters. The highest sensitivity index was
obtained for kf, which is consistent with the presumed role
of HA conformational change as a rate-limiting step.85
Changing the other rates without changing any of the non-
estimated parameters, such as HA and SA surface density,
does not materially aﬀect the results (Fig. 9). The relatively
low parameter sensitivities are indicative of the robustness of
the model.
3.5 Eﬀect of SA surface density on fusion kinetics
Another application that we found for the model is to check
the eﬀect of SA surface density on inﬂuenza fusion. For this,
we used the parameters obtained for the virus–cell fusion setup
and assumed o= 6 and q= 3 (1 bound, 2 free), while varying
the HA : SA surface density between 0.75 to 15.0.** Of these
concentrations, only HA : SA ratios between 5.0 and 2.5
resulted in at least 90% fusion (Fig. 10). At HA : SA con-
centrations lower than 1.67, fusion decreases dramatically,
with almost no fusion occurring at HA : SA = 1.25 and
below. This decrease in fusion eﬃciency is a necessary con-
sequence of the predicted requirement for at least two free
trimers in q; with more SA molecules available, the incidence
of HA binding would be higher, and it would presumably
require more time for the fusogenic complex to be assembled,
if this has not yet been physically prevented by bound mole-
cules at the contact site (Fig. 11).
These results are partly contrary to those obtained by
Schreiber et al., who predicted that a higher surface density
of SA (viz. receptor density) is slightly more eﬃcient than
increasing the HA concentration in accelerating the fusion
process.25 It is true that for HA : SA ratios between 15.0 and
5.0, the fusion process is accelerated, and that the extent of
fusion increases. However, at HA : SA ratios lower than 2.5,
the eﬀect is reversed. A probable reason for this discrepancy is
their omission of the HA conformational change requirement
for fusion. Furthermore, our results are consistent with earlier
studies that have observed lower incidences of fusion when
fusion partners with an extremely high SA content were used.30
Finally, the predictions may be signiﬁcant with respect to the
pathology of infection of certain types of inﬂuenza, which are
not limited to tissue in the respiratory tract, but have also been
observed in cells in the brain, lymph nodes, liver, kidney, spleen
and intestine, which express SA receptors in an appreciable
number. However, there was no infection in the esophagus,
heart and bone marrow, even if both esophageal and cardiac
tissues are in closer proximity to the respiratory tract than the
kidney,4 presumably due to the unavailability or insuﬃciency of
Fig. 8 Simulation of the Melikyan fusion data using parameters
obtained from the Imai data, with the exception of HA and SA surface
densities, and the ka value, which was presumed to be slower than in
virus–cell fusion experiments. ka values between 0.00225–0.00765 s
1,
which are approximately of order 104 slower than ka values for
virus–cell fusion data, were obtained. The results of the model with
o = 8, q = 2, as reported by Bentz,5 are shown for comparison.
Fig. 9 Sensitivity indices of estimated parameters. The model is
sensitive to changes in kf, the rate of HA conformational change.
Parameters tested were rates of binding (kb), unbinding, (kub), aggre-
gation (ka), fusion pore formation (kfp) and lipid channel formation
(klc), as well as the factor by which kf is decreased when bound HA
undergo a conformational change.
8 This was not assumed a priori in our model.
** Experiment involving virus–cell fusion experiments have an average
HA : SA surface density ratio of 3.0.
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SA receptors. It is also possible that the variation of SA surface
density among individuals confer selective advantages against
inﬂuenza. For instance, RBCs of thalassemia patients and
diabetes patients have been reported to have lower sialic acid
content.31,32 Given that most fusion experiments were per-
formed using red blood cell (RBC) ghosts, the predicted eﬀect
may be tested by performing fusion studies using RBC ghosts
from patients with these diseases; artiﬁcial model membranes
containing varying concentrations of puriﬁed glycophorin, the
main sialylated protein of the RBC, could also be used for
verifying our predictions.
4 Discussion
Determining the minimum requirement for a virus to create
a fusion pore would provide important insights into the ﬁrst
line of inﬂuenza pathogenesis. Knowledge of this minimum
requirement would also have interesting applications in drug
and artiﬁcial gene delivery vector design, where endosomal
escape has remained a perennial problem.33 Several groups
have worked on determining values of o and q for the past
20 years, starting with measurements on HA-trimer expressing
cells, and later, on virus-like or virus particles, once an
adequate visualization technology was available. However,
the experimental setups designed for this purpose were very
diﬀerent, and have all been documented to have an eﬀect on
fusion kinetics.7,34,35 Furthermore, the statistical models and
phenomenological methods used in data analysis were also
widely varied. It is consequently not surprising that the data
obtained appear to be very diﬀerent at a ﬁrst glance and that
the conclusions derived from them appear contradictory.
A possible solution would be to create a model of the
processes, for which consistent parameters could be obtained
for at least one virus–cell and one cell–cell fusion experiment.
Previous eﬀorts to model the process used mass action
kinetics to describe the fusion intermediates starting from the
conformational change within the HA aggregate that leads to
FP formation.5,24 The formation of the HA aggregate is not
included in the model as a step explicitly, since they have
assumed that this is not a rate-limiting step. o is instead
estimated using a nucleation model. The ﬁrst of the two models5
yielded a value ofo=8, and a value of q=2 or 3. A succeeding
paper24 that builds on this model by analyzing additional cell–cell
fusion experiments yields q=2, with the assumption thato=8.
Here, we try a diﬀerent approach where we create a
stochastic model that includes aggregate formation explicitly.
The inclusion of the aggregation step is necessary if we want to
derive a parameter set for a model that can ﬁt both virus–cell
and cell–cell fusion data. Apart from the fact that the HA
surface densities in viruses and cells are diﬀerent, only the
aggregate formation rate, ka, no matter how fast it is com-
pared to the rate of conformational change, kf, is the only
other thing that can vary between the two setups. All the other
steps, from the formation of q to FS, should be the same.
In fact, it is noted in an earlier paper of Bentz36 that the
aggregation step in HA-expressing cells appears to be an
unfavorable, probably highly reversible event. This is in stark
contrast to the step in viruses, where HA trimers might even be
almost pre-aggregated.36 Furthermore, it would be necessary
to know the states of HA in the aggregate (viz. bound or
unbound) if we want to know which of these participate in the
formation of q fusogenic units.
Our model is sensitive to both o and q, with the extent of
fusion being dependent on the aggregation step. On one hand,
this dependence on o even for virus–cell fusion setups can
appear counter-intuitive, since the density and relative
proximity of the trimers on a virus surface could make them
practically pre-aggregated. However, if one thinks of it as a
reaction at least in 2D, then it could be that constructing a
fusogenic aggregate might be slightly more complicated based
on how many bound molecules are there at the contact area to
begin with. In such a case, the dependence of the kinetics on o
could be explained. The extension of this model to a lattice, as
reported by Schreiber et al.25 would be particularly useful in
tackling such a question.ww
Fig. 10 SA surface density aﬀects viral fusion eﬃciency. For the variable
SA experiments, o = 6 and q = 3 were kept constant. The HA : SA
surface density ratios were then varied from 15.0 down to 0.75. Only
values between 5.0 and 2.5 HA : SA resulted in at least 90% fusion;
between 1.50 and 0.75 HA : SA, no appreciable fusion is expected to
occur, given that most of the HA molecules would be bound, and the
requirement for two free HA trimers in q is unlikely to be met.
Fig. 11 Inﬂuence of SA surface density on fusion-permissive (A) and
non-permissive (B) pore formation. Dotted lines represent the contact
area in which the fusion pore is formed. The insets show the pores that
are created when the SA surface density is lower (A); a higher surface
density of SA leads to more bound HA trimers, making it diﬃcult for
the requirement of at least two free HA molecules to occur within a
complex to be fulﬁlled.
ww This article is not discussed in detail since its purpose is not so
much as to determine the smallest fusogenic unit as it is to present a
new technique for approaching the problem.
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There are discrepancies between the rates obtained using ﬁts
from this model and those in that reported by Bentz,5 which
could probably be naturally expected from the fact that the
model structure and the assumptions held are diﬀerent. The ﬁt
generated by Bentz for the GP4f data is, of course, superior to
the ﬁt that we have obtained, but this might have been partly
due either to the overly scaled-down approximation of the
number of HA and SA molecules, or to an overﬁtting of
potentially noisy data. Nonetheless, the ability of the model to
closely capture both virus–cell and the general behavior of the
cell–cell fusion experiments, while keeping the parameters
that are expected to be constant, is promising. In the future,
a more complete comparison of the two models, towards
which modeling the virus–cell fusion experiments using the
methods of Bentz would be a ﬁrst step, would be particularly
interesting. It would likewise be interesting to factor in the
involvement of HA trimers outside the fusion site in fusion
pore expansion.37 Finally, we are working on creating an
experimental setup to verify either of the predictions. In the
advent of technologies that permit the manipulation of
individual molecules with nanometre precision, it would not
be so remote to conceptualize a nanoparticle with a deﬁned
number of hemagglutinin trimers at its surface. Coupled
with microscopy that allows the tracking of individual HA
trimers,38 such a technique should be able to settle the ques-
tion of the minimal fusion requirements deﬁnitively, while
functioning as a litmus test for the signiﬁcance of the results
obtained from modeling processes of this scale.
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Abstract 
We investigated uptake and individual endosome lysis events in fibroblast, normal and 
carcinoma cell lines using a colloidal mesoporous silica (CMS) nanoparticle (NP)-based 
reporter system. Endosome lysis was induced through the activation of protoporphyrin IX 
(PPIX). Surprisingly, this release-on-demand system resulted in more broadly-distributed 
lysis times than expected, particularly for Renca, a renal carcinoma cell line. An analysis of 
the NP load per endosome, endosome size and uptake characteristics indicate that Renca cells 
not only take up a lower amount of NPs in comparison with the fibroblast cells, but also have 
larger endosomes, and a lower NP load per endosome. We then extended an existing 
stochastic pi calculus model of gold NP intracellular distribution to understand how much 
factors that cannot be directly measured, such as variations in the PPIX load per NP, affect 
the distributions. Model results indicate that the lysis time distribution is primarily determined 
by the minimum net PPIX required to burst an endosome, a factor influenced by the NP load 
per endosome, as well as the endosome size. 
Keywords 
Supported lipid bilayer, fluorimetric reporter system, colloidal mesoporous silica 
nanoparticles, endosomal escape, escape-on-demand systems, rule-based models, sensitivity 
analysis 
Introduction 
Endosomal escape has been identified as one of the main bottlenecks in gene and drug 
delivery [1, 2]. To date, however, there are few papers that investigate single endosome lysis 
in real time because of low signal-to-noise ratios [3]. Previous studies have recorded the 
intracellular trafficking of individual nanoparticles and various delivery vectors [4-6], 
measured endosome or cellular contents ex vivo [2, 7], or tracked individual viruses as they 
move across the cell [8]. In these protocols, individual components of the virus or the vector, 
as well as cellular components, are labeled [8, 9]. In all studies involving delivery vector 
tracking [4-6], confocal laser scanning microscopy was used, since dye localization on a 
single plane is insufficient to definitively establish particle internalization [10]; it was 
reported in Akita et al. that at least 20 z-slice images were required for their method, and that 
at least 30 cells were needed to be imaged in this manner to obtain statistically meaningful 
results [4]. If this method were translated into a 30-hour observation period, as in [11], this 
would entail the capture, consolidation and analysis of 216,000 images. 
Due to such limitations, most of the studies have concentrated on the spatial distribution of 
the material[5, 6], or on the trafficking mechanisms used instead [4, 8]. Endosome escape 
efficiency is inferred from a minimal amount of sampling points [4]. Uptake events are 
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likewise rarely recorded in real time, again due to the low signal-to-noise ratio; real time 
recording frequently requires confocal or total internal reflection microscopy [8]. It is more 
typical for endosomal escape rates to be estimated from data fits [2]. Combining direct 
analysis of uptake and endosomal escape will not only yield time distributions of the escape 
events, but also information on the vector load per endosome, and the influence of endosome 
size on escape. Availability of such information for vectors tested on different cell lines 
would be important in evaluating their performance. 
To obtain real-time information on individual lysis events, we needed a reporter system that 
could be co-delivered with, or itself used as a delivery vector. An ideal detector system should 
have distinct signals for each target compartment, and the signals produced should not 
immediately diffuse into the cytosolic milieu. For this, we chose to modify a recently 
designed colloidal mesoporous silica (CMS) nanoparticle (NP) system to create a fluorogenic 
detector.  
CMS NPs have attracted great attention in the past years as potential drug delivery vehicles 
due to the non-toxicity and biocompatibility of silica [12-14]. Our spherical CMS NPs 
possess a controllable and well-defined uniform porosity, offer large surface areas, pore 
volumes, multifunctionality, and are small in size, a critical feature for endosomal uptake [15-
17]. The surface of these NPs can be modified by inorganic and organic functionalization to 
give multifunctional hybrid materials [18-21]. Functionalization of the external surface of 
CMS with polymers such as polyethylene glycol (PEG) [22] and polyethyleneimine (PEI) 
[23], which increase colloidal stability by preventing non-specific protein adsorption [24-27], 
is an important factor for functional drug delivery vehicles. The release of various types of 
cargo from mesoporous silica materials ranging from plant-derived model-drugs [28] to 
poorly water-soluble cancer therapeutics like doxorubicin [29] and paclitaxel [30] has been 
studied intensively. 
 
Cap systems on mesoporous silica acting as stimuli-responsive release mechanisms for 
controlled release have been widely studied in the past years [31, 32]. Inorganic nanoparticles 
[33], large molecules (i.e. cyclodextrins and rotaxanes) [34-36] and also polymers [37] have 
been used to prevent cargo from leaving the pore system. The opening-stimulus can be a 
change in pH [38], UV irradiation [39], or redox-activity [33]. A biomolecule-based enzyme-
responsive cap system for mesoporous silica is based on the formation of the biotin-avidin 
complex at the pore openings of the host [40]. This cap system was extended further to a 
temperature-responsive release-on-demand system based on DNA strands [41]. It was also 
possible to successfully enclose the microtubule depolymerizing plant toxin colchicine in the 
mesopores of CMS by capping these with a supported lipid bilayer [28]. This approach 
employs the so-called solvent exchange induced self-assembly of lipids around the CMS 
resulting in a highly biocompatible silica-lipid hybrid system (SLB@CMS) [42]. NP-
supported lipid bilayers exhibit a narrower size distribution and enhanced stability compared 
to liposomes [43-45]. 
 
Combining SLB@CMS with photochemical internalization (PCI) [46, 47] and 
photosensitizers (PS) leads to a highly potent drug delivery system [36]. PS generate reactive 
oxygen species (ROS) upon light-activation, leading to membrane rupture [48]. Recently, 
multifunctional CMS particles have been equipped with an on-board photosensitizer, namely 
amino-modified protoporphyrin IX (PpIX-NH2). This system has already been tested in 
multiple applications involving three cell active model drug systems.  
  
Another possibility to prevent adsorbed compounds from leaching before successful delivery 
is the covalent attachment of cargo into the pores of mesoporous silica [29, 49]. The release of 
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the bee venom melittin attached to SBA-15 via a pH-responsive acetal-linker [50], and a 
redox-sensitive disulfide-linker [51] have been reported in the context of drug delivery. Many 
therapeutic peptides have thiol functionalities and nucleic acids can be modified with thiol 
moieties. These can be used to build disulfide-linkers to prevent adsorbed compounds from 
leaching. The reductive milieu in the endosome, redox-driven intracellular disulfide cleavage, 
offers great potential for drug delivery.  
 
Here we combine PCI with a covalently bound photosensitizer and the redox-labile disulfide-
bridge approach to create highly potent multifunctional CMS nanoparticles acting as 
fluorimetric reporter vectors in different cell lines (Fig. 1).  
 
 
Fig. 1. CMS-based endosome lysis detector system (A). CMS nanoparticles (NP), to which 
inactive protoporphyrin IX (PpIX) and the quenched dye ATTO 633 are covalently attached, 
are encapsulated in a lipid bilayer. Cells are incubated with NPs for at least 6 hours prior to a 
lysis experiment together with a fluid-phase marker, AlexaFluor Dextran 488. Endosome lysis 
is induced by activating PPIX with 405 nm light (B). The reactive oxygen species (ROS) 
produced by this reaction oxidize double bonds in the lipid tails in both the SLB surrounding 
the NPS, as well as of the endosome. Following membrane disruption, the reductive 
intracellular milieu cleaves the bonds between the quencher and ATTO 633, leading to 
localized fluorescence at the site of lysis. 
Apart from the construction of a reporter system, it is useful to construct a model that can be 
used to understand variations in the lysis time distributions, especially the contributions of 
factors that could not be directly quantified, such as the PPIX load per NP. We have 
previously created a stochastic pi calculus model for describing the intracellular distribution 
of NPs and NP aggregates [52]. Here, we extended the model to include the PpIX-mediated 
endosome lysis reaction. The model is executed using SPiM 
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(http://research.microsoft.com/en-us/projects/spim/), developed by Andrew Philips and Luca 
Cardelli, at Microsoft Research, Cambridge[53, 54]. SPiM uses the Gillespie algorithm to 
describe the time evolution of the system by selecting the reaction that will occur, as well as 
its duration, with a probability proportional to the base rate of reaction and reactant 
availability [55]. Model results indicate that for a PpIX-dependent NP system, the lysis time 
distribution depends heavily on cell specific uptake parameters, rather than any inter-NP 
variability in PpIX load, provided that the PpIX load is not too low. 
In this paper, we demonstrate that the use of this reporter system for generating time 
distributions of lysis events, coupled with an appropriate stochastic model, is a powerful 
method for evaluating and analyzing the efficiency of delivery vectors. 
 
Materials and Methods 
Multifunctional mesoporous core-shell silica nanoparticles 
The multifunctional core-shell CMS nanoparticles were synthesized following a previously 
reported procedure [6]. We use a so-called delayed co-condensation approach to selectively 
introduce different functionalities on the inner and outer particle surface. This synthesis 
employs tetraethylorthosilicate (TEOS) as silica source, 3-(aminopropyl)-triethoxysilane 
(APTES) and 3-(mercaptopropyl)-triethoxysilane as functionalized silica precursors, 
cetyltrimethylammonium chloride (CTAC) as structure directing agent. The polyalcohol 
triethanolamine (TEA) slows down the condensation rate of TEOS and leads to a small size 
distribution and radial growth of CMS. Functionalized CMS with 3-mercaptopropyl moieties 
in the shells of the particles and 3-aminopropyl groups in the core were synthesized according 
to this procedure giving the sample CMS_NH2in_SHout after template removal (see Supporting 
Information for synthesis details and additional data). Post-synthesis modifications of the 
introduced functionalities are possible due to their reactive nature.  
 
CMS based detector system 
Figure 2A shows the post-synthesis functionalization of the outer surface of the CMS 
particles. In the first step the shell was covered with a short, bifunctional polyethyleneglycol 
linker (maleimide-dPEG8-COOH, (1-maleimido-3-oxo-7,10,13,16,19,22,25,28-octaoxa-4-
azahen-triacontan-31-oic acid), increasing monodispersity in water. The thiol moiety forms a 
stable bond with the maleimide functionalization of the PEG-linker in a Michael addition 
whereas the carboxy-functionality remains accessible for further modification. The amino-
modified photosensitizer protoporphyrin-IX (PpIX-NH2) was synthesized according to a 
modified literature procedure [42]. This precursor was covalently attached to the carboxy-
functions at the particle surface via an N-(3-dimethylaminopropyl-)N’-ethylcarbodiimide 
(EDC) assisted amidation to give the photosensitizer-modified sample CMS_NH2in_PEG-
PpIXout, as reported in detail in the Supporting Information. 
 
We designed a redox-sensitive fluorimetric dye-quencher system for the CMS core (Figure 
2B). In the first step the highly reactive ATTO 633-NHS ester was covalently attached to the 
amino group of cysteine (CysATTO 633). Subsequently, CysATTO 633 was reacted with the 
aminopropyl-functionality in an EDC assisted amidation to give the sample CMS_CysATTO 
633in_PEG-PPIXout. The thiol group of cysteine was activated with 2,2’-dithiopyridine, and 
cysteine-modified QSY21 (CysQSY21) was added. This resulted in a disulfide bridged dye-
quencher system in the particle core and gave the final sample CMS_CysATTO 633-
CysQSY21in_PEG-PPIXout. Detailed information on the synthesis and labeling procedures are 
given in the Supporting Information. 
  5 
 
 
 
 
 
Fig 2. Shell (A) and core (B)-reactions of CMS-NPs. Shell reactions: 1) PEGylation 2) 
PPIX-NH2 attachment via EDC-amidation. Core reactions: 1) ATTO 633-CYS attachment via 
EDC-amidation 2) The 2,2’-dithiopyridine attachment to the SH-group of ATTO 633Cys is 
followed by the bonding of QSY21Cys via a redox-labile disulfide bridge. 
 
Lipids. 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) and 1,2-Dioleoyl-sn-glycero-3-
phospho-ethanolamine (DOPE), were chosen for the study. Both lipids bear a sufficiently 
high number of double bonds with which the singlet oxygen produced upon PPIX activation 
can react to destabilize the membrane structure [56]. Additionally, both lipids have been 
previously reported to form stable, fluid bilayers on the CMS core in its pure form [28, 57]. 
DOPE is known to posses fusogenic properties because of its ability to adopt an inverted 
hexagonal phase [58], influencing the curvature and structural integrity of a lipid bilayer [59], 
and can fuse with cell membranes better than DOPC [58-60]. CMS particles were covered 
with SLBs comprised of either pure DOPC (DOPC@CMS) or pure DOPE (DOPE@CMS) 
lipid membranes labelled with 1 mol % Texas Red 1,2-dihexadecanoyl-sn-glycero-3-
phosphoethanolamine, triethylammonium salt (TR-DHPE).  
Supported lipid bilayer (SLB) deposition on CMS particles through solvent exchange. SLBs 
were deposited on CMS particles as previously described [42]. Briefly, CMS NPs in solution 
are centrifuged at 13000 rpm for five minutes. The supernatant is discarded and the particles 
are redispersed in a 2.5 mg/ml lipid solution in 40% vol ethanol:60 % vol water; this solution 
was subsequently titrated with water until a 95% vol water content is reached. The solution is 
allowed to equilibrate for 15 minutes, in the process forming the SLB on individual particles 
[42]; the NPs are separated from excess lipid by centrifugation, and subsequently resuspended 
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in a smaller volume comprised of 50% vol complete cell culture medium:50 %vol water 
solution. In this alcohol-free environment, the SLB is fully stabilized. The aggregation of NPs 
in this solution is minimized by brief sonication followed by filtration. 
Uptake experiments. DOPC@CMS particles were tested on non-phagocytic cell lines whose 
interactions with NPs were of interest: Beas2B, a human normal bronchial epithelium cell 
line; Huh7, a human hepatocarcinoma cell line; Renca-LacZ, a transformed murine renal 
carcinoma cell line; and 3T3, a mouse embryonic fibroblast cell line.  Cells were plated to a 
density of 0.75 x 104 cells/cm2 on 8-well ibiTreat-coated Ibidi chambers 3 - 4 days before the 
start of the experiment. Cells were subsequently incubated with 50 µg/cm2 DOPC@CMS over 
two-hour intervals up to eight hours, and washed with PBS five times post-incubation. 
External fluorescence was additionally quenched with a wash using 0.4 % w/w trypan blue 
[61, 62]. Cells were then fixed with 2 % formaldehyde in Leibovitz medium, reported to 
reduce cellular fluorescence [63], supplemented with 10% FCS for a total of two hours. 
Internalized NPs were visualized using fluorescence microscopy at 40x magnification, and 
recorded at an exposure time of 1 s. For each setup, eight random viewfields were chosen. 
Experiments were performed in triplicate. The relative number of particles taken up by each 
cell was approximated by taking the mean gray values across the area occupied by the cell. 
Analysis was done semi-automatically in ImageJ using an in-house program [64]. Control 
experiments were performed using 30 nm, fluorescein labeled Latex NPs (Sigma Aldrich). 
Lysis experiments. For in vitro lysis experiments, cells were incubated for 12 hours with 
DOPC@CMS or DOPE@CMS functionalized with PpIX and ATTO 633-QSY21 to ensure 
completion of uptake. Lysis experiments were performed on 3T3 and RencaLacZ cells, which 
appear to exhibit the highest and lowest uptake characteristics for DOPC@CMS particles. 
AlexaFluor Dextran 488 (MW=10 kDa) was used as a fluid-phase marker for endocytosis. 
Following incubation, cells were washed with PBS five times post-incubation, or until most 
of the fluorescence from the AlexaFluor Dextran was removed; washing with 0.4 % w/w 
trypan blue was performed to quench any remaining external fluorescence. PpIX was 
activated by a one- or two –minute exposure to a 405 nm laser prior to imaging. Fluorescence 
images were taken every second with an exposure time of 200 ms over a period of two 
minutes per viewfield. NP and endosome fluorescence were monitored using the following 
excitation/emission filter sets: 488 nm/525 nm (AlexaFluor dextran); 560 nm/645 nm (Texas 
Red); and 640 nm/690 nm (ATTO 633) (Chroma Technology). A negative control composed 
of DOPC@CMS or DOPE@CMS functionalized with ATTO 633-QSY21, but not PPIX, was 
used in parallel with all setups. Single endosome lysis events were detected using the same 
ImageJ plugin described previously. Briefly, images are segmented based on the fluid-phase 
marker channel (Fig. 3). Discontinuities that occur in both the red and green channels were 
recorded as an endosome lysis event, and the time distribution of these events was collected 
for the different experimental setups. Apart from lysis times, the endosome area and NP 
colocalization intensity, based on the mean gray values in the red channel, are recorded. 
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Fig. 3. Single-endosome lysis time evaluation. Individual endosomes (A) are identified using 
automatic segmentation [64] performed on the green channel, which is able to identify three 
out of four endosomes; the arrow indicates an endosome that was not properly segmented, 
and that had to be manually added. Colors represent automatically-defined ROIs, and not 
RGB channels (B). ATTO 633 fluorescence is artificially colored blue. For each endosome, 
the lysis time is determined through the occurrence of discontinuities in the time course in the 
red and green channels, as well as an increase in fluorescence in the long red channel (C). 
Modelling. To systematically evaluate the factors that influence lysis time distributions, we 
extended the generic stochastic pi calculus model that we have created for gold NP uptake 
and intracellular movement [65]. Specifically, we included PPIX and activated PPIX 
(Act_PPIX) counts as attributes of each NP process; an activation reaction, coupled with 
preconditions for lysis in the form of a minimum amount of Act_PPIX per endosome, also 
replaces the simple endosome lysis rate. We also redefine the aggregate size restrictions for 
100 nm CMS NPs, instead of 4 nm gold NPs. Finally, we made uptake rates variable to 
represent cell specific responses. Each simulation was carried out with a starting value of 
10000 NPs per cell; the PPIX load assigned to each NP was taken from a normal distribution 
with a mean of 50 PPIX per NP, and a width of 5. Sensitivity analysis was performed to 
identify the critical parameters of the model. We used code for SPiM v.0.05, which is run 
automatically using a Perl script that also permits parameter alteration. We omit the events 
downstream of endosomal escape, which we do not consider in this study. 
Results and Discussion 
Reporter system characterization 
The nitrogen sorption isotherm of the sample CMS-NH2core-SHshell is plotted in Fig. 4B upper 
panel. A Brunauer-Emmet-Teller (BET) surface area of 1160 m2g-1 is calculated from the 
isotherm. The lower panel shows the pore size distribution derived from non-local density 
functional theory and shows a narrow pore size distribution (inset in Fig. 4B) of 3.7 nm. The 
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quality of the membrane was previously assessed using confocal microscopy and correlation 
spectroscopy, and was shown to prevent cargo release before it reaches the delivery target 
[28], or before controlled release is initiated. Here, we provide further characterization of the 
system using single-cell uptake experiments and single-endosome lysis experiments. 
To demonstrate the efficiency of our disulfide bridged dye/quencher system in 
CMS_CysATTO 633-QSY21Cysin-_PEG-PpIXout the sample was investigated with 
fluorescence spectroscopy, Fig. 4C. The disulfide bridge between the two cysteine moieties is 
cleaved upon the addition of 10 mM L-glutathione which corresponds to the strength of the 
reductive milieu in the endosome. As a result, the covalently attached quencher CysQSY21 
can diffuse out of the pores, resulting in a fluorescence of ATTO 633.  
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Fig 4. CMS particle characterization. Lipid-coated CMS NP imaged using Transmission 
electron microscopy (A). Nitrogen sorption isotherm (B, adsorption plotted in black, 
desorption in blue) and NLDFT pore size distribution (B, inset) of the sample CMS-NH2core-
SHshell. Fluorescence emission spectra of the sample CMS_CysATTO 633-QSY21Cysin-
_PEG-PpIXout (black) and 30 seconds after the addition of 10 mM GSH (blue) (C). 
 
Statistics from single-endosome PPIX-mediated lysis with different lipids, cell types, and 
PPIX activation times 
We investigated the time distribution of endosome lysis as a function of PpIX activation time, 
lipid coat, and cell type. Our results generally show that DOPE@CMS exhibit marginally 
earlier lysis times than DOPC@CMS. An interesting observation is that the activation time 
appears to play a more prominent role in Renca-LacZ than in 3T3, as evinced by the bigger 
shift in the distribution when the activation time is decreased (Fig. 5C-5D, Table 1). 
Furthermore, the distribution of lysis times after a two-minute PPIX activation is considerably 
more spread than in 3T3, which could be an indication of cell-specific dependence of 
endosome lysis.  
 
Fig. 5. Time distributions of endosome lysis events after PPIX-activation in 3T3 (A and 
B) and Renca-LacZ (C and D) cells. PPIX-functionalized DOPC@CMS and 
DOPE@CMS were incubated overnight, then activated for either one or two minutes. 
Results generally show marginally earlier lysis times for DOPE@CMS. It is interesting to 
note that lysis appears to be more concentrated towards earlier times for 3T3 cells than for 
RencaLacZ; furthermore, the shift in the lysis times when activation is shorter is less 
prominent in 3T3. 
Table 1. Selected gauss fit parameters of endosomal escape data for DOPC@CMS and 
DOPE@CMS NPs in 3T3 and Renca-LacZ cultures 
Sample Activation Time (min) Mean Width 
DOPC@CMS, 3T3  2 17.4 + 0.9 17.0 + 1.5 
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DOPC@CMS, 3T3  1 23.7  + 1.8 17.2 + 2.9 
DOPE@CMS, 3T3  2 5.3 + 0.3 5.2 + 0.4 
DOPE@CMS, 3T3 1 15.4 + 1.6 24.0 + 2.7 
DOPC@CMS, Renca-
LacZ 
2 25.9 +7.3 39.3 + 15.6 
DOPC@CMS, Renca-
LacZ  
1 77.6 + 1.9 13.6 + 3.0 
DOPE@CMS, Renca-
LacZ 
2 31.1 + 5.3 28.0 + 10.1 
DOPE@CMS, Renca-
LacZ 
1 49.8 + 5.0 35.0 + 15.2 
 
In order to check if there were cell-specific differences that may have influenced the lysis 
events, we analyzed the size distribution of endosomes, demarcated by the AlexaFluor 
Dextran 488. We also obtained the red channel intensity within the area occupied by the 
endosome as a rough approximation of the endosome load. Although the colocalization 
intensity distribution appears to have a similar range (Fig. 6B), the disparities in the 
endosome area are relatively marked (Fig. 6A), with Renca-LacZ cells displaying more size 
variation, and tending towards larger endosomes. When a correlation is made between 
individual endosomes and corresponding mean gray values (Fig. 6C), it becomes evident that 
3T3 cells have a higher NP load per endosome on average.  
A possible reason for this is the higher expression and/or a longer lifetime of Rab5 in Renca-
LacZ, a protein that controls endosome fusion, and consequently endosome size distribution 
[66]. Expression profiles of 3T3 cells and differentiated counterparts show an increase in 
Rab5 expression in differentiated cells (Guo et al. 2000); Rab5 has also been reported to be 
overexpressed in several carcinoma cell lines, including lung adenocarcinoma [67] and HeLa 
[68]. One way of clarifying the results would be to use a Rab5 tag to have an approximation 
of both its expression and lifetime in the cell types tested. 
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Fig. 6. Endosome size and colocalization intensity data for 3T3 and RencaLacZ cells. 
Endosomes are largen and exhibit higher size variation in RencaLacZ cells than in 3T3 cells 
(A), as well as a lower CMS reporter load (B, C). The variation in endosome size may be a 
result of differences in Rab5 expression. 
Cell-type dependence of NP uptake 
Another interesting observation was that Renca-LacZ cells generally took up a smaller 
amount of CMS particles than 3T3 (Fig. 7). To confirm this, we conducted time-course 
uptake experiments using 3T3 and Renca cells, as well as two additional cell lines. From 
these experiments, we gathered information for between 500 and 1000 cells for each time 
point and each cell line. We ran a parallel experiment using 30 nm fluorescently-labeled 
Latex NPs as a form of control. Our results confirm that 3T3 cells take up more 
DOPC@CMS than Renca-LacZ on average (Fig. 8, Table 2). Additionally, the cell-to-cell 
uptake variation in Renca-LacZ cells appears to be at least twice of what could be expected 
from Renca-LacZ. Table 2 summarizes selected parameters from Gaussian fits of the uptake 
data eight hours post-incubation. The cell-specific uptake features can also be observed with 
Latex NPs, with Renca-LacZ cells being able to take up the highest amount, followed by 3T3 
and Huh7.  
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Fig. 7. Uptake in 3T3 cells (A) appears to be higher than in Renca-LacZ (B) after 12 hours of 
incubation with DOPC@CMS NPs. Note that individual cells of the same type appear to take 
up a widely variable numbers of NPs. NPs (red) were incubated together with Alexa-Fluor 
Dextran 488 (green). NPs inside endosomes appear as yellow spots. Images are taken at 40x. 
 
Fig. 8. Cell type differences in reporter system uptake. Uptake of DOPC@CMS NPs (A) in 
3T3, Renca-LacZ, Huh7 and Beas2B cells. The numbers of NPs taken up were approximated 
using the mean fluorescence intensity across a cell. A parallel experiment was performed 
using commercially available 30 nm latex nanoparticles (B) for 3T3, Renca-LacZ and Huh7 
cells. 
Table 2. Selected Gauss fit parameters of cell-type specific NP uptake profiles at eight hours 
post-incubation 
Sample Mean Width 
DOPC@CMS, 3T3  675.7 + 0.3 17.2 + 0.2 
DOPC@CMS, Renca-LacZ 644.5 + 1.7 41.7 + 2.4 
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DOPC@CMS, Huh7 673.9 + 1.2 20.9 + 1.1 
DOPC@CMS, Beas2B 726.9 + 9.4 132.5 + 14.3 
Latex, 3T3 1314.1 + 29.9 227.8 + 43.3 
Latex, Renca-LacZ 1603.54 + 19.3 1065.7 + 31.6 
Latex, Huh7 613.4 + 69.4 1314.5 + 102.0 
 
It is not the first time that cell type uptake dependence for non-functionalized NPs was 
reported. Non-functionalized silver NPs, for instance, are taken up better by peripheral 
monocytes, but not by T-cell populations [69]. A recent paper also indicates that apart from 
uptake differences resulting from cell surface properties, there are also cell-type specific 
cytoplasmic and nuclear pore penetration constraints [70]. Our results, together with other 
recent reports on cell-type dependent uptake specificity, indicate the need to investigate this 
phenomenon more closely, and to take results as a consideration in NP design and dosage. 
Stochastic pi calculus model of endosomal escape 
We extended the gold NP model to be able to systematically study the factors that influence 
endosomal escape. For a release-on-demand system such as PPIX, we expected a very narrow 
distribution of endosome lysis times. Considering the time window, which is two minutes 
post-PpIX activation, the spread is of course insignificant compared to non-release-on-
demand systems. However, what was striking is the disparity of the distributions in 3T3 and 
Renca cells. In order to check how much of the spread is caused by noise inherent to the 
reporter system, we added PpIX and Act_PpIX parameters to each NP, through which we can 
vary the PpIX load distribution per NP. As indicated in the methods section, we made the 
initial assumption that the NPs had a normally distributed PpIX load with a mean of 50, and a 
width of 5, which we changed in the course of the sensitivity analysis. For the first run, we 
also made the assumption that the binding and aggregation rates are the same as those used 
for gold NPs. Other parameters were also subjected to sensitivity analysis, results of which 
are summarized in Fig. 9. Interestingly, the model is most sensitive to the minimum number 
of PpIX required to burst an endosome. Although the current version of SPiM does not permit 
us to dynamically create endosomes that are assigned an unfixed size parameter (viz. taken 
from a distribution as in Fig. 6), this result is logical in that this minimum number is 
intimately linked with the NP load per endosome, as well as endosome size, which we have 
shown experimentally to be the main difference between the two cells. 
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Fig. 9. Fits of 3T3 data (A) and sensitivity analysis of the different model parameters (B) 
indicate that the minimum number of PPIX required to burst an endosome (indicated by an 
asterisk) is the most critical parameter in the model. Variations in NP batches could affect the 
results significantly as well, but our fit indicates an inter-NP variation of less than 10%. A 
more complete model that incorporates the effect of dynamically-assigned endosome size 
distribution, which is currently not possible in the existing simulator, would allow the results 
for Renca-LacZ to be fitted.  
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